Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),0.7573366481287712,2.088367122692692,0.0,0.01351165470416196,0.013,12/30,6.20%,GRIA3;CHRNB4;GRID2;GRIN2B;GRID1;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,ligand-gated channel activity (GO:0022834),0.7602872781347522,2.082322802999512,0.0,0.008203504641812619,0.015,12/29,6.20%,GRIA3;CHRNB4;GRID2;GRIN2B;GRID1;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,retinoid binding (GO:0005501),-0.6622115548461838,-1.9793602986429126,0.0,0.08393696143109347,0.071,7/22,6.77%,PTGDS;ALDH1A2;CYP26B1;RBP1;RBP4;RXRA;CRABP2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7835397135940702,1.9142634936784995,0.0016806722689075631,0.12900413181830825,0.276,9/17,6.20%,GRIA3;GRIN2B;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6544815687087359,-1.8203047685066223,0.0,0.3107792559315803,0.42,7/17,8.54%,PITPNC1;ATP10A;PITPNM2;PLTP;PITPNA;ABCA3;ATP8B1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6665818531842516,1.8200313206936336,0.0032520325203252032,0.3293465834139478,0.647,10/28,10.52%,CHRNB4;GRID2;GRID1;GABRA1;GRIK2;GRIK5;GRIK4;GRIK1;GABRG3;GABRG2
prerank,cGMP binding (GO:0030553),-0.7351745884503651,-1.818261609595505,0.006396588486140725,0.214623622899758,0.432,3/11,8.57%,PDE5A;RAPGEF2;PDE11A
prerank,amino acid:sodium symporter activity (GO:0005283),0.8060658919732582,1.8115080025590964,0.0035087719298245615,0.2883773161145424,0.687,2/11,1.38%,SLC1A3;SLC6A13
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.5967789853842156,-1.8067540565033144,0.0,0.18088946434991982,0.467,7/23,15.34%,PLCE1;PLCB1;EDNRA;BDKRB2;PLCB4;PLCG2;PLCH1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.7345116225791111,1.7742552296080762,0.013136288998357963,0.3693185619137603,0.811,2/15,0.34%,SLC1A3;SLC1A5
prerank,transmitter-gated ion channel activity (GO:0022824),0.647823856690336,1.773106957577955,0.003194888178913738,0.3213843583204238,0.814,13/29,13.82%,GRID2;GRID1;GABRA1;GRIK2;GRIK5;GRIA4;GRIK4;GRIK1;GABRG3;GLRA3;GABRG2;GLRA2;GABRB1
prerank,glutamate receptor activity (GO:0008066),0.6971717663490078,1.7710920677427848,0.003389830508474576,0.2865194635927202,0.815,12/19,18.15%,GRID2;GRID1;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIK1;GRM5;GRM7;GRM1;GRIA2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.6815296859127791,1.767059456859756,0.006535947712418301,0.2671232687941861,0.833,13/21,14.01%,POLG;POLK;POLQ;POLA1;POLL;POLE4;REV3L;POLH;POLN;POLB;POLE3;REV1;POLI
prerank,insulin-like growth factor I binding (GO:0031994),-0.6768908590626197,-1.7662957251372373,0.007281553398058253,0.2326860070051832,0.615,9/13,11.86%,IGFBP6;IGF1R;IGFBP5;ITGA6;IGFBP3;INSR;IGFBP2;ITGB4;ITGB3
prerank,ligand-gated calcium channel activity (GO:0099604),0.6972963786676263,1.7573431364577634,0.011513157894736841,0.2666621567685678,0.859,10/19,18.01%,TRPA1;ITPR1;GRIN2B;RYR2;GRIN2A;P2RX4;TRPM2;RYR3;MCOLN1;RASA3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6960820564898264,1.755247970611548,0.008375209380234505,0.2477721615880089,0.861,9/19,10.52%,GRID2;GRID1;GABRA1;GRIK2;GRIK5;GRIK4;GRIK1;GABRG3;GABRG2
prerank,signal sequence binding (GO:0005048),0.6080828810166585,1.7353758720095454,0.0029985007496251873,0.2746565524685303,0.907,6/35,5.93%,CEMIP;KDELR3;KDELR2;NUP214;KCNIP2;POM121
prerank,LRR domain binding (GO:0030275),-0.6605707954947908,-1.719496173559203,0.012165450121654502,0.3189250369987328,0.776,3/14,1.33%,PAWR;ERC1;ROBO1
prerank,phospholipid transfer activity (GO:0120014),-0.5803198404955663,-1.712999773092886,0.0026109660574412533,0.28717672880222217,0.79,9/21,15.25%,PITPNC1;PITPNM2;CERT1;PLTP;PITPNA;ABCA3;TNFAIP8L3;PRELID2;PRELID1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6818872098381036,-1.6936875405745373,0.011086474501108648,0.30241212211803775,0.845,8/12,25.65%,KDM4A;KDM4C;PHF8;HR;KDM4B;KDM3B;PHF2;KDM1A
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.7504747392225928,1.686002559463504,0.012544802867383513,0.39206070600373244,0.97,7/11,18.01%,TRPA1;ITPR1;RYR2;TRPM2;RYR3;MCOLN1;RASA3
prerank,DNA polymerase activity (GO:0034061),0.6497854489528516,1.6857331857445184,0.008361204013377926,0.36502148805376317,0.97,13/22,14.01%,POLG;POLK;POLQ;POLA1;POLL;POLE4;REV3L;POLH;POLN;POLB;POLE3;REV1;POLI
prerank,tropomyosin binding (GO:0005523),-0.6192608350384717,-1.683572764998616,0.0125,0.2938383924078645,0.872,3/16,1.10%,NEBL;TMOD3;CALD1
prerank,hyaluronic acid binding (GO:0005540),0.7656878653974963,1.676694585663726,0.012567324955116697,0.3657154539926504,0.98,1/10,0.02%,CEMIP
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7116992257432686,1.6735846360088333,0.01697792869269949,0.35172526151771605,0.984,3/14,2.38%,ADH1A;RDH10;RDH11
prerank,cadherin binding (GO:0045296),-0.3540595535327617,-1.6730789670957622,0.0,0.29176062796175023,0.895,107/315,18.20%,PHLDB2;PKP4;PTPRB;TJP1;TMOD3;PICALM;BAIAP2L1;ERC1;CALD1;PDLIM5;VCL;PTPRJ;FNBP1L;BSG;EGFR;AFDN;WASF2;ITGB1;NOTCH3;EZR;CDH1;PACSIN2;AHNAK;F11R;PROM1;ITGA6;BMPR2;CSNK1D;RDX;IQGAP1;FXYD5;KDR;EIF5;COBLL1;PLEC;NDRG1;ANLN;CDH8;HSPA8;MRTFB;S100A11;RPS2;ANXA1;APC;CTNND1;CHMP2B;GIPC1;TRIM25;CAPZB;YWHAB;NCK1;TJP2;EPN2;VAPA;LDHA;SLC3A2;CLINT1;ACVR1;RANGAP1;ZC3HAV1;EEF1G;EHD4;EPS8L2;CLIC1;PPFIBP1;VAPB;ARHGAP18;IST1;NIBAN2;TAGLN2;PTPN1;UBFD1;RPL34;PPL;GAPVD1;UBAP2;CD2AP;USO1;BAG3;PRDX1;PKM;RPL29;LIMA1;ENO1;FLNA;RAN;MACF1;PLIN3;EEF1D;BAIAP2;TES;CDH5;PSMB6;CTNNA1;RAB1A;PAK2;PKN2;EIF3E;RPL23A;EIF4H;EPHA2;CHMP4B;HNRNPK;ALDOA;DLG1;CDH4;SERBP1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6366779781281268,1.6698251659492327,0.01824212271973466,0.3417653836935084,0.986,4/21,2.74%,PDE1C;PDE9A;PDE7B;PDE4B
prerank,CXCR chemokine receptor binding (GO:0045236),0.7516404005757209,1.6691901823426507,0.024955436720142603,0.3248158896738617,0.987,2/11,1.71%,CXCL10;CXCL1
prerank,glycine binding (GO:0016594),0.7472321857821433,1.6595402631139458,0.017857142857142856,0.3321530455282521,0.992,7/11,17.62%,GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRIN3A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.6118688307453284,1.6505124347593818,0.022950819672131147,0.3410727694607741,0.995,4/23,2.74%,PDE1C;PDE9A;PDE7B;PDE4B
prerank,calcium-release channel activity (GO:0015278),0.6609898270950899,1.646968192801107,0.02329450915141431,0.33498792904298136,0.997,9/17,18.01%,TRPA1;MCOLN2;ITPR1;TPCN1;RYR2;TRPM2;RYR3;MCOLN1;RASA3
prerank,sialyltransferase activity (GO:0008373),-0.559253118092865,-1.6458925671302425,0.012987012987012988,0.33285013704435923,0.943,11/20,15.79%,ST3GAL6;ST6GAL1;ST8SIA4;ST3GAL4;ST3GAL1;ST6GALNAC2;ST6GALNAC3;ST3GAL3;ST8SIA2;ST3GAL5;ST3GAL2
prerank,chemokine activity (GO:0008009),0.5838793106143494,1.6440302063404053,0.01589825119236884,0.32805244765494523,0.997,5/31,10.57%,XCL1;CXCL10;CXCL1;CCL15;CCL25
prerank,exonuclease activity (GO:0004527),0.5457190351422693,1.6385486569147412,0.016058394160583942,0.3278884157090731,0.998,18/46,19.04%,ENPP1;POLG;FAN1;FEN1;PDE12;ENPP3;REV3L;EXOSC9;ISG20L2;EXOSC10;CNOT7;EXOSC8;EXOSC5;APEX2;DXO;WRN;REXO4;TRIR
prerank,sodium channel activity (GO:0005272),0.5609862646448704,1.6360036827199969,0.013392857142857142,0.32106265225603897,0.998,13/37,13.62%,ASIC2;GRIK2;GRIK5;GRIK4;CACNA1G;GRIK1;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,protein phosphatase 1 binding (GO:0008157),-0.5623373410534285,-1.6288991347387054,0.007594936708860759,0.3498258803947788,0.959,10/21,17.80%,SHOC2;PPP1R16A;AKAP11;PPP1R3B;SH3RF2;PPP1R16B;PHACTR4;KCNQ1;PPP1R3C;PPP1R11
prerank,1-phosphatidylinositol binding (GO:0005545),-0.5952259473157296,-1.6270589762417507,0.025943396226415096,0.3281469329560276,0.96,4/15,6.66%,PICALM;EEA1;WDFY3;SCARB1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6749149038393271,1.625395376557536,0.03754266211604096,0.3345871752027763,0.999,3/14,8.61%,SLC1A3;SLC7A11;SLC25A22
prerank,sterol binding (GO:0032934),0.5182703130961462,1.6217408326189837,0.0125,0.3302189017808373,0.999,6/56,3.45%,APOD;RORA;VDAC2;GRAMD1B;OSBPL3;OSBPL6
prerank,potassium channel activity (GO:0005267),0.4773219586575619,1.6182856487574397,0.0037641154328732747,0.326031223694871,0.999,21/89,12.40%,KCNK2;KCNS2;KCNT2;GRIK2;GRIK5;KCNQ3;KCNMA1;GRIK4;GRIK1;KCNG1;KCNH4;TMEM38B;KCNC2;TMEM175;HCN2;HCN1;KCND2;HCN3;KCNK1;KCNN2;KCNH7
prerank,platelet-derived growth factor binding (GO:0048407),0.7182537307279171,1.6170438276621348,0.03296703296703297,0.31773069658919634,0.999,3/11,6.76%,PDGFRA;COL4A1;COL1A2
prerank,anion transmembrane transporter activity (GO:0008509),-0.643319426566386,-1.613796125070058,0.024390243902439025,0.33916300238296276,0.973,4/12,5.80%,ABCG2;SLC22A6;SLC26A11;SLC39A8
prerank,outward rectifier potassium channel activity (GO:0015271),0.7105955480885756,1.612058814096493,0.01838235294117647,0.3194874018718099,0.999,4/11,10.52%,KCNK2;KCNT2;KCNIP2;KCND2
prerank,transcription coactivator binding (GO:0001223),0.6173595712633498,1.6068833975244934,0.030100334448160536,0.3208374580109696,1.0,4/20,4.13%,RORA;PGR;PPARD;TEAD2
prerank,ligand-gated cation channel activity (GO:0099094),0.4889649346285273,1.5978229179258503,0.006720430107526882,0.33218745551476525,1.0,22/75,18.56%,GRIA3;CHRNB4;GRIN2B;ASIC2;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1;ASIC1;P2RX4;TRPM2;KCNK1;KCNN2;KCNJ8;KCNJ10;MCOLN1;GRIN3A;GRIA2;KCNJ3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.4986227783017309,-1.595982825807104,0.007792207792207792,0.36365599998922693,0.985,8/27,7.97%,XPR1;SLC26A7;SLC26A2;ANO1;SLC22A6;SLC26A11;SLC39A8;SLC22A8
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4998727574717335,1.5903996089859114,0.009929078014184398,0.34023432303047113,1.0,11/60,4.82%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;EPHA6
prerank,hexosaminidase activity (GO:0015929),0.6862959531229884,1.5889201085130171,0.02586206896551724,0.33352145074948697,1.0,2/12,5.09%,CEMIP;CEMIP2
prerank,phosphatidylinositol binding (GO:0035091),-0.3905047900341963,-1.5879223684264634,0.009216589861751152,0.36410313253693477,0.988,35/91,23.50%,PITPNC1;PICALM;SNX24;PITPNM2;EEA1;MTM1;MCF2L;HIP1R;PARD3;ITPR2;MITD1;WDFY3;SCARB1;PITPNA;MAPT;TNFAIP8L3;PIGU;MYO1E;CCDC88A;GPAA1;SNX17;ESYT3;HIP1;DENND1A;PLEKHF2;BCAS3;DENND1B;NUMA1;EXOC8;FES;WDR45;PIGK;PASK;PITPNM1;EPB41
prerank,PDZ domain binding (GO:0030165),-0.4143067982107353,-1.577248341050648,0.0035587188612099642,0.37287260751891566,0.992,24/61,19.16%,CRIM1;RAPGEF2;ERC1;DOCK4;CXADR;F11R;SLC22A4;USHBP1;ATP2B1;FZD4;FZD7;ATP2B2;SNTG2;CXXC4;CRIPT;MAP2K2;PLEKHA2;FZD3;CCDC88C;KIDINS220;LLGL2;FZD8;SLC26A6;TGFBR3
prerank,chemokine receptor binding (GO:0042379),0.540996086798128,1.5575311084684091,0.03426791277258567,0.4068540900730113,1.0,5/35,10.57%,XCL1;CXCL10;CXCL1;CCL15;CCL25
prerank,leucine zipper domain binding (GO:0043522),-0.6397014585629158,-1.537790154135664,0.046875,0.4721601648996601,0.999,2/10,0.80%,PAWR;ERC1
prerank,Wnt-activated receptor activity (GO:0042813),0.6390873046777459,1.531488041561821,0.05357142857142857,0.4732663871174117,1.0,1/15,0.05%,ROR1
prerank,voltage-gated potassium channel activity (GO:0005249),0.45325274995171116,1.526000120911159,0.01837270341207349,0.4761785929669141,1.0,25/80,20.65%,KCNK2;KCNS2;KCNT2;KCNQ3;KCNMA1;KCNIP2;KCNG1;KCNH4;KCNC2;HCN2;HCN1;KCND2;HCN3;KCNE4;KCNK1;KCNN2;KCNH7;KCNJ8;KCNH8;KCNA6;KCNJ10;KCNJ3;KCNH1;KCNJ16;KCNS3
prerank,solute:proton symporter activity (GO:0015295),0.6060767064205128,1.5053573328453531,0.06478405315614617,0.5308150062349342,1.0,2/16,0.39%,SLC15A1;SLC2A13
prerank,actinin binding (GO:0042805),-0.5168590612068449,-1.4987703018257954,0.05853658536585366,0.5898514784644731,1.0,6/21,12.19%,CACNA1C;PDLIM5;NFKB1;PROM1;DAG1;CSRP2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5928019599100475,-1.4963464398384139,0.04481132075471698,0.5701338418218324,1.0,5/12,14.67%,VEGFD;VEGFC;CCDC88A;ITGB3;CDH5
prerank,glucuronosyltransferase activity (GO:0015020),-0.5198404534195575,-1.4935624515182615,0.04081632653061224,0.5526482397298578,1.0,3/19,8.23%,CSGALNACT1;EXT1;LARGE1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6271355361385919,-1.4879732087761905,0.0613107822410148,0.5470391036421149,1.0,3/10,4.03%,SLCO2A1;SLCO1C1;SLC22A6
prerank,semaphorin receptor binding (GO:0030215),-0.4935459807511193,-1.4864653761777018,0.023376623376623377,0.5285672607014703,1.0,10/23,18.21%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;PLXNB1;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4687276497526624,1.4806132082037224,0.03506311360448808,0.603935408289976,1.0,11/60,4.82%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;EPHA6
prerank,phosphatidic acid binding (GO:0070300),-0.5173440598239692,-1.4805549433834606,0.058355437665782495,0.5278377590416284,1.0,7/19,5.29%,PITPNC1;RAPGEF2;MARK1;RAPGEF6;PACSIN2;SMPD3;PLTP
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.472252882487107,-1.4804225054556637,0.049132947976878616,0.5073617445895666,1.0,11/25,24.25%,ART3;SIRT3;TNKS2;ZC3HAV1;PARP10;PARP9;PARP4;SIRT1;SIRT5;PARP1;PARP2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.586833563807512,1.4725340930102262,0.07255520504731862,0.617799376720519,1.0,4/18,17.79%,HSD11B1;HSD17B8;RDH5;HSD17B2
prerank,CCR chemokine receptor binding (GO:0048020),0.5240584179409826,1.4720636166014973,0.052884615384615384,0.6038503255018953,1.0,5/28,10.57%,XCL1;MSMP;CCL15;CNIH4;CCL25
prerank,rRNA binding (GO:0019843),-0.4245648895534462,-1.4717760890409999,0.02710843373493976,0.5152683284735432,1.0,22/42,31.19%,CAVIN1;RPS14;RPS9;DDX21;RPL5;ERI1;RPS5;RPL11;RPLP0;NGRN;MRPS7;UTP23;MRPL16;MRPS18A;RPL23;GTF3A;PTCD3;RPF2;FASTKD2;MRPL18;NOP53;MRPL11
prerank,actin binding (GO:0003779),-0.3266626940516876,-1.4698389478692415,0.0,0.5031889009936205,1.0,40/170,14.38%,SORBS1;PAWR;ABLIM1;SYNE2;MICAL2;CALD1;PDLIM5;VCL;MYRIP;ITGB1;EZR;NOS3;TPM1;PARVB;RDX;FXYD5;GSN;ANLN;PHACTR1;GIPC1;CAPZB;COBL;MAPT;EPS8L2;SSH1;DMD;CAP1;PHACTR4;COTL1;CCDC88A;DAG1;CEACAM1;SHROOM2;TMOD1;MYH10;LIMA1;TRPV4;MACF1;TLNRD1;TMSB4X
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6076202455518132,-1.4679500965733203,0.047505938242280284,0.4904544423584463,1.0,3/11,3.71%,MAP3K1;EGFR;MAP3K5
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6094417529025268,1.4652769270900132,0.06324786324786325,0.6141211839318491,1.0,6/14,18.69%,CAPN5;CAPN3;CAPN6;CAPN15;CAPN10;CAPN2
prerank,insulin-like growth factor binding (GO:0005520),-0.5428564066865764,-1.460153312414728,0.07537688442211055,0.4999213612951858,1.0,10/15,14.34%,IGFBP6;IGF1R;IGFBP5;ITGA6;IGFBP3;INSR;IGFBP2;ITGB4;ITGB3;IGF2R
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.6308437518295,1.459374045376504,0.0851063829787234,0.6203641871569054,1.0,4/12,10.17%,HDAC1;FOS;GTF2A1;TBPL1
prerank,calcium ion binding (GO:0005509),0.3794465258116119,1.457751190283792,0.004305705059203444,0.6120869359421941,1.0,68/323,14.83%,SCUBE1;ENPP1;ADGRL3;LRP1;PLSCR4;CLEC4E;S100A3;CDH6;PLA2G2C;PAM;ADGRV1;ASTN2;ITPR1;MASP1;NRXN1;FKBP9;TCHH;RYR2;LOXL2;KCNIP1;DCHS1;CEMIP2;CDH11;CAMKK2;CDH15;CDH3;CLEC3B;KCNIP2;ATP2A2;NOL3;CAPN3;RASGRP2;S100A7A;ENPP3;CALB1;MAN1C1;SYT3;AMY1A;AMY1C;AMY1B;KCNIP4;MICU3;PVALB;ITSN1;SYT7;MAN1B1;PPP3CB;RCN3;CABYR;S100A2;TRPM2;SYT5;S100A1;CDH10;HSP90B1;TESC;EML1;S100G;SPARCL1;BGLAP;RYR3;ASPH;MELK;PCLO;STIM1;HSPA5;NDUFAB1;FBN1
prerank,GDP binding (GO:0019003),-0.3737196456089029,-1.4572755353390068,0.02491103202846975,0.4932093353963746,1.0,21/63,19.30%,MRAS;KRAS;RRAS2;RASL12;RAP1A;RAB21;RAB5A;RAB5C;RAB31;MIEF1;RRAGC;RAB35;RALB;RAN;RRAS;RAP2C;RAP2B;RERG;DYNC1LI1;RAB4A;RAB8B
prerank,protein tyrosine kinase activity (GO:0004713),0.42130022969133424,1.45103640157378,0.02423469387755102,0.6223476930538755,1.0,21/108,11.12%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;PEAK1;TXK;ERBB4;EPHB1;FGFR1;JAK1;EPHA6;CAMKK2;PTK2;EPHB6;AXL;FGR;EPHA3;FYN
prerank,cholesterol binding (GO:0015485),0.47766935431268776,1.4457664067569724,0.06866952789699571,0.6278415552533924,1.0,5/47,3.45%,APOD;VDAC2;GRAMD1B;OSBPL3;OSBPL6
prerank,tau protein binding (GO:0048156),-0.41138373993809496,-1.441593103821435,0.04504504504504504,0.525797029528136,1.0,15/40,25.27%,PICALM;ROCK2;MARK1;ACTB;MARK4;APOE;GSK3B;MARK3;PRKAA1;MARK2;HDAC6;TTBK1;BAG2;TAOK2;BRSK1
prerank,pentosyltransferase activity (GO:0016763),-0.431226973896264,-1.4379106348167963,0.05592105263157895,0.5214517323082766,1.0,13/36,18.85%,UPP2;ART3;SIRT3;TNKS2;ZC3HAV1;LARGE1;LACC1;PARP10;PARP9;PARP4;SIRT1;QPRT;SIRT5
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5195278391107047,-1.429850429156645,0.059895833333333336,0.5306348528369206,1.0,5/18,5.01%,TMOD3;BAIAP2L1;PDLIM5;S100A11;ANXA1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5884879185965004,-1.429753985677786,0.0735632183908046,0.515246693996973,1.0,4/11,10.34%,SGMS1;SGMS2;AASDHPPT;GNPTAB
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5383842318261944,1.4285841916918918,0.07413793103448275,0.6807650002887314,1.0,10/22,18.58%,CPEB1;RBM24;RBMS3;ELAVL4;ZFP36L2;NUDT21;DHX36;EXOSC9;EXOSC8;ILF3
prerank,death domain binding (GO:0070513),-0.5805964229744731,-1.4237095349207103,0.10772833723653395,0.5193466676901075,1.0,5/11,9.83%,BCL2L1;MCL1;CRADD;DAPL1;BAX
prerank,myosin V binding (GO:0031489),0.5833658133482319,1.4188692522309365,0.10880829015544041,0.7034479562317268,1.0,3/15,6.42%,NPC1L1;RAB8A;RAB3C
prerank,AMP binding (GO:0016208),-0.5717528102739238,-1.4187023128903375,0.0997624703087886,0.5192640293314552,1.0,5/11,20.07%,PRKAG2;MPPED2;PRKAG3;PFKL;APRT
prerank,frizzled binding (GO:0005109),-0.4289905183288942,-1.418407414128814,0.060941828254847646,0.5061200633674384,1.0,13/34,18.77%,WNT5B;WNT9A;RNF43;WNT4;DVL1;FZD7;LRP6;WNT6;SFRP1;CCDC88C;WNT16;SDCBP;WNT11
prerank,histone demethylase activity (GO:0032452),-0.45531774522750657,-1.4171921651838626,0.06914893617021277,0.49657576116463037,1.0,12/27,25.65%,KDM4A;KDM4C;RIOX2;PHF8;FBXL19;JARID2;HR;KDM4B;KDM3B;PHF2;KDM2B;KDM1A
prerank,FAD binding (GO:0071949),-0.4658423609387499,-1.417098976225205,0.061452513966480445,0.4840609966594187,1.0,10/24,17.98%,DDO;MICAL2;PRODH;CYB5R3;NQO2;MTHFR;CYB5R1;MICAL3;AIFM1;NDOR1
prerank,cytokine activity (GO:0005125),0.4012409615550211,1.4150779579690973,0.030379746835443037,0.7033298832612876,1.0,10/131,5.34%,IL33;IL34;XCL1;CXCL10;NRG1;WNT5A;CXCL1;IL16;TSLP;CCL15
prerank,phospholipase inhibitor activity (GO:0004859),-0.5840554543541924,-1.4117903685173043,0.10722100656455143,0.4860375064133381,1.0,6/10,37.01%,ANXA5;ANXA1;ANXA4;ANXA9;APOC1;SNCB
prerank,copper ion binding (GO:0005507),0.476730718264605,1.4092855899991426,0.07515337423312883,0.7112921083548117,1.0,11/42,14.03%,PAM;TYR;LOXL3;LOXL2;CCS;ACR;COMMD1;TP53;P2RX4;HEPH;ATP7A
prerank,tau-protein kinase activity (GO:0050321),-0.4848410408738657,-1.4055830961544944,0.07838479809976247,0.4918306857056879,1.0,13/20,29.29%,ROCK2;MARK1;MARK4;SIK3;GSK3B;MARK3;PRKAA1;MARK2;TTBK1;TAOK2;BRSK1;PHKG2;TTBK2
prerank,ion channel activity (GO:0005216),0.42674183796106596,1.4010260207486498,0.058981233243967826,0.7296293540247458,1.0,15/80,6.86%,GRIA3;NALCN;CHRNB4;GRID2;GRIN2B;GRID1;GRIK2;GRIK5;GRIA4;GRIA1;GRIK4;GRIN2A;TRPV3;GRIK1;TMC3
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5233422505186159,-1.4009608098635213,0.07838479809976247,0.49309802658676133,1.0,7/15,22.27%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8;SLC26A6;CFTR
prerank,GTPase inhibitor activity (GO:0005095),-0.5488613611260656,-1.3988708045353568,0.0951276102088167,0.48738786112108295,1.0,7/13,21.30%,SLIT2;IQGAP1;CPEB2;ARL2;GPS1;RHOH;IQGAP2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.590177338047111,-1.3895156023982118,0.09803921568627451,0.5004825841832116,1.0,6/10,22.73%,KDM4A;KDM4C;RIOX2;PHF8;KDM4B;KDM2B
prerank,triglyceride lipase activity (GO:0004806),0.5386061536623546,1.3841463057746037,0.10277324632952692,0.7822377574947321,1.0,3/20,5.09%,CEL;LIPC;LIPH
prerank,chloride channel inhibitor activity (GO:0019869),-0.5727698275136952,-1.382601254604488,0.11711711711711711,0.5095008975306797,1.0,4/10,9.43%,WNK4;WNK1;STX1A;STX7
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.48064843548593794,1.3819143965714398,0.09576138147566719,0.7757694276436286,1.0,13/34,14.84%,OGT;GAB2;MYO10;GBF1;MYO1B;FCHSD2;ADAP2;CYTH3;COMMD1;ARAP2;MYO1G;DAPP1;FERMT2
prerank,guanyl ribonucleotide binding (GO:0032561),-0.3037505937934194,-1.3793202162769391,0.007518796992481203,0.507594569182639,1.0,65/196,21.92%,PDE5A;RAPGEF2;RHOBTB1;MRAS;KRAS;MPPED2;RRAS2;GBP7;RASL12;RAP1A;INSR;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ARL6;RAB21;ADSS2;GBP4;RAB5A;RHOC;RAB5C;GBP2;GCH1;RAB31;PDE11A;MIEF1;DRG2;EEF1A1;RRAGC;RAB13;ARL2;RAB35;REM1;GBP6;RALB;TGM2;RAN;RAB38;RRAS;GNL1;RAP2C;ATL3;NOA1;ARL1;TUBB2A;RAB6A;RAP2B;TSR1;RERG;DYNC1LI1;RAB4A;RAB8B;RRAGB;MFHAS1;ARL4C;TUBA1C;RAB1B;SCG5;RHOH;TUBA4A;TUBB2B;MTG2
prerank,transcription corepressor binding (GO:0001222),0.4948750270284801,1.375262273141506,0.09075907590759076,0.7894120526686322,1.0,5/27,9.49%,RORA;PER3;ZBTB16;PER2;WIZ
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5270114874592723,1.3712469852198237,0.11245674740484429,0.7912718104727018,1.0,7/20,15.02%,CASK;MAGI3;DLG2;AK1;AK4;AK8;AK3
prerank,nucleotide diphosphatase activity (GO:0004551),0.5700517997178608,1.3681820030661476,0.13556338028169015,0.7886243970317491,1.0,3/14,10.38%,ENPP1;FHIT;NUDT13
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3674478505531137,-1.3572725469738087,0.060498220640569395,0.5590748702268712,1.0,17/55,16.26%,SLC13A3;SLC16A2;SLC6A6;SLC38A11;SLC25A32;SLC22A4;SLC16A6;SLC16A11;SLC7A1;SLC16A1;SLC16A4;SLC38A5;SLC38A10;SLC7A5;SLC16A9;SLC36A4;PDPN
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5920512175723442,1.3544859164753797,0.15344827586206897,0.832207630554302,1.0,3/12,5.41%,PIK3R1;GAB2;IRS1
prerank,hydro-lyase activity (GO:0016836),-0.388957394846833,-1.352281456913087,0.0764525993883792,0.5621474347320807,1.0,18/41,27.89%,HACD4;HACD1;CA4;ACO1;ECHDC1;L3HYPDH;ACO2;ENO1;PCBD2;HADHA;CDYL;AUH;CBS;FAHD2A;CYP2S1;ALAD;PARK7;HACD2
prerank,nuclear export signal receptor activity (GO:0005049),0.6004438324777889,1.3508447485052353,0.13451327433628318,0.8331171153679011,1.0,6/11,19.94%,CSE1L;NUP214;NUP42;EIF4ENIF1;XPO6;XPO1
prerank,voltage-gated cation channel activity (GO:0022843),0.3961041505602888,1.3473999898561082,0.06297229219143577,0.8338454789165765,1.0,25/97,17.62%,KCNS2;CACNA1E;ITGAV;GRIN2B;CACNG3;KCNQ3;KCNMA1;GRIN2A;KCNG1;CATSPER3;KCNH4;KCNC2;CACNB4;HCN2;HCN1;CACNG4;KCND2;HCN3;KCNK1;KCNH7;KCNH8;CACNA2D1;NCS1;KCNA6;GRIN3A
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5490262001614343,-1.3460962762337279,0.15207373271889402,0.5678267137680302,1.0,3/10,4.65%,B4GALT1;B3GALT1;B4GALT5
prerank,"DNA binding, bending (GO:0008301)",-0.5150787880269723,-1.34501399540237,0.1308641975308642,0.5595514097224187,1.0,6/14,17.69%,LEF1;FOXC1;FOXD1;FOXL1;HHEX;HMGB2
prerank,transforming growth factor beta binding (GO:0050431),-0.43775230571111257,-1.3448627679923069,0.1164021164021164,0.5491631430438383,1.0,13/23,24.22%,LTBP4;THBS1;CD109;ACVR1;ACVRL1;LRRC32;TWSG1;TGFBR3;VASN;TGFBR2;NRROS;TSKU;HYAL2
prerank,ADP binding (GO:0043531),-0.4309762012462646,-1.342010115202919,0.08734939759036145,0.5463462540667012,1.0,11/25,23.79%,PRKAG2;GCLC;PGK1;MIEF1;ME1;MYH10;ERN1;ATP5F1D;MYO18A;MYH9;COQ8A
prerank,protein tyrosine kinase binding (GO:1990782),-0.3443311607097353,-1.340375657680906,0.03065134099616858,0.5406286066094409,1.0,23/71,14.89%,EPHA4;DOCK4;PITPNM2;ITGB1;BMPR2;SIRPA;SQSTM1;PTPN14;GRB14;NEDD9;NCK1;TJP2;ACVR1;PTPN2;PTPN1;RNF41;CEACAM1;PCNA;NOX4;CPNE3;ELMO2;CDH5;TOB1
prerank,voltage-gated sodium channel activity (GO:0005248),0.50551218632204,1.3388493267482193,0.14375,0.8555690992636599,1.0,10/22,21.36%,SCN2B;CACNA1G;HCN2;HCN1;HCN3;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.37201948099414284,-1.338840394106214,0.04075235109717868,0.5346111530811629,1.0,4/48,1.22%,TRPM3;TRPM6;SLC12A7;PIEZO2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.5983649026336822,1.3387485458895967,0.15858208955223882,0.8417439174628517,1.0,1/10,1.38%,SLC6A13
prerank,neuropeptide hormone activity (GO:0005184),0.5182940822160843,1.3339642173547888,0.1472,0.847452881638205,1.0,3/22,8.91%,HCRT;SPX;NPY
prerank,MAP kinase activity (GO:0004707),-0.5058036401918855,-1.3320030071889646,0.1258741258741259,0.5437260567179647,1.0,3/14,6.48%,MAPK4;MAPK9;MAPK14
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.565726209434869,1.330962624562853,0.14411247803163443,0.8457704320751518,1.0,7/13,15.71%,GABRA1;GABRG3;GLRA3;GABRG2;GLRA1;GLRA2;GLRB
prerank,gated channel activity (GO:0022836),-0.4950152513739493,-1.3299180998195697,0.1291866028708134,0.5400690793707225,1.0,7/14,21.46%,PIEZO2;TMC7;TMC6;TMEM266;PACC1;TMEM63B;PIEZO1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5851470379870503,1.3291686283851156,0.13957597173144876,0.8392545252979692,1.0,2/12,9.45%,GPR88;GPR52
prerank,mRNA methyltransferase activity (GO:0008174),-0.5203266493140295,-1.3253872568723601,0.16009852216748768,0.5441083509157492,1.0,3/12,8.67%,NSUN2;TRMT61B;CMTR1
prerank,phospholipase binding (GO:0043274),0.579905781156962,1.3230679931422435,0.14113597246127366,0.8509326469268427,1.0,4/13,11.12%,ARHGAP6;PDPK1;DGKQ;FYN
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.5316901330437203,-1.320851539923909,0.13734939759036144,0.5471656702281387,1.0,6/11,24.61%,NUDT3;NUDT4;NUDT7;DCPS;NUDT16;NUDT16L1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4652137858024823,-1.3183556396357445,0.12303664921465969,0.5447708689663181,1.0,8/18,22.99%,LTBP4;BMPR2;ACVR1;ACVRL1;ACVR2B;TGFBR3;TGFBR2;ACVR2A
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5647928991092698,-1.3151112117740245,0.15086206896551724,0.5445985889982803,1.0,6/10,19.62%,SHANK3;GNAS;SQSTM1;SHANK1;SHISA7;IGSF11
prerank,ligand-gated anion channel activity (GO:0099095),0.520526273333665,1.3112569005965766,0.152428810720268,0.8872999708417744,1.0,8/17,15.71%,GABRA1;GABRG3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;GLRB
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5039323572575612,1.3110767777239365,0.15110356536502548,0.8745579360301021,1.0,3/21,10.65%,CHRNB4;GRIA1;GRM5
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.3040103890957422,-1.3109054010684815,0.03508771929824561,0.5474104220494721,1.0,44/147,14.85%,PLCE1;DOCK5;RAPGEF2;RAPGEF5;ARHGEF18;DOCK4;DENND4A;FGD5;FNIP1;DOCK1;RAPGEF6;ARHGEF28;CYTH1;RASGRF1;RAP1A;RIN3;DENND3;RAPGEF1;NUCB1;ARHGEF15;LAMTOR5;EPS8L2;NGEF;MADD;SPATA13;GAPVD1;RGL2;RAB3IP;CCDC88A;DENND2C;DENND5B;ALS2;EIF2B4;HERC2;DENND6A;LAMTOR3;CCDC88C;BCR;EEF1D;DENND1A;DENND4C;ARHGEF11;RAPGEF3;MON1A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4155500252338534,-1.3080450734893134,0.11081081081081082,0.5463100027484339,1.0,8/26,9.96%,ABCG2;SLC16A2;SLC6A6;SLC16A6;SLC16A11;SLC16A1;SLC16A4;MPC1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3829484923318318,-1.3075126906755343,0.09032258064516129,0.5391731277781914,1.0,9/42,5.01%,TMOD3;CD200;BAIAP2L1;PDLIM5;BSG;ESAM;SIRPA;S100A11;ANXA1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5247720055274013,-1.307431854220428,0.175,0.5309975694963459,1.0,6/11,18.60%,ATP10A;ATP8A1;ABCA3;ATP8B1;ABCB4;ATP8A2
prerank,ferrous iron binding (GO:0008198),0.4971641288621989,1.3040002365436143,0.16139240506329114,0.8912362347560817,1.0,7/21,13.45%,HIF1AN;DNAJC24;EGLN2;FXN;HEPH;FTO;ALKBH3
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.4953344822853566,-1.3020729004340115,0.15704387990762125,0.5359869455356485,1.0,5/13,11.40%,EIF5;SH3BP4;ARHGDIB;ITGB1BP1;CCDC88A
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.508453128517493,-1.3018782648268823,0.15587529976019185,0.5283649810375757,1.0,6/12,21.19%,LTBP4;BMPR2;ACVR1;ACVRL1;TGFBR3;TGFBR2
prerank,kinase activator activity (GO:0019209),-0.39970173253274327,-1.3009111993776081,0.13372093023255813,0.5233175377340044,1.0,13/30,24.20%,PRKAG2;RPLP1;GPRC5C;WNK1;MADD;CAB39;WNT11;MARK2;RGCC;MOB1B;DUSP19;BCL10;MT3
prerank,lipase activator activity (GO:0060229),0.592852381630462,1.2999430022968994,0.14788732394366197,0.8954593682720446,1.0,3/10,11.12%,ARHGAP6;PDPK1;FYN
prerank,BMP binding (GO:0036122),-0.5320691290251411,-1.2989373228911334,0.18439716312056736,0.520543535010588,1.0,2/11,2.75%,NBL1;BMPR2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.45421402643231334,1.2970447517411263,0.14683153013910355,0.8939791912648112,1.0,8/35,7.72%,ENPP1;PLCL1;GPLD1;PLCXD3;SMPD4;PLCXD1;ENPP3;ENPP6
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4135957463381459,-1.2964956417487412,0.12631578947368421,0.5193589864516457,1.0,9/27,12.90%,SLC9B2;ITPR2;ATP2B1;SLC41A1;MRS2;CNNM2;CNNM4;SLC4A8;ATP2A3
prerank,cytokine receptor activity (GO:0004896),0.3862649239270285,1.2955617091711253,0.0912751677852349,0.887329666786179,1.0,10/83,9.53%,GHR;IL15RA;IL2RA;IL1R2;IL18RAP;CCR9;ACKR2;IL17RD;IFNLR1;IL1RAP
prerank,cAMP binding (GO:0030552),0.5801579520837795,1.2953572411117564,0.16226415094339622,0.8756476586848141,1.0,5/11,14.27%,RAPGEF4;PDE4B;CNBD2;HCN1;PDE4A
prerank,phospholipase activator activity (GO:0016004),0.5837161492905438,1.2916100148829253,0.1634446397188049,0.879008203254092,1.0,3/10,11.12%,ARHGAP6;PDPK1;FYN
prerank,serotonin receptor activity (GO:0099589),0.4885482339905391,1.2881643283166127,0.1735668789808917,0.8574882122538441,1.0,7/22,20.18%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.4885482339905391,1.2881643283166127,0.1735668789808917,0.8574882122538441,1.0,7/22,20.18%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.4885482339905391,1.2881643283166127,0.1735668789808917,0.8574882122538441,1.0,7/22,20.18%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,phosphatidate phosphatase activity (GO:0008195),0.5350493612614717,1.2859886220719903,0.1854419410745234,0.8552090094471684,1.0,5/13,15.44%,LPIN3;PLPPR3;PLPPR2;PLPP5;LPIN2
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5772627763528215,1.2849714128774594,0.198943661971831,0.8481759497501298,1.0,3/10,3.37%,DPP6;FAP;DPP10
prerank,MAP kinase phosphatase activity (GO:0033549),0.5569847481060988,1.2827952362119894,0.1786339754816112,0.8459632162303601,1.0,5/12,22.62%,DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.5489179986992524,-1.2816204305165086,0.19753086419753085,0.5506902165789336,1.0,3/10,3.33%,CD200;CXADR;SIRPA
prerank,sequence-specific mRNA binding (GO:1990825),0.584545840716304,1.2811665927441254,0.1956521739130435,0.8415830644306591,1.0,7/10,25.54%,RBM24;FMR1;LARP6;DHX9;SSB;ETF1;SHFL
prerank,peptidoglycan binding (GO:0042834),-0.5348871033427517,-1.2798193986740436,0.17155756207674944,0.5474383888522485,1.0,7/10,39.86%,HK1;PGLYRP1;RNASE7;NOD2;JCHAIN;NLRP3;TLR2
prerank,peptidase activator activity (GO:0016504),-0.4278629292581159,-1.279050620659385,0.15748031496062992,0.541812495763718,1.0,9/22,13.34%,CAV1;CASP8AP2;PCOLCE2;VCP;MAL;APH1A;CLPX;APH1B;PSME3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4827222825342652,-1.2718174280995889,0.1527777777777778,0.5518997122430439,1.0,3/14,4.04%,SLC26A7;SLC26A2;SLC26A11
prerank,nuclease activity (GO:0004518),0.4153309866426133,1.2698076183467375,0.14285714285714285,0.8752777533491631,1.0,13/52,20.20%,ENPP1;ANKLE1;FEN1;ERCC5;PDE12;DIS3L2;NME1;RNASEH1;ISG20L2;RNASE12;WRN;REXO4;DDX1
prerank,DNA polymerase binding (GO:0070182),0.5028757395548965,1.2692882563474077,0.19170984455958548,0.8667476276892043,1.0,2/18,2.23%,FANCI;NAT10
prerank,adenylate cyclase binding (GO:0008179),0.5824288187038635,1.2676778450062538,0.2062043795620438,0.862533191062548,1.0,4/10,13.23%,ADCY5;AKAP5;ADCY2;AKAP6
prerank,general transcription initiation factor binding (GO:0140296),0.47551369983635333,1.266661060770654,0.1763779527559055,0.8563040238587737,1.0,10/25,22.14%,TAF12;THRA;GTF2A1;TAF1B;PSMC5;AR;THAP7;TAF11;GTF2B;GTF2A2
prerank,anion:anion antiporter activity (GO:0015301),-0.46176512009777115,-1.2663982935523947,0.18181818181818182,0.5586273278138135,1.0,8/17,26.68%,SLC26A7;SLC26A2;SLC26A11;SLC4A3;SLC25A5;SLC26A6;SLC25A4;SLC25A11
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4861312296822451,-1.2663176954140969,0.1884422110552764,0.5514056286552661,1.0,7/14,22.94%,CASP8AP2;MAL;BAD;CTSH;ATP2A3;BCL2L13;APAF1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4591170695079384,-1.266022418008204,0.1761904761904762,0.5448353199354723,1.0,7/15,14.14%,HS3ST3A1;HS3ST4;HS3ST1;NDST1;NDST3;HS3ST2;HS3ST3B1
prerank,transcription coregulator binding (GO:0001221),0.40551378603063687,1.262531798923424,0.1286549707602339,0.8618620359892016,1.0,8/50,9.49%,RORA;PER3;PGR;PPARD;TEAD2;ZBTB16;PER2;WIZ
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5485500785997968,1.2619943720754285,0.19444444444444445,0.8535278213624057,1.0,6/12,16.72%,SDHB;CISD3;FXN;CISD2;AOX1;ISCA1
prerank,ribonuclease P activity (GO:0004526),0.5615711622900381,1.2617101639237862,0.20320855614973263,0.8448038658426978,1.0,4/11,9.77%,RPP40;POP5;PRORP;POP7
prerank,retinoic acid receptor binding (GO:0042974),0.49923136070108437,1.260437324946746,0.19793459552495696,0.8394087751679205,1.0,8/17,15.19%,NSD1;SNW1;CNOT1;NRIP1;MED1;MED25;ASXL1;PRMT2
prerank,phospholipase C activity (GO:0004629),-0.40235394865220125,-1.2600091958043051,0.1349206349206349,0.5525792466660479,1.0,7/25,15.34%,PLCE1;PLCB1;EDNRA;BDKRB2;PLCB4;PLCG2;PLCH1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5618300102207021,1.2586454398810676,0.22202486678507993,0.8271496676319116,1.0,5/10,22.62%,DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5618300102207021,1.2586454398810676,0.22202486678507993,0.8271496676319116,1.0,5/10,22.62%,DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,metalloendopeptidase activity (GO:0004222),0.3880527874389652,1.257792365491539,0.12234042553191489,0.8209509821681135,1.0,15/76,10.24%,ECE1;ECE2;ADAMTS14;ADAMTS6;MBTPS2;MMP28;MMP24;MMP25;ADAM19;OMA1;ADAMTS12;MMP11;ADAMTS2;NRDC;PITRM1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5424484549278734,1.257622426777257,0.21415929203539824,0.8124598275251421,1.0,1/11,0.86%,ROR2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5558365900956483,1.256780063876225,0.20950704225352113,0.8068912615528149,1.0,1/11,2.20%,CHRNB4
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.40284351101050153,1.2557810063284325,0.1722689075630252,0.8021273722761095,1.0,7/53,8.61%,SLC1A3;SLC1A5;SLC7A11;SLC43A1;SLC7A8;SLC66A1;SLC25A22
prerank,GTP binding (GO:0005525),-0.2780521291236815,-1.2549375784521102,0.03896103896103896,0.5585989799361054,1.0,63/172,24.20%,RHOBTB1;MRAS;KRAS;RRAS2;GBP7;RASL12;RAP1A;INSR;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ARL6;RAB21;ADSS2;GBP4;RAB5A;RHOC;GBP2;GCH1;RAB31;DRG2;EEF1A1;RRAGC;RAB13;ARL2;RAB35;REM1;GBP6;RALB;TGM2;RAN;RAB38;RRAS;GNL1;RAP2C;ATL3;NOA1;ARL1;TUBB2A;RAB6A;RAP2B;TSR1;RERG;DYNC1LI1;RAB4A;RRAGB;MFHAS1;ARL4C;TUBA1C;RAB1B;SCG5;RHOH;TUBA4A;TUBB2B;MTG2;LANCL2;RAB9A;RAP1B;NUDT16;RHOU
prerank,GTPase activator activity (GO:0005096),-0.2622167939780859,-1.250934598550166,0.02127659574468085,0.5615478209633786,1.0,93/313,16.17%,RANBP3L;PLCE1;DOCK5;TBC1D4;PLCB1;RAPGEF2;RAPGEF5;ARHGEF18;DOCK4;DENND4A;FGD5;CHN2;RGS3;SIPA1L1;FNIP1;RGS6;DOCK1;RAPGEF6;ARHGEF28;RGS5;NRP1;CYTH1;SIPA1L2;RASGRF1;IQGAP1;TBC1D8;RAP1A;RIN3;RAP1GAP2;ARHGAP10;DENND3;ARHGAP42;TBC1D22B;ARHGAP17;ARAP3;RASGRP3;SRGAP2;RAPGEF1;ERRFI1;BNIP2;NUCB1;ARFGAP2;ARHGEF15;RANGAP1;RUNDC1;RALBP1;LAMTOR5;EPS8L2;ELMOD3;NGEF;MADD;ARHGAP18;SGSM2;ELMOD2;SPATA13;GAPVD1;RGL2;RAB3IP;GMIP;GRTP1;CCDC88A;DENND2C;ARHGAP27;PGAM5;RP2;ARHGAP28;DENND5B;TBC1D7;ALS2;EIF2B4;HERC2;EVI5L;DENND6A;TBC1D22A;LAMTOR3;CCDC88C;BCR;TBC1D10B;EEF1D;DENND1A;ARHGAP15;DENND4C;ASAP2;ARHGEF11;RAPGEF3;MON1A;TBCK;RAP1GDS1;TBC1D13;RGS10;SBF1;ARHGAP44;LLGL2
prerank,chloride channel regulator activity (GO:0017081),-0.4689288292782212,-1.249622396683784,0.18937644341801385,0.55786204556197,1.0,4/14,9.43%,WNK4;WNK1;STX1A;STX7
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.495601352507831,-1.2495292602070098,0.21226415094339623,0.5512503210097989,1.0,7/12,28.57%,CASP8AP2;BAD;CTSH;ATP2A3;BCL2L13;APAF1;CASP1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5268686218337593,-1.2476922108093227,0.21800947867298578,0.5492830609735898,1.0,3/10,9.46%,MECOM;ASH1L;PRDM16
prerank,histone methyltransferase binding (GO:1990226),-0.49785382812495665,-1.2437353706604901,0.2199074074074074,0.5523428415172826,1.0,5/11,22.24%,LCOR;CBX3;CBX1;LCORL;PHF1
prerank,phosphatidylglycerol binding (GO:1901611),-0.4788259615808427,-1.2433759957286534,0.18203309692671396,0.54667803994151,1.0,3/13,6.69%,PITPNC1;PLTP;PITPNA
prerank,low-density lipoprotein particle binding (GO:0030169),0.4994401717530732,1.2432672547119532,0.22131147540983606,0.8398889739852287,1.0,3/16,5.25%,COLEC12;LIPC;SORL1
prerank,titin binding (GO:0031432),-0.4800593872172916,-1.2429901390998654,0.22588235294117648,0.5409715289374332,1.0,4/13,13.14%,ACTN2;CAMK2D;CALM1;TRIM63
prerank,death receptor activity (GO:0005035),0.5320050426531352,1.2429468335145863,0.22568807339449543,0.832328088915252,1.0,3/11,7.98%,EDA2R;NGFR;TNFRSF19
prerank,dynactin binding (GO:0034452),-0.49766494525460103,-1.2394012795958649,0.20297029702970298,0.5433540717897396,1.0,6/12,26.57%,GSK3B;MAPT;SNX6;BICD2;BICDL1;BICD1
prerank,N-acetyltransferase activity (GO:0008080),0.4876604858714502,1.2382667167050088,0.225752508361204,0.8403465067456801,1.0,4/19,10.37%,NAA10;NAT10;NAA50;NAT8L
prerank,solute:anion antiporter activity (GO:0140323),-0.47670150308581843,-1.2377169795500353,0.20930232558139536,0.5414318708113048,1.0,4/14,6.46%,SLC26A7;SLC26A2;SLC26A11;SLC4A3
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5409951100844455,1.2339935566333415,0.22181818181818183,0.8474135722779633,1.0,2/12,2.74%,PDE7B;PDE4B
prerank,GABA-A receptor activity (GO:0004890),0.48913811984489497,1.232972176202525,0.20333333333333334,0.8427156010858914,1.0,5/18,13.82%,GABRA1;GABRD;GABRG3;GABRG2;GABRB1
prerank,pyridoxal phosphate binding (GO:0030170),0.47584104448454007,1.2325863789848543,0.19838709677419356,0.8354706492073478,1.0,4/20,6.15%,THNSL2;GLDC;PDXK;ABAT
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.43838152499510896,1.231756391771215,0.2111111111111111,0.8301174602959847,1.0,8/30,17.97%,SLC25A37;SLC30A10;SLC30A5;SLC39A7;SLC30A3;ATP7A;SLC39A13;SLC39A14
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5073940684097163,1.2307616708016218,0.19204152249134948,0.8251473882700096,1.0,2/15,3.26%,CCR9;ACKR2
prerank,gamma-tubulin binding (GO:0043015),-0.4144876351113553,-1.2306980229185973,0.1691919191919192,0.5525568239203097,1.0,10/21,25.27%,MARK4;NDRG1;OFD1;TUBGCP5;GIT1;RAD51D;CDK5RAP2;DIXDC1;RAB11FIP5;BRSK1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4667501501033265,1.2274455609151391,0.2297734627831715,0.829263614553335,1.0,4/21,15.71%,CHRNB4;GRIK2;P2RX4;GLRB
prerank,single-stranded DNA helicase activity (GO:0017116),0.47553592815272866,1.2253025536990667,0.2235494880546075,0.8289053468060191,1.0,7/19,21.66%,MCM7;POLQ;PIF1;RFC3;DHX9;HELQ;RFC4
prerank,phosphatase inhibitor activity (GO:0019212),0.48001737953248536,1.2208849416844174,0.2224,0.8369337931347902,1.0,2/20,4.56%,PTN;BOD1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.3819161637533304,-1.2192417319507114,0.1891891891891892,0.5750833887154935,1.0,8/27,16.43%,SLC9A2;SLC8A3;SLC9B2;SLC3A2;SLC41A1;CNNM4;SLC4A8;SLC9A5
prerank,miRNA binding (GO:0035198),0.4355964017270425,1.2159917865096566,0.21375186846038863,0.8465741042295435,1.0,9/30,11.21%,AGO4;SPOUT1;FMR1;DND1;ZC3H7B;ZNF346;HNRNPA2B1;SOX2;AGO3
prerank,single-stranded DNA binding (GO:0003697),0.35910001838055694,1.2121978187407456,0.18791064388961892,0.8524816161024125,1.0,28/93,18.65%,RBMS1;ERCC1;MCM7;ERCC5;MSH3;RTF1;NEIL3;POLA1;RPA1;HMCES;ERCC4;WBP11;XPC;BRCA2;MCM4;DHX36;TOP3A;SPRTN;RAD52;LONP1;MCM10;SSBP2;DHX9;CRY2;MCMDC2;FBH1;SSBP1;REXO4
prerank,poly-purine tract binding (GO:0070717),0.4445298961870675,1.2101606476143931,0.22926829268292684,0.8520640676123923,1.0,5/27,6.65%,RBMS1;EIF4A3;RBMS3;FMR1;ELAVL4
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.4369273090074708,-1.20531094164121,0.2119815668202765,0.6036495989952325,1.0,8/15,30.24%,PLA2G4A;SH3PXD2B;JPH2;SNX3;PLA2G4E;LANCL2;RUBCNL;VEPH1
prerank,metal ion binding (GO:0046872),0.30806021231566955,1.204860579737904,0.07024793388429752,0.8637003563571148,1.0,85/477,14.56%,SCUBE1;ENPP1;ADGRL3;LRP1;PLSCR4;CLEC4E;HRG;S100A3;CDH6;PLA2G2C;PAM;ADGRV1;ASTN2;ITPR1;MASP1;PDXK;NRXN1;FKBP9;TCHH;RYR2;FAN1;FEN1;LOXL2;KCNIP1;CISD3;DCHS1;CEMIP2;CDH11;CAMKK2;CDH15;CDH3;LRRK2;CLEC3B;KCNIP2;ATP2A2;NOL3;CAPN3;CLYBL;RASGRP2;S100A7A;ENPP3;CALB1;ADCY2;CDC42BPA;PRKACB;MAN1C1;SYT3;PIF1;AMY1A;AMY1C;AMY1B;PINK1;KCNIP4;MICU3;PVALB;OPA1;ITSN1;SYT7;MAN1B1;PPP3CB;DHX36;RCN3;CABYR;S100A2;TRPM2;SYT5;S100A1;CDH10;HSP90B1;FIGNL1;YDJC;DIS3L2;TESC;EML1;S100G;SPARCL1;BGLAP;RYR3;ASPH;MELK;PCLO;NME1;STIM1;HSPA5;NDUFAB1
prerank,poly(A) binding (GO:0008143),0.467295651623245,1.2047571404502655,0.25127334465195245,0.856148380281476,1.0,4/21,6.65%,RBMS1;EIF4A3;RBMS3;ELAVL4
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5089294134148108,-1.2045886652371507,0.2331002331002331,0.5990243157911046,1.0,3/10,6.91%,SLC24A3;SLC8A3;SLC3A2
prerank,clathrin adaptor activity (GO:0035615),-0.44577447886669475,-1.2008591216992355,0.22277227722772278,0.6020178763731482,1.0,9/15,35.49%,HIP1R;DAB2;AP2A1;HIP1;AP2S1;AP2B1;AP1M1;AP1G1;AP1G2
prerank,GABA receptor activity (GO:0016917),0.4567720490937118,1.2002941006172356,0.23076923076923078,0.864666936850562,1.0,6/21,15.98%,GABRA1;GABRD;GABRG3;GABRG2;GABRB1;GABBR2
prerank,endopeptidase activator activity (GO:0061133),-0.5017854770976858,-1.1998455749926467,0.2541176470588235,0.5979665933446893,1.0,8/10,34.19%,APH1A;APH1B;PSME3;PSME2;ADRM1;VSIR;PSME1;NLRC4
prerank,R-SMAD binding (GO:0070412),-0.4316730892947379,-1.199791566062678,0.23950617283950618,0.5918426121052365,1.0,4/18,8.34%,SMAD6;DDX5;DROSHA;SMAD3
prerank,TBP-class protein binding (GO:0017025),0.46800977932371257,1.199778513397645,0.24115755627009647,0.8586595701185448,1.0,8/21,22.14%,TAF12;THRA;GTF2A1;TAF1B;PSMC5;TAF11;GTF2B;GTF2A2
prerank,FMN binding (GO:0010181),0.5368455679047808,1.1994943701528429,0.26371681415929205,0.8520787247812137,1.0,3/11,6.90%,POR;MTRR;DUS2
prerank,ubiquitin protein ligase binding (GO:0031625),-0.2530141670228641,-1.1988406778614882,0.05217391304347826,0.5877600445154239,1.0,93/253,26.33%,SNCAIP;SMAD6;FOXO1;VCL;EGFR;NPLOC4;TRIB2;KDM4A;BECN1;UBE2G1;LAPTM4B;NEK6;SQSTM1;TMBIM6;HSPA8;ARIH1;ACTG1;SKI;GABARAP;DBT;APC;RPL5;HLTF;CUL1;TXNIP;GABARAPL1;JKAMP;FZD4;UBB;GSK3B;PRR5L;RNF8;VCP;TPI1;PCBP2;SMAD3;RPL11;CASP8;NFKBIA;UBE2A;RALB;OTUB1;HERC2;PSMA3;SMG5;PRKAR2A;SLC25A5;PRKAR2B;UBE2N;CKB;USP25;UCHL1;TRAF3;CDKN1A;HSPBP1;UBE2L6;PER1;NEDD8;CUL3;FZD8;ISG15;LAPTM5;UBC;CBS;MAP1LC3A;AMBRA1;ERBB3;APBB1;MFHAS1;HDAC6;RPL23;FAF2;MAP1LC3B;RTN4;TRAF1;MID1;RFFL;UBA52;SMAD7;IKBKE;BCL10;AXIN2;HSPD1;RNF20;RPA2;IKBKG;SUMO1;NDUFS2;CHEK2;HSPA1A;BRCA1;ARRB2;RB1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4785979538394243,1.1978962122065275,0.26495726495726496,0.8500897699207637,1.0,7/17,15.02%,AK1;AK4;NME6;NOL9;AK8;NME1;AK3
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2503060234213468,-1.1975713115926736,0.02,0.5848582265116962,1.0,97/268,26.33%,SNCAIP;SMAD6;FOXO1;VCL;EGFR;NPLOC4;TRIB2;KDM4A;BECN1;UBE2G1;LAPTM4B;NEK6;SQSTM1;TMBIM6;HSPA8;ARIH1;ACTG1;SKI;GABARAP;DBT;APC;RPL5;HLTF;CUL1;TXNIP;GABARAPL1;JKAMP;FZD4;UBB;GSK3B;PRR5L;RNF8;VCP;TPI1;PCBP2;SMAD3;RPL11;CASP8;NFKBIA;UBE2A;PARP9;SUMO3;RALB;OTUB1;HERC2;PSMA3;SMG5;PRKAR2A;SLC25A5;PRKAR2B;PTPRN;UBE2N;CKB;USP25;UCHL1;TRAF3;CDKN1A;HSPBP1;UBE2L6;PER1;NEDD8;CUL3;FZD8;ISG15;LAPTM5;UBC;CBS;MAP1LC3A;AMBRA1;ERBB3;APBB1;MFHAS1;HDAC6;RPL23;FAF2;MAP1LC3B;RTN4;TRAF1;MID1;RFFL;UBA52;SMAD7;IKBKE;BCL10;AXIN2;HSPD1;RNF20;RPA2;IKBKG;SUMO1;DTX3L;NDUFS2;CHEK2;HSPA1A;BRCA1;ARRB2;RB1
prerank,filamin binding (GO:0031005),-0.4931184832218234,-1.1965212307861914,0.2585034013605442,0.5814247487568672,1.0,2/11,0.72%,NEBL;DPYSL3
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.45537162899377914,1.196037823498199,0.22776911076443057,0.8490246336568237,1.0,7/21,13.23%,AKAP5;AKAP7;RYR2;WASF3;PRKACA;ACBD3;AKAP6
prerank,semaphorin receptor activity (GO:0017154),-0.4936004199830177,-1.1959517260328278,0.25727069351230425,0.5769771652596142,1.0,4/11,2.72%,PLXNA2;PLXNA4;NRP2;NRP1
prerank,manganese ion binding (GO:0030145),-0.338446892536943,-1.1953088939051748,0.16785714285714284,0.572597967425282,1.0,12/48,14.15%,B4GALT1;MPPED2;XPNPEP3;SOD2;ADPRM;MGAT1;LARGE1;GYG1;DYRK2;ME1;PRIMPOL;GALNT1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.43979147929690543,1.192410225321974,0.2343987823439878,0.854112816277438,1.0,3/26,7.43%,PTN;BOD1;PPP1R14A
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.43554307015060667,1.1911743772094274,0.2480127186009539,0.8513008062375935,1.0,11/28,17.55%,RPP40;POP5;FEN1;PRORP;MRPL44;POP7;DBR1;AGO3;EDC3;RNASEH1;RPP21
prerank,protein homodimerization activity (GO:0042803),0.29988551727338303,1.1882149401692244,0.07128309572301425,0.8549462394127973,1.0,127/589,18.07%,TBX18;ENPP1;HSD11B1;PDGFRA;ECE1;GHR;XCL1;TENM3;PTPRT;ACOX2;TIMM10;NTRK2;HIF1AN;NR2F2;GLDC;ERBB4;PIP4K2A;ABCD2;MASP1;PDXK;FAP;ODC1;CIP2A;PHETA2;FGFR1;RABL3;TPST1;EPRS1;TYR;JUP;POU3F3;TENM4;SOX6;KMT2A;RNF40;ERCC5;KYNU;MTCL1;CPQ;FMR1;ZBTB16;GRHPR;MSH3;LRRK2;PEX7;MTMR1;ACTN1;ADCY8;MTHFD1L;TENM2;SRF;DSCAML1;TRIM37;PTPRO;SYNDIG1;QTRT2;GLIPR2;TERF1;CIDEA;UXS1;TRIM8;APPL2;CPOX;TENM1;COMMD1;CR2;IRAK1;NUDT21;HOGA1;EIF2AK1;PRPS1L1;PRPS1;PTPA;PYCARD;ACOT7;SLK;BCL2L2;HMGCS1;PDK2;SLC4A1;ACSL6;S100A1;ZNF318;GALE;KCNN2;CISD2;RAB11FIP3;CADM3;PEX11A;TESC;SYNE1;AXIN1;SDCBP2;NECTIN3;TSG101;RDH5;SNF8;BAK1;RIPK1;TFAP4;ABCB7;PRMT2;GDNF;PHETA1;CENPF;ZHX3;FGFR2;AOX1;CRPPA;MMAA;ZDHHC2;CYP2R1;HARS1;SLC39A13;RRAGA;MMUT;SARS1;ADRA2A;VPS4B;GOLGA5;LDB1;GNPTG;TOP2A;CAMK2A;MSH6;DPYD;WRN
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4533891424058027,1.1857415117179766,0.2435064935064935,0.8493040099758946,1.0,8/21,17.25%,CDK14;CDK8;CDKL3;CDK13;CDKL1;CDK10;CCNK;CDK5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4533891424058027,1.1857415117179766,0.2435064935064935,0.8493040099758946,1.0,8/21,17.25%,CDK14;CDK8;CDKL3;CDK13;CDKL1;CDK10;CCNK;CDK5
prerank,leak channel activity (GO:0022840),0.46614976110795875,1.182280541737373,0.27580645161290324,0.8541376435932764,1.0,5/18,15.94%,KCNK2;NALCN;TMEM175;KCNK1;KCNK13
prerank,metallopeptidase activity (GO:0008237),0.3420111788611203,1.1791268390899416,0.2027194066749073,0.8579900737142844,1.0,28/113,17.31%,ECE1;ECE2;ADAMTS14;ADAMTS6;MBTPS2;MMP28;MMP24;MMP25;EIF3H;ADAM11;ADAM19;METAP1D;OMA1;ADAMTS12;MMP11;ADAMTS2;NRDC;ADAM12;PITRM1;SPRTN;ADAMTS20;ADAMTS10;ADAM2;ADAMTS19;DPEP1;PSMD14;RNPEP;ADAM8
prerank,endodeoxyribonuclease activity (GO:0004520),0.4581515847189912,1.1777761088318177,0.2515625,0.8552292028174738,1.0,5/20,13.74%,ERCC1;FEN1;ERCC5;ERCC4;MBD4
prerank,sulfotransferase activity (GO:0008146),0.40643690983074077,1.1759459616157883,0.258751902587519,0.8546788551979334,1.0,2/33,3.16%,CHST8;TPST1
prerank,GTPase regulator activity (GO:0030695),-0.2547849021631062,-1.1751722013705441,0.05925925925925926,0.616979166245844,1.0,61/212,15.41%,RANBP3L;TBC1D4;PLCB1;RAPGEF2;CHN2;SLIT2;RGS3;SIPA1L1;RGS6;DOCK1;RGS5;RGS12;NRP1;SIPA1L2;SIRPA;IQGAP1;TBC1D8;ARL2BP;RAP1GAP2;EIF5;ARHGAP10;ARHGAP42;SH3BP4;TBC1D22B;ARHGAP17;ARAP3;RASGRP3;SRGAP2;ERRFI1;BNIP2;ARFGAP2;RANGAP1;RUNDC1;RALBP1;ITGB1BP1;ELMOD3;ARHGAP18;SGSM2;CPEB2;ELMOD2;ARL2;GMIP;GRTP1;CCDC88A;ARHGAP27;PGAM5;RP2;ARHGAP28;TBC1D7;ALS2;EVI5L;TBC1D22A;BCR;IPO7;TBC1D10B;ARHGAP15;ASAP2;TBCK;RAP1GDS1;TBC1D13;RGS10
prerank,NADP binding (GO:0050661),0.41368875708257197,1.173665551897721,0.2565284178187404,0.8553826979505205,1.0,5/32,8.29%,HSD11B1;GRHPR;MTRR;DUS2;KCNAB1
prerank,ATPase activator activity (GO:0001671),0.4562936282630061,1.1700540501193846,0.2854785478547855,0.8612560336799191,1.0,5/20,13.76%,DNAJC19;DNAJC1;DNAJC24;DNAJC10;DNAJC15
prerank,protein kinase C activity (GO:0004697),0.4748454093798373,1.1655310979759135,0.2871287128712871,0.8703374588521013,1.0,5/14,9.17%,PRKD3;PRKCI;PRKD1;PRKCA;PRKCB
prerank,neuropeptide receptor activity (GO:0008188),0.4195167795195013,1.1633929729716632,0.2617124394184168,0.8706202031396597,1.0,2/29,2.03%,SORCS3;NPFFR1
prerank,CoA-ligase activity (GO:0016405),0.4817666640210492,1.1572845406740115,0.3086003372681282,0.8853753024450414,1.0,1/14,1.09%,ACSS3
prerank,growth factor activity (GO:0008083),0.3555815370407078,1.154533803219544,0.22802197802197802,0.8880434053569303,1.0,13/74,16.73%,PTN;NRG1;CXCL1;AMELX;NRG3;IL12A;ENDOU;IGF2;CLEC11A;FGF5;AREG;GDNF;JAG1
prerank,NF-kappaB binding (GO:0051059),0.4361201801389735,1.1543305666192702,0.28019323671497587,0.8820215167238297,1.0,4/24,7.08%,HDAC1;HIF1AN;CDKN2A;BRMS1
prerank,G protein-coupled receptor activity (GO:0004930),0.31100433567072483,1.1533782232642402,0.17885264341957255,0.8787069619520725,1.0,29/239,10.95%,ADGRL3;GPR88;RXFP3;ADGRV1;CALCRL;PDGFRL;GPR3;NPFFR1;C5AR1;P2RY1;GPR37L1;ADGRB2;ADGRB1;ADORA2A;CRHR2;MRGPRE;GPR22;LPAR3;ADGRB3;TRHR;GPR183;GPR176;ADGRL1;NPY;TAPT1;GPR52;LPAR1;GRM5;GPR26
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.44759739883428035,1.1530450670848411,0.2917369308600337,0.8732784232740262,1.0,6/20,17.97%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;SLC39A13;SLC39A14
prerank,lipoprotein particle binding (GO:0071813),0.44772641946061065,1.152554887091011,0.28019323671497587,0.868410447589245,1.0,3/20,5.25%,COLEC12;LIPC;SORL1
prerank,calcium channel regulator activity (GO:0005246),0.3982038946910407,1.1520776321466322,0.2791728212703102,0.8635070926393315,1.0,9/37,15.57%,ITPR1;NRXN2;NRXN1;STIMATE;NPY;CACNG4;STIM1;PACSIN3;SGK1
prerank,monocarboxylic acid binding (GO:0033293),0.4564781888027041,1.151620013317171,0.27677100494233936,0.858511952440953,1.0,2/18,2.85%,NR2F2;NR1H4
prerank,3'-5' DNA helicase activity (GO:0043138),0.465627796832082,1.147112411246985,0.27378964941569284,0.867634159188526,1.0,7/16,18.21%,MCM7;NAV2;RECQL;DHX9;HELQ;WRN;FBH1
prerank,Toll-like receptor binding (GO:0035325),0.51964216219114,1.1428725006967608,0.31625441696113077,0.8756017195747666,1.0,4/11,17.68%,UNC93B1;TLR6;TIRAP;MYD88
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4929396722763184,1.138811841798649,0.3145869947275923,0.8829642553646792,1.0,2/12,7.22%,TRAF4;TRIM37
prerank,steroid hydroxylase activity (GO:0008395),0.46960813125536405,1.1372772919993401,0.2966101694915254,0.8819027863561825,1.0,1/16,0.29%,CYP7B1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.313521110921725,-1.1344048292060953,0.21725239616613418,0.7229897917376565,1.0,24/51,32.05%,SLC16A2;SLCO2A1;SLCO1C1;SLC22A4;SLC22A6;SLC25A3;SLC22A8;SLC35D2;SLC7A5;SLC20A1;MFSD2A;SLC35E4;TMEM241;SLCO5A1;SLC35C2;MCU;SLCO4A1;SLC25A11;SLC5A6;SLCO4C1;SLCO1B1;SLC5A5;SLC35E2A;SLC35E2B
prerank,voltage-gated ion channel activity (GO:0005244),0.49115368003372445,1.1320713897212362,0.3212996389891697,0.8926929664595659,1.0,4/14,10.52%,VDAC2;CACNA1E;HCN1;KCND2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.4401774366419021,-1.13171741101514,0.30963302752293576,0.7234016084022276,1.0,5/12,21.46%,PIEZO2;TMC7;TMC6;TMEM63B;PIEZO1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.44656906202714075,-1.1316752411822317,0.32293986636971045,0.7165227083648991,1.0,8/12,47.46%,SLC2A1;SLC2A4;SLC2A2;PPBP;SLC5A3;SLC2A5;SLC2A3;SLC2A6
prerank,alanine transmembrane transporter activity (GO:0022858),-0.43669688810904317,-1.1300109105574518,0.31685393258426964,0.7144142862603379,1.0,5/12,21.01%,SLC6A6;SLC3A2;SLC38A5;SLC36A4;SLC38A7
prerank,nuclear localization sequence binding (GO:0008139),0.4501378975500176,1.126133694276548,0.3073089700996678,0.9072179463750407,1.0,9/18,22.52%,NUP214;POM121;TNPO1;KPNA1;CABP1;TNPO2;KPNB1;KPNA2;IPO4
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4701474282797344,1.125955595599898,0.33447098976109213,0.9013728161572753,1.0,4/14,9.77%,RPP40;POP5;PRORP;POP7
prerank,beta-tubulin binding (GO:0048487),0.3976944387093394,1.1247897798987767,0.3052464228934817,0.8986465212356988,1.0,5/31,10.91%,DLEC1;CCT5;LRPPRC;ARL8B;IFT74
prerank,MHC class II protein complex binding (GO:0023026),-0.46740729283309645,-1.1227837934304434,0.3087885985748218,0.7284756829880471,1.0,4/11,17.22%,HSPA8;ANXA11;PKM;CD74
prerank,organic cation transmembrane transporter activity (GO:0015101),0.4600330007939275,1.1215865786960189,0.3191126279863481,0.9030691359862058,1.0,5/16,18.50%,SLC18A3;SLC7A8;SLC25A26;SLC25A17;SLC44A1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.41415351192232597,-1.121384540023207,0.3148614609571788,0.7255324909561547,1.0,6/16,22.27%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR
prerank,protein kinase activator activity (GO:0030295),-0.3043562550235766,-1.1208799830146055,0.25263157894736843,0.7201122019381165,1.0,19/60,19.39%,PRKAG2;AFAP1L2;RICTOR;IQGAP1;RPLP1;GPRC5C;WNK1;CALM1;MADD;CAB39;MAP2K2;ALS2;ETAA1;CDKN1A;PAK2;ERBB3;WNT11;MARK2;RGCC
prerank,thyroid hormone receptor binding (GO:0046966),0.40539509360982934,1.1208728526859821,0.3001579778830964,0.8992638524435989,1.0,10/28,20.82%,MED12;NCOA3;BRD8;NSD1;HMGN3;MED1;GTF2H1;PRMT2;TAF11;GTF2B
prerank,vinculin binding (GO:0017166),0.5132720371505037,1.1180999029668963,0.35304990757855825,0.9024317833894708,1.0,3/11,6.32%,UTRN;CORO2B;ACTN1
prerank,pyrophosphatase activity (GO:0016462),0.3676945026100698,1.1154847355018696,0.29668674698795183,0.9051232948616015,1.0,11/50,14.93%,ENPP1;ENTPD2;ENTPD5;ENPP3;ITPA;NUDT9;TRPM2;ENTPD7;BNIPL;PLPP5;DHX9
prerank,cytokine receptor binding (GO:0005126),0.33303867559591693,1.1130164435090764,0.3129973474801061,0.9068589638460363,1.0,11/83,12.11%,IL34;IL1RN;XCL1;JAK1;TSLP;SPRED1;SPRED2;IL1RAP;CCL25;PYCARD;IL12A
prerank,hormone activity (GO:0005179),0.3609458880874714,1.1128617516658559,0.3095890410958904,0.9013038009466577,1.0,7/54,11.20%,HCRT;EDN3;SPX;TRH;NPY;CCL25;ERFE
prerank,androgen receptor binding (GO:0050681),-0.35902848039422935,-1.1125624405938888,0.2914572864321608,0.7372423760765019,1.0,5/25,7.65%,FOXP1;DDX5;KDM4C;SMARCA4;TMF1
prerank,ribonuclease P RNA binding (GO:0033204),0.5075371124875849,1.1091590321166263,0.35154826958105645,0.907680792419162,1.0,3/10,9.77%,RPP40;POP5;POP7
prerank,adenyl nucleotide binding (GO:0030554),-0.44291219545818006,-1.1082970586926837,0.3325635103926097,0.7359117554054753,1.0,6/11,30.00%,HSPH1;BAG3;HSPBP1;BAG2;SIL1;BAG4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.44291219545818006,-1.1082970586926837,0.3325635103926097,0.7359117554054753,1.0,6/11,30.00%,HSPH1;BAG3;HSPBP1;BAG2;SIL1;BAG4
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.2860708237883467,-1.1070424252575606,0.2605633802816901,0.7327374156175397,1.0,17/70,20.29%,B4GALT1;CSGALNACT1;B3GALT1;GXYLT2;EXT1;LARGE1;HEXB;HYAL1;MGAT4B;B3GALNT1;LFNG;GCNT1;MFNG;B3GLCT;B3GNT2;HAS1;GXYLT1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.30577979575365716,-1.1064717881254056,0.28135593220338984,0.7276370722974381,1.0,19/49,24.52%,SQSTM1;ABRAXAS2;VCP;PARP10;OPTN;MINDY1;RNF169;BRCC3;TAB2;PSMD4;RAD23B;TNFAIP3;HDAC6;ZFAND2B;IKBKE;ZRANB3;ZFAND6;IKBKG;ATRIP
prerank,sequence-specific DNA binding (GO:0043565),0.2809719250320684,1.1061868317679937,0.18635437881873726,0.9113400178087214,1.0,97/590,16.31%,TBX18;RORA;ZBTB20;ISL2;MSC;ATF5;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;TEAD1;ETV5;TEF;NR2F2;TCF7L2;TCF4;SMAD5;NR1H4;ZIC4;MEIS2;NFATC3;ZNF740;POU3F3;PPARD;TEAD2;TBX3;FOS;ZIC1;KMT2A;HOXC9;ZNF423;FOXN2;CXXC1;MYCN;DMRTA2;EPAS1;HLF;LIN28B;E2F4;GLIS1;MBD3;ZCWPW1;SRF;CSRNP3;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;TERF1;CSRNP2;ZKSCAN3;PIF1;ERH;SOX2;OLIG2;BHLHE22;GLI3;ZBTB43;HOXC8;SOX10;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;SOX9;TFEB;HOXB4;DMRTA1;PRDM5;NFIX;HOXC4;ZFP1;RFX4;SREBF1;CUX2;MYRF;ARNT2;LONP1;ELK1;BPTF;CREB3L1;ZBTB32;HNRNPD;TFAP4;SAFB2;ATF2;FOXJ3;KLF11;HOXA9;MAFB;KDM2A;ZBTB7A;ONECUT2
prerank,nucleotidase activity (GO:0008252),-0.42320304349433774,-1.1053503906773972,0.3116883116883117,0.7242630519899483,1.0,8/15,32.64%,NT5DC3;NT5E;NT5C3B;NT5C1A;NT5M;ACP3;BPNT1;NT5C2
prerank,receptor tyrosine kinase binding (GO:0030971),0.3522569900864909,1.104303768893126,0.30185979971387694,0.9115858807433405,1.0,10/56,11.43%,PIK3R1;NRG1;CBLB;FLT3LG;GAB2;PIK3R2;IRS1;FIZ1;TP53;NRG3
prerank,hexosyltransferase activity (GO:0016758),-0.26576087748302074,-1.1035807824948092,0.24696356275303644,0.7230172906927057,1.0,24/101,16.13%,B4GALT1;TMTC2;CSGALNACT1;B3GALT1;TMTC1;ALG9;B4GALT5;EXT1;GBE1;TMTC4;LARGE1;GYG1;HEXB;HYAL1;MGAT4B;ALG12;MTAP;B3GALNT1;FUT9;LFNG;DPY19L4;GCNT1;MFNG;B3GLCT
prerank,tubulin binding (GO:0015631),0.28869329510438113,1.103388350870729,0.23982398239823982,0.9086556248738684,1.0,60/295,14.85%,DLEC1;ATF5;CCDC61;REEP2;MDM1;MAP4K4;GJA1;EFHC1;IRAG2;MTCL1;FMR1;CCT5;NEFH;LRRK2;CENPE;STARD9;CEP295;SUN2;CLIP3;LRPPRC;TTLL6;IFT81;UNC5C;SNPH;TERF1;HAUS8;FAM161A;GOLGA2;STMN2;NAV3;PHF6;OPA1;BRCA2;CCSAP;CAPN6;STMN4;ARL8B;IFT74;KATNA1;TBCE;FYN;NUSAP1;GAS8;AGBL4;RMDN1;DNM1;TUBGCP4;SYBU;POLB;KIF5C;CLIP2;KIF9;EML1;TPGS1;MAP9;STMN1;CLASP2;KIF3C;TUBGCP6;KIFC2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5046535007036483,1.1026545960808791,0.352622061482821,0.9051555251537663,1.0,4/10,16.90%,STAMBPL1;ATXN3;YOD1;STAMBP
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3537065213346609,-1.1024641719980914,0.3224932249322493,0.7194741879497569,1.0,11/24,27.64%,DAPK1;CAMK2D;CAMK2B;CAMK2G;EEF2K;PTK2B;MKNK1;CAMK1G;CAMKK1;PHKA2;PHKG2
prerank,regulatory RNA binding (GO:0061980),0.375658305805332,1.101446229482048,0.3141592920353982,0.9033008162406377,1.0,9/38,11.21%,AGO4;SPOUT1;FMR1;DND1;ZC3H7B;ZNF346;HNRNPA2B1;SOX2;AGO3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4928635192554061,1.1009268495903015,0.3471971066907776,0.8991622633004556,1.0,2/11,9.94%,HCN2;HCN1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.4225339309141446,-1.1007352047403747,0.3397129186602871,0.7180988407025021,1.0,8/13,15.33%,PDGFD;PTPRJ;IL1R1;VEGFD;PDGFA;PDGFC;ITGB3;ERN1
prerank,receptor ligand activity (GO:0048018),0.2950812872689964,1.0988936179184225,0.29105322763306907,0.9003815072174239,1.0,12/245,2.18%,IL33;PTN;IL34;EPHA7;CXCL10;NRG1;EDN3;EDA;WNT5A;CXCL1;SEMA5A;IL16
prerank,damaged DNA binding (GO:0003684),0.37011681792088846,1.0983708444149223,0.3343239227340267,0.8963871177786434,1.0,11/44,15.54%,ERCC1;FEN1;POLQ;ERCC5;NEIL3;RPA1;ERCC4;XPC;XRCC1;ERCC2;CRY2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4587426945972253,-1.0980999827803448,0.35698447893569846,0.7185541501889758,1.0,4/10,13.13%,PIK3C2B;PIK3CB;PIK3CD;ATM
prerank,snoRNA binding (GO:0030515),-0.33404510573407264,-1.0972937329353782,0.3129973474801061,0.7144006068337683,1.0,12/30,30.39%,PRKDC;DDX21;NUDT4;NUDT7;IMP3;NUFIP1;TSR1;NUDT16;NUDT16L1;NHP2;BMS1;RRP9
prerank,protein phosphatase binding (GO:0019903),-0.25958441654096637,-1.0967107177881958,0.2552083333333333,0.7099418733360247,1.0,37/117,17.80%,FOXO1;EGFR;SIRPA;IQGAP1;SHOC2;MAP3K5;VRK3;FBXL2;PPP1R16A;MAPK14;AKAP11;MVP;PPP1R3B;MTMR9;SH3RF2;ITGA1;PPP6R1;VCP;PPP1R16B;MAPT;MAP2K7;CTTNBP2NL;BAD;PHACTR4;AP3B1;KCNQ1;CEACAM1;SMG5;FLT4;PPP1R3C;CDH5;TRAF3;MET;TBK1;SKAP1;ERBB2;PPP1R11
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.4454236333882608,1.095818786970716,0.3449920508744038,0.8933737194708086,1.0,6/16,10.69%,PTPRT;PTPRR;PTPRN2;PTPRU;PTPRO;PTPRA
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.4454236333882608,1.095818786970716,0.3449920508744038,0.8933737194708086,1.0,6/16,10.69%,PTPRT;PTPRR;PTPRN2;PTPRU;PTPRO;PTPRA
prerank,carboxylic acid binding (GO:0031406),0.38342183374966654,1.095588506858953,0.33948863636363635,0.8886220859317944,1.0,11/38,17.62%,THNSL2;HIF1AN;GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRM7;CASTOR1;GRIN3A
prerank,acid-thiol ligase activity (GO:0016878),0.46459542616785154,1.095030867300934,0.3543859649122807,0.8849061477678135,1.0,1/13,1.09%,ACSS3
prerank,transcription cis-regulatory region binding (GO:0000976),0.28046769250938935,1.0940189670519456,0.2557651991614256,0.8827101255941601,1.0,63/406,15.75%,TBX18;RORA;GBX1;ZBTB20;ISL2;BHLHA9;TRPS1;MSC;ATF5;HOXC10;TEAD1;ETV5;HDAC1;TCF7L2;BASP1;ERBB4;THRA;NR1H4;PER3;REST;FOS;SOX6;FOXN2;ZFP37;EPAS1;CREB3L2;PRDX5;BCOR;ZBTB46;ALX4;PER2;TWIST1;SOX2;MXI1;GLI1;GLI3;ZBTB43;HOXC8;SOX10;TP53;NFXL1;DHX36;ZNF25;MSX1;SOX9;TWIST2;TFEB;PRDM5;CARM1;PEG3;SREBF1;CUX2;LONP1;ELK1;CREB3L1;FOXM1;TFAP4;PBX2;AR;ATF2;MYC;CRY2;KLF11
prerank,Tat protein binding (GO:0030957),-0.4626894816999505,-1.0933718403437394,0.3597285067873303,0.7130214666715146,1.0,3/10,6.18%,ACTB;SMARCA4;GABARAPL1
prerank,mRNA binding (GO:0003729),0.2910169019095381,1.09244789661286,0.289237668161435,0.8824122718947165,1.0,58/249,18.69%,RBFOX1;EIF4G3;RBMS1;CPEB1;GNL3;TRA2B;EIF4A3;NANOS3;NOVA1;MYEF2;RBM46;RBM24;LSM14A;SNRNP35;RNF40;SF3B6;ZC3H12D;RBMS3;FMR1;DND1;LARP6;CCT5;BOLL;KHDRBS3;ELAVL4;PCBP3;HNRNPA2B1;CELF4;NUDT21;LUC7L2;TP53;RBFOX3;DHX36;EDC3;CSDC2;RBM20;HDLBP;EIF4ENIF1;RBM4B;SLBP;DHX9;RC3H2;SNRNP70;FYTTD1;HNRNPLL;SRRM2;IGF2BP3;RBM5;PPP1R8;THOC5;HNRNPL;SRRM3;CALR;SRSF6;DXO;LSM14B;KHDRBS1;YTHDF1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.4301516232759717,1.0921705427057633,0.34966216216216217,0.872670335387266,1.0,5/17,10.41%,EPHA7;EPHB1;EPHA6;EPHB6;EPHA3
prerank,ephrin receptor activity (GO:0005003),0.4301516232759717,1.0921705427057633,0.34966216216216217,0.872670335387266,1.0,5/17,10.41%,EPHA7;EPHB1;EPHA6;EPHB6;EPHA3
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.3204559893381796,-1.091993939800494,0.30177514792899407,0.7109220913677362,1.0,10/38,11.77%,SORBS1;SHANK3;MAGI2;MAPK8IP3;NCK1;SHANK1;SPAG9;FRS2;SH2B1;DLG5
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4835583800195865,1.0906752651230702,0.34558823529411764,0.8722934720858845,1.0,2/10,9.92%,NAA10;NAA50
prerank,deoxyribonuclease activity (GO:0004536),0.4614427320834772,1.0887238147492007,0.3497536945812808,0.8734836675651029,1.0,4/14,14.14%,ERCC5;ERCC4;MBD4;NME1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.40123073996998404,-1.088155247392449,0.3542168674698795,0.7151014567408712,1.0,3/16,19.42%,PIR;ETHE1;ALOX12
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.45620926505659337,1.0861156632274995,0.37992831541218636,0.8762073934548916,1.0,5/14,14.14%,AK1;AK4;NME6;AK8;NME1
prerank,phosphatase binding (GO:0019902),-0.25740611021427506,-1.0856825384607174,0.27312775330396477,0.715783517038664,1.0,35/105,18.81%,CTSC;EGFR;SIRPA;MAGI2;IQGAP1;CNST;SHOC2;MAP3K5;VRK3;WNK1;FBXL2;MAPK14;MVP;MTMR9;SH3RF2;ITGA1;PPP6R1;VCP;SMAD3;MAP2K7;BAD;PPP3R1;AP3B1;CEACAM1;FLT4;PPP1R3C;CDH5;TRAF3;MET;TBK1;SKAP1;ERBB2;DLG1;CHCHD3;SNX3
prerank,5'-nucleotidase activity (GO:0008253),-0.42452173871356025,-1.0856635648992632,0.34299516908212563,0.7100110693206104,1.0,7/13,32.64%,NT5DC3;NT5E;NT5C3B;NT5C1A;NT5M;ACP3;NT5C2
prerank,symporter activity (GO:0015293),-0.45885897194501973,-1.0853498950097156,0.34579439252336447,0.7050704760211851,1.0,10/10,54.15%,MFSD2A;SLC5A6;SLC5A5;SLC4A4;SLC46A2;SLC28A2;SLC28A3;SLC5A8;SLC28A1;SLC5A12
prerank,amino acid binding (GO:0016597),0.3923190076696852,1.083953666466539,0.3493253373313343,0.8778715084932656,1.0,10/31,17.62%,THNSL2;GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRM7;CASTOR1;GRIN3A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4433843836304293,-1.0836970011067135,0.3665158371040724,0.7036403264673663,1.0,10/11,55.69%,DDAH1;DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.39005454660437966,-1.0824389044451477,0.34005037783375314,0.701437920588774,1.0,6/18,22.48%,SMAD6;TGFB2;SMAD3;TGFBR3;TGFBR2;SMAD7
prerank,water transmembrane transporter activity (GO:0005372),-0.44347484654219943,-1.082128158203433,0.3579418344519016,0.6967880096331368,1.0,8/11,55.32%,PDPN;AQP11;AQP1;SLC4A11;AQP9;AQP6;AQP7;SLC5A1
prerank,NADPH binding (GO:0070402),0.46322585273877687,1.0820511357748008,0.38448275862068965,0.8785510420047029,1.0,4/13,8.29%,GRHPR;MTRR;DUS2;KCNAB1
prerank,alkali metal ion binding (GO:0031420),0.45845371565781123,1.0804652573285023,0.37943262411347517,0.8781453327248118,1.0,3/13,6.54%,ATP1A2;PDXK;CAPN3
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.43388853005843375,1.080157008868574,0.3646677471636953,0.8739563642854287,1.0,4/16,15.03%,SLC1A5;SLC25A22;SLC25A30;SLC25A14
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4897529613613505,1.0791058904847872,0.38640429338103754,0.8722505270165835,1.0,3/10,13.55%,CDKN2A;CDKN2D;CDKN2C
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2716957463574745,1.0787427656784412,0.22311557788944725,0.8685126195002195,1.0,147/831,17.30%,TBX18;RORA;GBX1;ZNF367;ZEB1;ZBTB20;BHLHA9;ZFHX3;TRPS1;MSC;ATF5;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;MEIS1;TEAD1;ETV5;TEF;HDAC1;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;MEIS2;PGR;NFATC3;ZNF740;MYT1;POU3F3;PPARD;NR1H2;TEAD2;REST;TBX3;FOS;ZBTB24;SOX6;ZIC1;FOXO6;GTF2A1;HOXC9;ZNF423;ZBTB16;MYCN;DMRTA2;ZFP37;EPAS1;HLF;FOXS1;E2F4;ZBTB46;GLIS1;SRF;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;ZKSCAN3;TWIST1;CHD2;SOX2;MXI1;GLI1;OLIG2;WIZ;BHLHE22;NSD1;GLI3;ZBTB43;HOXC8;TBPL1;SOX10;TP53;NFXL1;DHX36;ZBTB39;ZNF25;MED8;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TWIST2;TFEB;HOXB4;ST18;HIVEP3;HIC2;DMRTA1;ZNF628;PRDM5;NRIP1;NFIX;HOXC4;ZFP1;RFX4;PEG3;SREBF1;CUX2;ARNT2;ELK1;BPTF;ZSCAN18;ZBTB32;MYNN;FOXM1;HOXC5;TFAP4;DHX9;PBX2;ZBTB25;AR;ATF2;MYC;FOXJ3;KLF11;HOXA9;MAFB;ZKSCAN5;ZBTB7A;ZNF467;ONECUT2;ZNF3;ZFP62;ZIC5;CIART;MAZ;NR1D2;ZBTB12;DNMT3A;SARS1;ZBTB11
prerank,kinase activity (GO:0016301),0.312992039194378,1.0783040055688635,0.32575757575757575,0.8649487952319718,1.0,26/109,14.07%,PDXK;MAP4K4;PKMYT1;PRKD3;CDC7;CDKL5;SCYL3;PSTK;LRRK2;IPMK;NADK;COASY;PI4KA;DGKQ;PAPSS2;PINK1;PRKD1;MTOR;CKM;IRAK1;CHKA;GK;DGKI;AGK;IP6K1;LYN
prerank,NAD+ binding (GO:0070403),-0.4360492682301756,-1.0780030976899762,0.3620689655172414,0.7022421026961497,1.0,7/12,18.85%,SIRT3;ZC3HAV1;PARP9;CRYL1;HADH;SIRT1;SIRT5
prerank,adrenergic receptor binding (GO:0031690),-0.39587283755341757,-1.0777952817007497,0.35858585858585856,0.6972815836897508,1.0,4/16,3.34%,RAPGEF2;ARRDC3;GNAS;MAGI2
prerank,CoA hydrolase activity (GO:0016289),-0.40010907636657866,-1.0754504162812994,0.3670886075949367,0.6979039189508872,1.0,5/16,15.36%,ACOT8;NUDT7;ACOT13;ACAA2;ACOT6
prerank,zinc ion binding (GO:0008270),0.2839790252722477,1.0750918072359896,0.3230769230769231,0.8700349668706581,1.0,62/293,18.03%,ENPP1;ECE1;ZEB1;HRG;ADH1A;TIMM10;MYCBP2;PAM;HIF1AN;CBLB;PDXK;GRIN2B;EPRS1;DUSP12;MYT1;SLC30A5;DNAJC24;KMT2A;CHD4;ZFP37;DHX58;SIRT6;GRIN2A;ACR;TARS1;ENPP3;CALB1;MDM4;TRIM8;DPYS;BIRC2;NSD1;SLU7;SEC24B;PITRM1;PGGT1B;TP53;GLRA1;ZFPM2;P2RX4;USP33;PTGR2;KDM1B;TRIM2;HDAC10;RABIF;KDM5C;ZBTB32;TMEM163;ZKSCAN5;KDM2A;ZNF3;USP16;DPEP1;SEC24A;CALR;RNPEP;SEC23A;ADAM8;PEX12;SUV39H2;MBD1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.31732846452461144,-1.0742590163599646,0.3264094955489614,0.695868641123983,1.0,11/37,21.21%,SLCO2A1;SLCO1C1;SLC22A4;SLC22A6;SLC22A8;COX15;COX5B;COX4I1;COX6B1;SLCO5A1;UQCRQ
prerank,methylation-dependent protein binding (GO:0140034),0.3402480282803279,1.0691128825122518,0.3638928067700987,0.883468109611097,1.0,21/57,22.66%,KMT2E;L3MBTL1;PYGO1;FMR1;RRP8;CXXC1;ZCWPW1;SPIN1;WDR5;MORC4;MPHOSPH8;BPTF;CHD8;MBTD1;MSH6;THAP7;ING3;RBBP5;KDM5A;ATRX;ZMYND8
prerank,protein serine/threonine kinase activity (GO:0004674),-0.22027304175175277,-1.067792219828218,0.2033898305084746,0.7070292980391641,1.0,104/334,23.57%,DAPK1;MAP3K1;MAPK4;ROCK2;PRKCH;MARK1;EGFR;MYLK;BMPR2;IRAK2;CSNK1D;MARK4;NEK6;CAMK2D;SQSTM1;PRKDC;MAP3K5;TOP1;SIK3;MINK1;WNK4;VRK3;PRKAA2;TLK1;MAPK9;CDK6;SNRK;WNK1;HIPK3;MAPK14;NRBP2;SIK1;GSK3B;HIPK1;ACVR1;CDC42BPB;RIOK1;ACVRL1;TLK2;NEK7;STK38L;MAST3;DYRK2;RPS6KA5;CDK19;CAMK2B;MAP3K8;ATR;CDKL2;CAMK2G;RPS6KA1;RIOK3;FASTK;SRPK1;GAK;PRKCZ;HIPK2;ATM;CSNK1G3;IRAK4;BCR;PTK2B;MAP3K4;CPNE3;STK17B;CDC42BPG;ERN1;MARK3;PRKCD;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;MAP3K10;ACVR2B;STK32B;CDK9;AKT1;CSNK2B;NUAK2;CSNK1A1;SBK1;VRK2;MARK2;MAP4K3;ULK3;MKNK1;ALPK1;PKN3;PIM2;TGFBR2;NEK10;CDKL4;TTBK1;PASK;STK39;IKBKE;ACVR2A;BRD2;CDK16;PLK4;IKBKB;PAK4
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.42841129300316105,1.065654875632175,0.40384615384615385,0.8890787413217057,1.0,4/16,6.31%,PTEN;SACM1L;MTMR4;MTMR1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4403613997766922,1.0654254961069676,0.37961335676625657,0.8848364447871968,1.0,7/15,21.56%,KMT2A;CXXC1;WDR5;ASH2L;SETD4;KMT2C;RBBP5
prerank,alpha-tubulin binding (GO:0043014),0.3819027657356423,1.0640885002260922,0.36932707355242567,0.8840962542318759,1.0,5/31,11.12%,DLEC1;EFHC1;ARL8B;TBCE;FYN
prerank,phosphatase activator activity (GO:0019211),-0.39573930441885485,-1.0637856162217472,0.39414414414414417,0.7122034526415717,1.0,7/14,30.22%,CALM1;PHACTR4;FRS2;PPP2R5D;PPP2R5B;PPP2R5C;PPP1R15A
prerank,methylated histone binding (GO:0035064),0.33428335865821096,1.0629816922871977,0.3562585969738652,0.8826748275007342,1.0,22/62,22.66%,KMT2E;L3MBTL1;PYGO1;FMR1;RRP8;CXXC1;ZCWPW1;SPIN1;WDR5;MORC4;MPHOSPH8;DPF2;BPTF;CHD8;MBTD1;MSH6;THAP7;ING3;RBBP5;KDM5A;ATRX;ZMYND8
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.2891105229442832,-1.0628709112134078,0.28975265017667845,0.709312578432002,1.0,6/49,5.01%,ANXA3;ANXA5;MCTP1;SYT9;PLA2G4A;ANXA1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.47800114962413504,1.062627184440933,0.4244604316546763,0.8789326111187447,1.0,2/11,15.27%,RDH11;AKR1B1
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.37878834514694815,-1.0619983825266461,0.38613861386138615,0.7064173423792195,1.0,5/17,15.36%,ACOT8;PLA2G6;ACOT13;ACAA2;ACOT6
prerank,voltage-gated chloride channel activity (GO:0005247),-0.4573443322387781,-1.0598146130840613,0.41139240506329117,0.706744096669511,1.0,3/10,8.51%,ANO6;ANO1;CLCN5
prerank,intracellular chloride channel activity (GO:0061778),-0.3882573074751069,-1.057968676272641,0.36211031175059955,0.7013601581012643,1.0,2/16,2.46%,ANO6;ANO1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.3882573074751069,-1.057968676272641,0.36211031175059955,0.7013601581012643,1.0,2/16,2.46%,ANO6;ANO1
prerank,protein kinase binding (GO:0019901),-0.21551111799566688,-1.0561636012631213,0.19444444444444445,0.7015035346222147,1.0,100/479,14.67%,PRKAG2;EPHA4;MAP3K1;MAPK4;RHOBTB1;SLC12A7;IL31RA;CAV1;PDLIM5;PTPRJ;BCL2L1;ACTB;TRIB2;ITGB1;PTPRK;EZR;BMPR2;BECN1;ELAVL1;RICTOR;SIRPA;IQGAP1;NEK6;CSPG4;SQSTM1;CCND2;CAVIN2;ATG13;RHOBTB2;MAPK8IP3;SKI;APC;RAC1;NEDD9;DVL1;MAVS;ACE;CAV2;TFRC;ADAM10;SYN1;CDC42;RPS7;WNK1;TRIM5;ERRFI1;TJP2;PARN;RPS19;TRIM14;CALM1;SIK1;MVP;PFKFB2;GSK3B;ACVR1;RHOC;ACVRL1;GCH1;MAPT;SMAD3;ANK2;YWHAG;MAP2K7;AP2A1;EXOC2;FRMD5;BAD;EEF1A1;CAVIN3;PPM1D;PPEF2;ADCY6;PTPN2;SPAG9;PTPN1;KCNQ1;CCDC88A;MAPKAP1;HSPB1;CEACAM1;ACTA2;SPRED3;PLCG2;SMAD1;NR3C1;NOX4;PRKAG3;PRKAR2A;CYLD;TRPV4;IRAK4;GATA6;NBEAL2;HINT1;PRKAR2B;CCND1;GRB2;TICAM1;CDH5
prerank,mRNA 3'-UTR binding (GO:0003730),0.31682217400262,1.0546393840884418,0.35956580732700133,0.8986823940539151,1.0,17/79,12.16%,RBMS1;CPEB1;RBM24;RNF40;RBMS3;FMR1;DND1;CCT5;BOLL;ELAVL4;ZFP36L2;HNRNPA2B1;NUDT21;TP53;DHX36;CSDC2;EXOSC9
prerank,voltage-gated calcium channel activity (GO:0005245),0.3617406160801214,1.054180715012198,0.3783783783783784,0.895269720245536,1.0,9/37,15.95%,CACNA1E;ITGAV;CACNG3;CACNA1G;CATSPER3;CACNB4;CACNG4;CACNA2D1;NCS1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.47283887529378055,1.0540789117546,0.3958333333333333,0.8907418265916539,1.0,3/10,11.25%,FAN1;DAXX;FAAP20
prerank,GTPase binding (GO:0051020),-0.22893236645297316,-1.0522454508591843,0.2727272727272727,0.7063168332723481,1.0,43/194,14.29%,PLCE1;PICALM;ERC1;DOCK4;FGD5;CAV1;FNBP1L;AFDN;RNF152;RAPGEF6;BECN1;IQGAP1;EXOC4;RIN3;YBX3;NDRG1;UNC13B;RASIP1;EXOC5;SH3BP4;SRGAP2;ARHGDIB;RANGAP1;PPP6R1;RALBP1;RUSC2;EXOC2;SGSM2;RRAGC;OPTN;RNF41;MYO1C;MAPKAP1;TBC1D7;ALS2;GOLGA4;EVI5L;ENO1;CCDC186;FLNA;YBX1;LSM2;BICD2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2883132578527058,1.0502198920200718,0.38686987104337633,0.8972554171020859,1.0,27/173,15.40%,TBX18;ZEB1;ZBTB20;ZFHX3;TRPS1;PPARA;NFATC3;PPARD;REST;TBX3;ZBTB16;ZFP37;ZBTB2;BCL6;ZKSCAN3;MXI1;ZBTB39;ZNF25;ZBTB26;MYT1L;HIC2;PRDM5;PEG3;CREB3L1;ZBTB32;ZBTB25;MYC
prerank,C-C chemokine receptor activity (GO:0016493),0.39992056534003223,1.048660799433325,0.3794266441821248,0.8971748990778362,1.0,2/21,3.26%,CCR9;ACKR2
prerank,potassium channel regulator activity (GO:0015459),0.34013848218954706,1.047416169727246,0.39680232558139533,0.8961301149030166,1.0,10/49,15.57%,DPP6;DPP10;KCNIP1;KCNIP2;KCNAB1;KCNIP4;KCNE4;KCNAB3;WNK2;SGK1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.47022518220630805,1.0463051550653515,0.3989071038251366,0.8945375758182111,1.0,3/10,10.52%,GABRA1;GABRG3;GABRG2
prerank,protein kinase regulator activity (GO:0019887),-0.25175929229310845,-1.0447967789577084,0.33175355450236965,0.7205424718178705,1.0,31/95,21.10%,PRKAG2;CCNYL1;RPLP1;CCND2;GPRC5C;APC;WNK1;YWHAB;NCK1;CCNG1;MADD;CAB39;PRKAG3;PRKAR2A;PRKAR2B;CCND1;MAPK8IP1;CDKN1A;KIDINS220;CCNE2;CCNL2;CSNK2B;WNT11;GSKIP;MARK2;HEXIM1;RGCC;NPM1;DNAJC3;ELP3;DUSP19
prerank,fibroblast growth factor binding (GO:0017134),0.40728630178279496,1.0443609068010067,0.4080560420315236,0.8954124053294764,1.0,3/21,3.03%,ITGAV;FGFBP3;FGFR1
prerank,cell adhesion mediator activity (GO:0098631),0.3783307770112655,1.0439035706388435,0.39666666666666667,0.8919049302206017,1.0,8/24,10.72%,DSCAM;CNTN4;DSCAML1;JAM3;PALLD;NEXN;CNTN6;LRRC4C
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3212603206647116,1.0433177011624022,0.4098798397863818,0.8887838448720302,1.0,12/73,16.07%,RXFP3;SORCS3;CALCRL;NPFFR1;GPR37L1;CRHR2;CCKBR;F2R;S1PR2;LGR5;LHCGR;GPR37
prerank,calcium channel activity (GO:0005262),0.3124210276200765,1.041004035629742,0.3907894736842105,0.8910329347397055,1.0,14/84,12.52%,SLC24A5;CACNA1E;ITGAV;CACNG3;RYR2;TRPV3;CATSPER3;TRPC3;CACNB4;CACNG4;P2RX4;TRPM2;TRPC7;CUL5
prerank,poly(U) RNA binding (GO:0008266),0.4078173563388966,1.040872083996282,0.40378006872852235,0.8868000891109609,1.0,3/20,5.00%,RBMS1;RBMS3;FMR1
prerank,C-C chemokine binding (GO:0019957),0.39445409288822353,1.0401109445529602,0.38974358974358975,0.8844618870122344,1.0,2/22,3.26%,CCR9;ACKR2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.43119711364098323,1.0398395443943405,0.41379310344827586,0.8808099749514078,1.0,3/15,8.99%,PIK3R1;PIK3R2;CCKBR
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.26737836681647714,-1.0394241188192517,0.38202247191011235,0.7295093052270941,1.0,15/72,11.60%,PICALM;PLCB1;MARK1;ACTN2;SNX18;HIP1R;PARD3;GSN;SNX21;FZD7;VILL;KCNJ2;RAB35;KCNQ1;MAPKAP1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.2188211713221971,-1.037781912722935,0.2828282828282828,0.7288260527637616,1.0,55/254,17.73%,NFIB;MECOM;FOXO1;MEF2C;RBPJ;LEF1;ELK3;ERG;FOXC1;ELF1;MEF2A;KLF4;NFKB1;FOXC2;KLF7;RUNX1;MLXIP;ATF6;NFYC;PRDM2;SIX1;ELF4;SOX4;PLAG1;IRF2;SOX17;PLAGL1;SMAD3;PRDM16;IRF1;MYBL1;NR4A1;NR4A2;ETS1;CASZ1;MZF1;ZNF76;RLF;SMAD1;NR3C1;ZIC3;GTF2I;CDC5L;ZNF585A;ZNF585B;ELK4;NFYB;CREB1;NFKB2;CLOCK;ESR1;UBP1;CREB3;HHEX;SOX18
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2611025997243961,-1.0376372270302991,0.35080645161290325,0.7241733706917098,1.0,15/82,14.02%,SPOCK2;APP;CST3;COL4A3;PSMF1;SERPIND1;PTTG1;RENBP;NGF;SERPINE1;SERPINI1;SERPINA2;GAPDH;SERPINE2;FURIN
prerank,retinoic acid binding (GO:0001972),-0.41533360718536194,-1.0328732814282404,0.4145785876993166,0.7317012126833097,1.0,2/12,6.39%,CYP26B1;RXRA
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.37899676387609826,-1.032143155603564,0.4010152284263959,0.7236583635115535,1.0,6/16,22.25%,ATP6V0A4;ATP5F1B;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.37899676387609826,-1.032143155603564,0.4010152284263959,0.7236583635115535,1.0,6/16,22.25%,ATP6V0A4;ATP5F1B;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.26067915758970717,1.0309875683337437,0.3780241935483871,0.9022149088985779,1.0,127/732,17.30%,TBX18;RORA;ZNF367;ZEB1;ZBTB20;ISL2;ZFHX3;MSC;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;MEIS1;TEAD1;TEF;HDAC1;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;MEIS2;PGR;NFATC3;ZNF740;MYT1;POU3F3;PPARD;NR1H2;TEAD2;REST;TBX3;FOS;ZBTB24;SOX6;ZIC1;FOXO6;HOXC9;ZNF423;ZBTB16;FOXN2;MYCN;DMRTA2;HLF;FOXS1;E2F4;GLIS1;SRF;NPAS2;PAX9;ZBTB2;BCL6;NR2C1;ZKSCAN3;CHD2;SOX2;MXI1;GLI1;OLIG2;WIZ;BHLHE22;NSD1;GLI3;SOX10;TP53;DHX36;ZBTB39;MED8;HOXB9;ZBTB26;RFX2;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TFEB;HOXB4;ST18;HIVEP3;HIC2;DMRTA1;ZNF628;PRDM5;NRIP1;NFIX;HOXC4;ZFP1;RFX4;SREBF1;ARNT2;ELK1;BPTF;ZSCAN18;ZBTB32;MYNN;HOXC5;TFAP4;DHX9;PBX2;ZBTB25;AR;ATF2;MYC;FOXJ3;KLF11;HOXA9;MAFB;ZKSCAN5;ZBTB7A;ZNF467;ONECUT2;ZFP62;ZIC5;CIART;MAZ;NR1D2;ZBTB12;DNMT3A;SARS1;ZBTB11
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.41777478524324,-1.0293653769718016,0.4176904176904177,0.7256757129382941,1.0,5/12,8.58%,IGF1;GNAS;INSR;SOCS2;YWHAG
prerank,GTPase activity (GO:0003924),-0.22908073284017216,-1.0278409214703572,0.39705882352941174,0.7247832662036944,1.0,55/192,19.48%,RHOBTB1;MRAS;KRAS;RRAS2;GNAS;GBP7;RASL12;RAP1A;DRG1;RAB23;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;RAB21;ARHGDIB;GBP4;RAB5A;RHOC;RAB5C;DNM3;GBP2;GCH1;GPN1;RAB31;DRG2;EEF1A1;RRAGC;ARL2;RAB35;NKIRAS1;GBP6;RALB;RAN;RAB38;RRAS;GNL1;RAP2C;GNAZ;ATL3;GPN3;GNA14;ARL1;RAB1A;RAB6A;GTPBP1;RAP2B;GNG11;TSR1;RERG;GSPT2;RAB4A;RAB8B;RRAGB
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.3246863784083015,-1.0269025836937422,0.39344262295081966,0.7223264911283706,1.0,4/25,4.46%,MICAL2;CYP26B1;NOS3;FMO2
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.4452479529049479,1.0258292737315486,0.4308510638297872,0.9127981174370892,1.0,4/12,13.82%,GABRA1;GABRG3;GABRG2;GABRB1
prerank,DNA binding (GO:0003677),0.2577216513929882,1.024471107948113,0.41446028513238287,0.9124372165810913,1.0,152/694,19.87%,RORA;C1D;ISL2;RBMS1;ATF5;ARID3A;PPARA;MEIS1;TEAD1;ETV5;NR2F2;TCF7L2;TCF4;POLG;TAF12;ERCC1;NR1H4;MBD6;ZIC4;MEIS2;TIPIN;PGR;MCM7;POU3F3;PPARD;NR1H2;FAN1;FEN1;POLQ;TBX3;SOX6;ERCC5;GTF2A1;ZNF423;ZBTB16;CHD4;MYCN;MSH3;RTF1;EPAS1;HLF;FOXS1;TLR8;E2F4;NEIL3;MBD3;ACR;POLA1;CSRNP3;HP1BP3;NPAS2;RPA1;LYAR;BCL6;ALX4;HMCES;NR2C1;ERCC4;TERF1;CSRNP2;ZKSCAN3;POLL;WBP11;SPTY2D1;CHD2;SOX2;GLI1;APLP2;XPC;SRRT;BRCA2;RFC3;CR2;SOX10;TP53;MCM4;SMARCA1;DHX36;TOP3A;ZNF292;GTF3C4;RFX2;ESR2;SOX9;CENPC;CDT1;POLG2;SPRTN;HIC2;RAD52;PRDM5;TSG101;MBD4;SREBF1;CUX2;MYRF;LONP1;MCM10;ERCC2;SSBP2;BPTF;ZBTB32;CHD8;TFAP4;DHX9;SAFB2;MLF1;AIFM2;RC3H2;MYC;CRY2;FOXJ3;WDR76;MAFB;ZBTB7A;ZNF3;ZCCHC3;RBM5;NHEJ1;CALR;TRIM26;DNMT3A;TOP2A;SAFB;MCMDC2;SMC1A;MSH6;MBD1;WRN;FBH1;HDGFL2;ILF3;SSBP1;REXO4;KHDRBS1;ATAD5;HIF1A;DEDD2;ZNF711;CARF;RBM6;CREBZF;ARNT;CBFB;GTF3C3;NR2C2;SP1;CNBP;HIVEP2;LRRFIP1;HOXB2;POLE
prerank,calcium activated cation channel activity (GO:0005227),-0.3666311737918972,-1.0223065797546227,0.4198473282442748,0.7289192539201365,1.0,2/17,2.46%,ANO6;ANO1
prerank,small GTPase binding (GO:0031267),-0.2269905360531649,-1.0221361770663282,0.4050632911392405,0.7245786841830308,1.0,37/169,14.29%,PLCE1;PICALM;ERC1;DOCK4;FGD5;CAV1;AFDN;RNF152;RAPGEF6;IQGAP1;EXOC4;RIN3;YBX3;NDRG1;UNC13B;EXOC5;SH3BP4;SRGAP2;ARHGDIB;RANGAP1;PPP6R1;RALBP1;RUSC2;EXOC2;SGSM2;OPTN;RNF41;MYO1C;MAPKAP1;TBC1D7;ALS2;GOLGA4;EVI5L;CCDC186;FLNA;LSM2;BICD2
prerank,N-acyltransferase activity (GO:0016410),0.36380455493979547,1.021543768371472,0.4267716535433071,0.9162188713679347,1.0,8/32,16.38%,NAA10;NAT10;CERS4;TLCD3B;NAA50;NAT8L;CERS6;GNPNAT1
prerank,RNA stem-loop binding (GO:0035613),0.4414672439732946,1.0212791907155048,0.44308231173380036,0.9125335850660217,1.0,5/12,15.34%,EPRS1;FMR1;LARP6;DHX9;RC3H2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.2579408376904126,1.0207450814869103,0.41431451612903225,0.90970234261547,1.0,128/731,17.30%,TBX18;RORA;ZNF367;ZEB1;ZBTB20;ZFHX3;MSC;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;MEIS1;TEAD1;TEF;HDAC1;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;MEIS2;PGR;NFATC3;ZNF740;MYT1;POU3F3;PPARD;NR1H2;TEAD2;REST;TBX3;FOS;ZBTB24;SOX6;ZIC1;FOXO6;HOXC9;ZNF423;ZBTB16;MYCN;DMRTA2;HLF;CREB3L2;FOXS1;E2F4;GLIS1;SRF;NPAS2;PAX9;ZBTB2;BCL6;NR2C1;ZKSCAN3;TWIST1;CHD2;SOX2;MXI1;GLI1;OLIG2;WIZ;BHLHE22;NSD1;GLI3;SOX10;TP53;DHX36;ZBTB39;MED8;HOXB9;ZBTB26;RFX2;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TFEB;HOXB4;ST18;HIVEP3;HIC2;DMRTA1;ZNF628;PRDM5;NRIP1;NFIX;HOXC4;ZFP1;RFX4;SREBF1;ARNT2;ELK1;BPTF;ZSCAN18;CREB3L1;ZBTB32;MYNN;HOXC5;TFAP4;DHX9;PBX2;ZBTB25;AR;ATF2;MYC;FOXJ3;KLF11;HOXA9;MAFB;ZKSCAN5;ZBTB7A;ZNF467;ONECUT2;ZFP62;ZIC5;CIART;MAZ;NR1D2;ZBTB12;DNMT3A;SARS1;ZBTB11
prerank,bHLH transcription factor binding (GO:0043425),-0.34860488993819627,-1.0201738425813571,0.3884057971014493,0.7248894235312098,1.0,8/19,25.65%,LMO2;PSMD9;SMAD3;SIRT1;MAP3K10;BHLHE40;BHLHE41;KDM1A
prerank,alpha-actinin binding (GO:0051393),-0.341465579078612,-1.0200500222203226,0.40664961636828645,0.7205074737462013,1.0,14/24,38.65%,CACNA1C;PDLIM5;DAG1;PDLIM3;MAGI1;PKD2L1;TTN;PPARG;SYNPO2;PDLIM2;PDLIM1;NRAP;MYPN;KCNA5
prerank,nucleoside-diphosphatase activity (GO:0017110),0.4480187384571353,1.0188562456715442,0.4426229508196721,0.9109722239355413,1.0,2/12,4.53%,ENTPD2;ENTPD5
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.2760825936764316,-1.0184530931409383,0.4075342465753425,0.7198799963827375,1.0,17/53,17.98%,DDO;MICAL2;NOS3;PRODH;CYB5R3;XDH;ETFDH;NQO2;PPOX;MTHFR;NOS1;NOX4;CYB5R1;SDHA;MICAL3;AIFM1;NDOR1
prerank,protein phosphatase activator activity (GO:0072542),-0.38929726982450363,-1.0184486513716842,0.4288939051918736,0.7153083084208433,1.0,5/13,18.58%,IGFBP3;CALM1;PHACTR4;PPP2R5D;PPP2R5B
prerank,DNA replication origin binding (GO:0003688),0.37742343141673057,1.0177727298355452,0.4491803278688525,0.9094332273562279,1.0,9/23,20.91%,MCM7;POLA1;MCM4;MCM10;DHX9;ORC2;MCMDC2;KAT7;ORC5
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.25670568394048227,1.0172930197248662,0.43478260869565216,0.9064849204004081,1.0,113/597,18.42%,TBX18;ZBTB20;ISL2;MSC;ATF5;ETV1;PKNOX2;RUNX2;HOXC10;TEAD1;ETV5;TEF;TCF7L2;TCF4;BASP1;ERBB4;THRA;SMAD5;ZIC4;PER3;MEIS2;MCM7;NFATC3;ZNF740;PPARD;TEAD2;REST;TBX3;FOS;SOX6;ZIC1;HOXC9;FOXN2;MYCN;DMRTA2;HLF;CREB3L2;LIN28B;BCOR;E2F4;GLIS1;POLA1;SRF;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;PER2;SOX2;GLI1;OLIG2;BHLHE22;GLI3;ZBTB43;HOXC8;SOX10;TP53;MCM4;DHX36;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;SOX9;CENPC;TFEB;HOXB4;DMRTA1;PRDM5;NFIX;CARM1;HOXC4;ZFP1;RFX4;MBD4;SREBF1;CUX2;ARNT2;MCM10;ELK1;TSPYL2;CREB3L1;ZBTB32;TFAP4;DHX9;AR;ATF2;CRY2;ORC2;FOXJ3;KLF11;HOXA9;ZBTB7A;ONECUT2;NONO;HNRNPL;ATMIN;ZIC5;NR1D2;ZBTB12;MBD2;ASH2L;ZNF32;MCMDC2;SUV39H2;KAT7;NFAT5;SKOR2;HEY1;BRD7
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3132564557879644,1.0164437658378167,0.4195710455764075,0.9045675169491284,1.0,15/71,11.70%,CDC14B;PTPRT;PTEN;PTPRR;PTPRN2;DUSP1;PTPN22;DUSP22;PALD1;PTPRU;PTPRO;PTPN13;TNS2;PTPRA;UBASH3B
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3997757936243729,-1.0157065850891143,0.4482758620689655,0.717572927446653,1.0,6/13,30.74%,AGPAT4;LCLAT1;PNPLA3;AGPAT2;AGPAT5;LPCAT2
prerank,chemokine binding (GO:0019956),0.3625851498860725,1.0133757365374663,0.42045454545454547,0.9093733375171311,1.0,4/30,8.43%,ITGAV;CCR9;ACKR2;PLP2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3732292967334272,1.0125864004249123,0.4157303370786517,0.9073958131810749,1.0,7/25,13.62%,GAB2;FCHSD2;ADAP2;PLEKHA1;COMMD1;MYO1G;DAPP1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.35867454748615746,1.0108820245721164,0.4345718901453958,0.9080291541288815,1.0,11/33,20.82%,NCOA3;ERCC5;UVSSA;ELP4;ZNF326;DHX9;AR;AGO1;LLPH;CDC73;GTF2B
prerank,potassium ion leak channel activity (GO:0022841),0.419999354621007,1.0089432906007152,0.43485617597292725,0.908981247255922,1.0,4/15,15.94%,KCNK2;TMEM175;KCNK1;KCNK13
prerank,chemorepellent activity (GO:0045499),0.3715170433146065,1.0088988143769115,0.44339622641509435,0.9048165158595034,1.0,3/25,1.98%,EPHA7;NRG1;SEMA5A
prerank,lysine N-methyltransferase activity (GO:0016278),0.3876453057967776,1.0087016803153954,0.4297520661157025,0.9009990027726028,1.0,7/20,23.36%,EEF1AKMT4;VCPKMT;SETD4;EHMT2;ATPSCKMT;EHMT1;ANTKMT
prerank,RNA polymerase core enzyme binding (GO:0043175),0.35381472739595254,1.008367446930368,0.4512,0.8977177660670758,1.0,16/33,27.62%,NCOA3;ERCC5;SPTY2D1;UVSSA;ELP4;ZNF326;DHX9;AGO1;CDC73;GTF2B;MAF1;RRN3;RPRD2;ELP2;CTR9;WDR43
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.32207507777184874,-1.0074556817443454,0.430939226519337,0.7335613309497427,1.0,9/27,22.04%,CRCP;POLR2B;POLR2G;PRIMPOL;POLR2C;POLR1H;POLRMT;POLR1C;POLR3K
prerank,lipoprotein particle receptor binding (GO:0070325),0.37009906915465174,1.005739859261504,0.4486571879936809,0.9008009211938832,1.0,7/27,18.62%,LRP1;HSPG2;RELN;HSP90B1;CLU;LDLRAP1;SYT1
prerank,5'-3' exonuclease activity (GO:0008409),0.42417724349265923,1.004452872036041,0.4413309982486865,0.9002005902454413,1.0,5/14,23.45%,FAN1;FEN1;DXO;TRIR;DCP2
prerank,amyloid-beta binding (GO:0001540),0.3012998538925108,1.0026421372339598,0.4314789687924016,0.9011802247452643,1.0,12/79,7.19%,LRP1;HSPG2;GRIA3;GRIN2B;GRIA4;GRIA1;NGFR;TLR6;SORL1;ATP1A3;GRIN2A;C1QA
prerank,double-stranded DNA binding (GO:0003690),0.25362034117039284,0.9984953632013105,0.4746450304259635,0.9083931499943906,1.0,91/531,18.37%,TBX18;ZBTB20;ISL2;RBMS1;MSC;ETV1;PKNOX2;RUNX2;HOXC10;TEAD1;ETV5;TEF;TCF4;SMAD5;ZIC4;MEIS2;NFATC3;ZNF740;PPARD;FEN1;TEAD2;TBX3;FOS;ZIC1;ERCC5;HOXC9;FOXN2;MYCN;MSH3;DMRTA2;HLF;LIN28B;E2F4;GLIS1;NEIL3;SRF;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;TERF1;OLIG2;BHLHE22;GLI3;ZBTB43;HOXC8;SOX10;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;SOX9;POLG2;SPRTN;TFEB;HOXB4;DMRTA1;NFIX;HOXC4;ZFP1;RFX4;SREBF1;CUX2;ARNT2;ELK1;CREB3L1;ZBTB32;TFAP4;DHX9;ATF2;FOXJ3;KLF11;HOXA9;ZBTB7A;ONECUT2;ZCCHC3;ZIC5;NR1D2;ZBTB12;SAFB;ZNF32;MSH6;MBD1;NFAT5;FBH1;SKOR2;HDGFL2;HEY1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2939518976734001,0.9980333923921717,0.45132743362831856,0.9055100256630705,1.0,21/100,14.84%,ZFYVE28;OGT;GAB2;WDR45B;MYO10;GBF1;MYO1B;FCHSD2;ADAP2;CYTH3;COMMD1;ZFYVE26;ARAP2;GSDMD;MYO1G;PLEKHA5;ARFIP1;DAPP1;CLVS1;SNX12;FERMT2
prerank,solute:sodium symporter activity (GO:0015370),-0.3174729502618935,-0.9972785711159156,0.4190751445086705,0.7546291424104455,1.0,22/27,56.38%,SLC4A10;SLC20A1;SLC4A8;SLC4A7;SLC5A6;SLC4A9;SLC4A5;SLC4A4;SLC34A3;SLC5A3;SLC28A2;SLC13A5;SLC28A3;SLC5A10;SLC5A8;SLC17A7;SLC28A1;SLC5A1;SLC34A2;SLC5A2;SLC5A9;SLC17A1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4396071456133954,0.9972096952429292,0.45768566493955093,0.9037235153671703,1.0,2/13,4.12%,FAN1;FEN1
prerank,RNA polymerase II complex binding (GO:0000993),0.3531706828904713,0.9971015789536969,0.4668769716088328,0.8999661645405304,1.0,10/32,20.82%,NCOA3;ERCC5;UVSSA;ELP4;ZNF326;DHX9;SCAF1;AGO1;CDC73;GTF2B
prerank,SH2 domain binding (GO:0042169),0.34914755244121476,0.9969860115740595,0.43993506493506496,0.8961818004118594,1.0,5/31,7.71%,DLC1;PAG1;IRS1;RUFY1;PTK2
prerank,syntaxin binding (GO:0019905),0.31030535592092173,0.9958167783817812,0.4666666666666667,0.8952012227041577,1.0,24/61,23.48%,VAMP2;LRRK2;NAPB;SNAP23;SNPH;SYT3;SYP;GOLGA2;SNAP29;SYNPR;SCFD1;SYT5;UNC13A;VPS52;STXBP5;TMED9;UNC13C;SYT6;SYT1;NAPG;CACNA1A;ABL1;BLOC1S6;STXBP4
prerank,nuclear import signal receptor activity (GO:0061608),0.4176774791283688,0.9937187949370987,0.4631578947368421,0.8969481036361698,1.0,7/15,22.52%,TNPO1;KPNA1;TNPO2;IPO9;KPNB1;KPNA2;IPO4
prerank,ribosome binding (GO:0043022),0.32784757341180626,0.9936683568091746,0.46266471449487556,0.8931032182883383,1.0,18/46,27.73%,CPEB1;NAA10;FMR1;SEC61B;EIF2S1;BAG6;EFL1;EIF3C;YTHDF1;MRPS27;NAA16;GEMIN5;CCDC47;ETF1;SHFL;SEC61A1;IGHMBP2;MAIP1
prerank,poly-pyrimidine tract binding (GO:0008187),0.3783114376777096,0.9924941199329341,0.47651006711409394,0.8922816626126474,1.0,3/23,5.00%,RBMS1;RBMS3;FMR1
prerank,ubiquitin binding (GO:0043130),-0.25125995052381944,-0.9924553269444876,0.4729241877256318,0.7623157608893255,1.0,25/73,22.98%,NPLOC4;DDI2;MARK4;SQSTM1;RNF185;ASCC2;TOLLIP;SMAD3;HSPB1;OTUB1;UBE2N;USP25;UCHL1;RAE1;UBE2L6;RAD23B;BUB3;TNFAIP3;FAF2;VPS28;MVB12B;ILRUN;WDR48;ADRM1;VPS36
prerank,nuclear receptor coactivator activity (GO:0030374),0.31916595446743895,0.9923628960314561,0.4463276836158192,0.8887718169673154,1.0,11/52,14.23%,NCOA2;MED12;NCOA3;ACTN1;BRD8;NCOA1;PRKCB;ENY2;CARM1;MED1;ELK1
prerank,syntaxin-1 binding (GO:0017075),0.3782129750500102,0.9908349348982,0.473421926910299,0.8891193684180461,1.0,9/22,18.62%,VAMP2;LRRK2;SNPH;SYP;SYNPR;UNC13A;STXBP5;UNC13C;SYT1
prerank,receptor antagonist activity (GO:0048019),0.3998539385520926,0.9907264507096277,0.47735191637630664,0.8854938349742224,1.0,1/17,0.62%,IL1RN
prerank,aspartic-type peptidase activity (GO:0070001),-0.4209062677102212,-0.9903094128092187,0.48,0.7631914765533047,1.0,1/10,2.50%,DDI2
prerank,phosphatase activity (GO:0016791),0.29668145279268077,0.9891727564104486,0.4772727272727273,0.8857477121826172,1.0,13/73,15.60%,LPIN3;ATP1A2;SACM1L;DUSP12;PTPN22;PLPPR3;PTPRO;PLPPR2;PLPP6;DUSP8;PLPP5;LPIN2;ACP2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.44645057504465036,0.9844696527874749,0.49222797927461137,0.8943679269947847,1.0,3/11,7.82%,RPA1;HNRNPA2B1;TERF1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3247399666968678,-0.9839898531931089,0.4854111405835544,0.774427162906261,1.0,8/24,22.42%,OSBPL8;PLA2G4A;CERT1;GOLPH3L;JPH2;SNX3;PLA2G4E;LANCL2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3875319806499179,0.9808037254795035,0.488135593220339,0.9002472746024855,1.0,3/18,8.99%,PIK3R1;PIK3R2;CCKBR
prerank,carboxy-lyase activity (GO:0016831),0.3739197440150368,0.9801985075570547,0.4697452229299363,0.8980818290427895,1.0,3/23,9.39%,ODC1;UXS1;GGCX
prerank,microtubule minus-end binding (GO:0051011),-0.3831550198849806,-0.9780522108778457,0.482837528604119,0.784774309125706,1.0,5/13,19.65%,CEP290;TUBGCP5;MACF1;CAMSAP2;NUMA1
prerank,nuclear receptor binding (GO:0016922),0.2804606603373808,0.9762631765979828,0.49625,0.9047941816455511,1.0,28/111,17.04%,PPID;TCF7L2;NR1H4;NCOA2;GRIP1;DNAAF4;MED12;JUP;NCOA3;BRD8;NCOA1;PRKCB;DAXX;NSD1;HMGN3;SNW1;CNOT1;NRIP1;MED1;MED25;ASXL1;GTF2H1;PRMT2;DCAF1;MMS19;ZBTB7A;TRIP4;CALR
prerank,tRNA binding (GO:0000049),0.33082500352602623,0.975236061944501,0.5143288084464555,0.903695607210521,1.0,20/43,27.23%,NAT10;CTU1;ELP1;PSTK;CARS1;TRNAU1AP;PTCD1;SARS1;SARS2;SEPSECS;MRPS27;TRMT10A;AIMP1;AARS1;TRMT10C;SSB;NSUN6;YARS2;IGHMBP2;ALKBH8
prerank,growth factor receptor binding (GO:0070851),-0.23676378401707582,-0.9751746272326549,0.5253456221198156,0.7877002488699609,1.0,22/95,18.62%,PDGFD;PTPRJ;FER;IL1R1;ERAP1;VEGFD;VEGFC;IL6ST;PDGFA;FGF1;PDGFC;FRS2;CCDC88A;ITGB3;TRIP6;HIP1;GRB2;ERN1;ESM1;EGF;SDCBP;EFEMP1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.2003909567440289,-0.9740222187490529,0.5666666666666667,0.7860337366530652,1.0,129/431,23.33%,PRKAG2;DAPK1;RHOBTB1;MARK1;MRAS;KRAS;RRAS2;GBP7;MARK4;ABCD3;NEK6;RASL12;MAP3K5;RAP1A;INSR;DRG1;ABCD4;HSPA8;TOP1;RHOQ;RHOBTB2;SIK3;MINK1;WNK4;RAC1;TLK1;CDK6;SYN1;GBP5;SNRK;PEX1;CDC42;WNK1;PRAG1;ARL6;RAB21;SIK1;PGK1;ADSS2;ACVR1;ABCC6;GBP4;RAB5A;CDC42BPB;RHOC;ACVRL1;GBP2;GCH1;RAB31;TLK2;STK38L;ABCF1;DYRK2;DRG2;RPS6KA5;EEF1A1;RRAGC;RAB13;TAP2;ABCF2;SMARCA5;ARL2;RAB35;REM1;GBP6;RALB;RTEL1;SRPK1;SYN3;TGM2;CLPX;PSMA6;MYH10;GUK1;PMVK;RAN;RAB38;PFKL;RRAS;GNL1;P2RX7;TBCK;RAP2C;STK17B;ABCB8;CDC42BPG;ERN1;ATL3;NOA1;ARL1;TUBB2A;RAB6A;ATP5F1D;AKT1;RAP2B;NUAK2;TSR1;RERG;DYNC1LI1;MARK2;MCM6;MAP4K3;CLP1;RAB4A;RRAGB;MLKL;TRNT1;MKNK1;MFHAS1;ARL4C;TUBA1C;ABCB9;RAB1B;SCG5;RHOH;TWF2;TUBA4A;TUBB2B;AK6;MTG2;MYO18A;LANCL2;NDUFA13;DDX25;CAD;RAB9A;MYH9;RAP1B;PRPS2
prerank,potassium ion antiporter activity (GO:0022821),0.39950613873503993,0.9738348290163507,0.485,0.9034937607279679,1.0,3/15,6.01%,SLC24A5;SLC9A9;SLC9A1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.346219670620379,0.9729669275931115,0.4946889226100152,0.9017746762999231,1.0,3/32,4.87%,SLC1A5;SLC43A1;SLC7A8
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.39830706523080894,0.9721527637008741,0.4882882882882883,0.8999970458272538,1.0,3/14,6.31%,PTEN;MTMR4;MTMR1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.31372800604956363,-0.9692027571688898,0.5,0.7936824074560359,1.0,5/22,13.08%,PICALM;MESD;APOE;AP2A1;SNX17
prerank,vitamin D receptor binding (GO:0042809),0.4056164062260892,0.9683577207156909,0.5025996533795494,0.9064196238837449,1.0,5/14,20.83%,MED12;SNW1;MED1;TAF11;MED14
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.26720387832052617,0.9630237760990067,0.5710982658959538,0.9163998310291512,1.0,44/181,20.71%,PPARA;PTPRT;MIER2;HDAC1;HIF1AN;TCF7L2;CDKN2A;NR1H4;NCOA2;JUP;PPARD;TBX3;FOS;NCOA3;MDFIC;CHD4;BRMS1;FIZ1;PIAS2;NCOA1;TP53;ZFPM2;SNW1;ATN1;NRIP1;MED1;ARNT2;ELK1;DHX9;DMAP1;AR;ATF2;TRIP4;LDB2;LDB1;BBS1;HIF1A;ARNT;SP1;DDRGK1;MTA3;MTA1;RERE;BBS4
prerank,chloride channel activity (GO:0005254),0.30808990966848454,0.9627099219388452,0.5083102493074793,0.9134102839842599,1.0,14/59,15.71%,ANO4;GABRA1;GABRD;CLCC1;GABRG3;CLCN3;CLCN2;GLRA3;GABRG2;GLRA1;CLCN6;GLRA2;GABRB1;GLRB
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3159555580538076,0.9613631143657744,0.5059701492537313,0.9129140727065272,1.0,8/49,7.72%,ATP1A2;SACM1L;DUSP12;PTPN22;PLCXD3;PLCXD1;PTPRO;ENPP6
prerank,transition metal ion binding (GO:0046914),0.24880277828624947,0.9584759468189008,0.5879873551106428,0.9162943332842719,1.0,79/397,18.07%,ENPP1;ECE1;ZEB1;HRG;ADH1A;TIMM10;MYCBP2;PAM;HIF1AN;CBLB;PDXK;GRIN2B;EPRS1;TYR;DUSP12;MYT1;FEN1;LOXL3;LOXL2;SLC30A5;DNAJC24;KMT2A;CHD4;ZFP37;DHX58;SIRT6;GRIN2A;CCS;ACR;TARS1;ENPP3;CALB1;ADCY2;MDM4;TRIM8;DPYS;COMMD1;BIRC2;AGMO;NSD1;SLU7;SEC24B;PITRM1;PGGT1B;TP53;GLRA1;ZFPM2;P2RX4;USP33;ENDOU;PTGR2;HEPH;KDM1B;TRIM2;HDAC10;B4GALT7;PIM1;ATP7A;RABIF;KDM5C;ZBTB32;TMEM163;AOX1;ZKSCAN5;KDM2A;ZNF3;CYP2R1;USP16;DPEP1;SEC24A;CALR;RNPEP;GALNT2;SEC23A;ADAM8;PEX12;SUV39H2;MBD1;WRN
prerank,epidermal growth factor receptor binding (GO:0005154),-0.30716423531925535,-0.957372751101886,0.5053475935828877,0.8188217550817588,1.0,11/25,28.29%,FER;CCDC88A;HIP1;GRB2;EGF;EFEMP1;LINGO1;CNOT9;FAM83B;ARF4;SNX2
prerank,estrogen receptor binding (GO:0030331),0.3360406505671695,0.9562454314912855,0.5206106870229008,0.9182862283718504,1.0,12/32,18.17%,PPID;DNAAF4;NCOA1;NSD1;CNOT1;NRIP1;MED1;PRMT2;DCAF1;MMS19;TRIP4;TAF10
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.38627134459301543,0.9559864564830075,0.5216,0.9152117344235139,1.0,5/17,18.06%,BLVRB;DHCR24;PTGR2;PECR;DPYD
prerank,microtubule binding (GO:0008017),0.25560474559896895,0.9554145002345127,0.5538990825688074,0.9130881221072142,1.0,54/222,19.15%,CCDC61;REEP2;MDM1;MAP4K4;IRAG2;MTCL1;FMR1;NEFH;LRRK2;CENPE;STARD9;CEP295;SUN2;CLIP3;LRPPRC;SNPH;TERF1;HAUS8;FAM161A;GOLGA2;NAV3;OPA1;CCSAP;CAPN6;KATNA1;NUSAP1;GAS8;RMDN1;DNM1;TUBGCP4;SYBU;POLB;KIF5C;CLIP2;KIF9;EML1;TPGS1;MAP9;CLASP2;STIM1;KIF3C;TUBGCP6;KIFC2;KIF2A;CLASP1;CEP44;CDK5;ALMS1;MAST1;KIF21A;SPEF1;PEX14;KIF13B;SVBP
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.23302372092945103,-0.955361395473783,0.5877192982456141,0.8189056183961562,1.0,26/85,24.52%,PLA2G4A;MGLL;PON3;NDST3;GDPD3;PAFAH2;LIPA;LIPE;ENPP2;ABHD2;PLA2G6;TARS2;PAFAH1B2;PTRH2;PLAAT3;DDHD2;ESD;PLA2G4E;PNPLA3;PLA2G4C;MRPL58;LYPLA1;FAAH;GDPD1;AOAH;PGLS
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3751594332751179,0.9547590575985442,0.5042735042735043,0.9111106479488366,1.0,4/19,11.43%,NRG1;DGKQ;GRM5;NRG3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.31560814095457934,0.9505886218699529,0.5155096011816839,0.9180103071538842,1.0,16/42,25.27%,PIK3R1;PIK3R2;NEDD4;IRS1;FGR;CRK;LDLRAP1;PIK3R3;SH3BP2;PTPN11;BCAR3;NCK2;ABL1;VAV2;YWHAE;CRKL
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.34427322449652703,0.947918314812629,0.5044642857142857,0.921218881284277,1.0,6/28,17.68%,EDA;TRAF4;TRIM37;RIPK1;FEM1B;MYD88
prerank,amino acid transmembrane transporter activity (GO:0015171),0.3074389455018377,0.9464486957086425,0.5350500715307582,0.9212709434030337,1.0,6/47,7.32%,SLC1A5;SLC6A13;SLC7A11;SLC43A1;SLC7A8;SLC66A1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.38193614442416324,-0.9463901256869093,0.5154185022026432,0.8364133832791473,1.0,1/10,0.82%,CACNA1C
prerank,endopeptidase activity (GO:0004175),0.25473625207189254,0.9455304742965028,0.5868131868131868,0.9199345123267059,1.0,51/257,19.88%,ECE1;ECE2;ADAMTS14;MASP1;ADAMTS6;MBTPS2;FAP;MMP28;MMP24;MMP25;PCSK2;HTRA3;USP1;CASP6;ADAM19;CASP4;OMA1;ACR;ADAMTS12;PSMA5;USP42;MMP11;PSMB5;PLAU;LGMN;ADAMTS2;RHBDL3;NRDC;PITRM1;PSMA4;USP33;HTRA2;SPRTN;PSMB9;ADAMTS20;ADAMTS10;USP34;PSMA7;ADAMTS19;USP16;USP13;USP49;PSMA2;USP14;EEF1AKMT4-ECE2;RHBDD1;TASP1;CTSK;USP46;PLAT;PRTN3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.32815706857802124,-0.9444391276717977,0.5425,0.8366916344177671,1.0,5/20,20.68%,LPGAT1;AGPAT4;LCLAT1;PNPLA3;AGPAT2
prerank,phosphotyrosine residue binding (GO:0001784),0.32224170021844767,0.9439624074176665,0.5370919881305638,0.9205427540666306,1.0,11/37,20.64%,PIK3R1;PIK3R2;IRS1;FGR;CRK;LDLRAP1;PIK3R3;SH3BP2;PTPN11;BCAR3;NCK2
prerank,translation initiation factor activity (GO:0003743),0.3303886700142214,0.9437377878963223,0.5484848484848485,0.9175336700658553,1.0,8/36,18.72%,EIF4G3;EIF3H;EIF2B1;EIF4A2;EIF2S1;EIF5B;EIF3C;EIF3G
prerank,exopeptidase activity (GO:0008238),0.3011123395506614,0.9434768661019114,0.5416666666666666,0.9146318725542569,1.0,7/50,6.96%,DPP6;FAP;DPP10;METAP1D;BLMH;DPEP3;CPM
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3285545600340749,0.9427859939908766,0.5349544072948328,0.9128617739666485,1.0,12/34,23.36%,EEF1AKMT4;KMT2E;VCPKMT;DOT1L;N6AMT1;SETD4;EHMT2;ATPSCKMT;MEN1;CAMKMT;EHMT1;ANTKMT
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4138014949259312,0.9424547828779694,0.5207956600361664,0.9102082459540577,1.0,5/11,22.77%,SLC35B3;LRRC8A;SLC25A17;SLC19A1;SLC25A24
prerank,exoribonuclease activity (GO:0004532),0.40248604518753356,0.9417183829734306,0.5457875457875457,0.9085592627766093,1.0,5/12,15.89%,EXOSC9;EXOSC10;CNOT7;EXOSC8;EXOSC5
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.3892817260775383,0.9413157987227174,0.5502645502645502,0.9060514634260985,1.0,2/15,5.02%,ALDH1A1;ALDH3B1
prerank,histone deacetylase binding (GO:0042826),0.28007677398721154,0.940880150442409,0.5463917525773195,0.9036301031727995,1.0,24/88,21.00%,MIER2;HDAC1;TOP2B;CHD4;BCOR;GMNN;BRMS1L;BRMS1;PHF6;KAT2A;GLI3;NUDT21;TP53;DHX36;ZMYND15;HDAC10;TFAP4;TOP2A;THAP7;NACC1;SP1;MTA3;MTA1;MEF2B
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.29881071890584865,0.9405625447204005,0.5376044568245125,0.9009266973305047,1.0,8/55,12.52%,SLC24A5;ITPR1;RYR2;ATP2A2;TRPV3;TRPC3;TRPM2;CUL5
prerank,sterol transfer activity (GO:0120015),0.3731586427867032,0.9405465321607565,0.530278232405892,0.8974970575290809,1.0,4/17,19.36%,GRAMD1B;MTTP;OSBP;NPC2
prerank,ion channel inhibitor activity (GO:0008200),-0.2754973046255996,-0.94037416975067,0.5329341317365269,0.8413339912416888,1.0,7/35,9.43%,CAMK2D;WNK4;WNK1;STX1A;CALM1;MCUB;STX7
prerank,endoribonuclease activity (GO:0004521),-0.290842617155355,-0.9388036678763562,0.5710227272727273,0.8403522669654293,1.0,10/32,22.60%,KHNYN;SMG6;NYNRIN;DICER1;RNASEL;ENDOV;ERN1;AGO2;LACTB2;YBEY
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.38177369329012745,0.9376230246706052,0.5250836120401338,0.9012251585732671,1.0,1/15,1.30%,PLA2G2C
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3682160063401276,-0.9375519585185044,0.4976635514018692,0.838533053586647,1.0,5/12,15.24%,PIK3C2B;PIK3CB;PIK3CD;ATM;PIK3R6
prerank,channel activity (GO:0015267),0.31229117262158707,0.9343035960886723,0.5648286140089419,0.9057175536388716,1.0,3/41,6.19%,TRPA1;SLC14A1;TRPV3
prerank,histone methyltransferase activity (GO:0042054),-0.28572448226788033,-0.9340177313404966,0.5356125356125356,0.842557093858951,1.0,6/32,10.67%,SMYD3;KMT5B;NTMT1;PRMT7;SMYD2;PRMT8
prerank,double-stranded RNA binding (GO:0003725),0.28437803527119404,0.9332905150833378,0.5652759084791387,0.9047763715778843,1.0,26/70,22.26%,AGO4;ADARB2;FMR1;DHX58;ZNF346;ACTN1;TLR8;DUS2;MRPL44;DHX30;STAU2;EIF2AK2;DHX36;AGO3;DHX9;RC3H2;ADAR;PRKRIP1;AGO1;ILF3;FXR1;LRRFIP1;EIF4A1;DHX15;DHX33;EIF4B
prerank,mannosyltransferase activity (GO:0000030),-0.3199284747998161,-0.9321847100411113,0.5473145780051151,0.8422552492047829,1.0,5/21,10.16%,TMTC2;TMTC1;ALG9;TMTC4;ALG12
prerank,ATPase binding (GO:0051117),-0.23988198915149506,-0.9312814921334999,0.6541353383458647,0.8395196839695043,1.0,24/71,23.67%,CAV1;EGFR;EZR;PTPN3;ATP6V0A4;RDX;SNTA1;ATP1B3;TMTC4;ANK2;RALB;PEX26;USP25;ESR1;CHMP4A;NUFIP1;ATP6V0A2;CLPP;SELENOS;TOR1AIP1;ATP6V0A1;ATP6V1G1;PLN;DNAJB1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3633390778452046,-0.9307803881838421,0.5450236966824644,0.8359553103756064,1.0,5/12,26.31%,AGO2;DCPS;NCBP2;CYFIP2;NCBP3
prerank,ubiquitin-dependent protein binding (GO:0140036),0.41678731662200097,0.9305740353907213,0.542649727767695,0.907975912208792,1.0,5/10,25.28%,FAN1;FAAP20;ANKRD13B;IDE;DNAJC2
prerank,histone deacetylase activity (GO:0004407),0.36817739146774664,0.9294052852220243,0.5614617940199336,0.9072655255234208,1.0,3/19,5.75%,MIER2;HDAC1;SIRT6
prerank,omega peptidase activity (GO:0008242),0.28054335546076653,0.9289375665306583,0.5802631578947368,0.9048940949666132,1.0,31/89,25.21%,GGT5;STAMBPL1;GGT7;USP1;UCHL3;USP42;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;USP21;USP16;USP13;STAMBP;PSMD14;USP49;USP14;USP46;USP45;USP48;USP31;UFD1;USP24;USP22;OTUD7A;JOSD2;USP2;USP36
prerank,galactosyltransferase activity (GO:0008378),0.40971390678060365,0.9258469060029436,0.5400696864111498,0.9086047610455735,1.0,5/11,13.64%,B4GALT2;A3GALT2;B4GALT3;B4GALT4;B4GALT7
prerank,calcium-activated potassium channel activity (GO:0015269),0.4086152306722596,0.9248549142598808,0.5593803786574871,0.9076488131620555,1.0,2/11,12.30%,KCNMA1;KCNN2
prerank,phospholipase activity (GO:0004620),0.28587009612581954,0.9248488802728156,0.5570652173913043,0.9042978744265643,1.0,10/67,12.04%,PLCL1;GPLD1;PRDX6;LIPC;LIPH;SMPD4;PNPLA7;ABHD16A;LYPLA2;ABHD12
prerank,muscle alpha-actinin binding (GO:0051371),-0.3534509267530533,-0.9246870849157083,0.5528255528255528,0.8456911519620283,1.0,9/15,37.65%,PDLIM5;PDLIM3;PKD2L1;TTN;SYNPO2;PDLIM2;PDLIM1;NRAP;MYPN
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3840159894818336,0.9244595349970047,0.5611015490533563,0.9019617133116191,1.0,4/14,18.56%,KCNIP2;KCNE4;KCNJ8;KCNJ3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3645081516392408,-0.9217128878302057,0.5704545454545454,0.8480938638886534,1.0,3/12,8.83%,PARN;PAN3;CNOT8
prerank,protease binding (GO:0002020),0.27098896631760583,0.9207593349242519,0.5803108808290155,0.9069875631601281,1.0,22/99,17.52%,SLC2A13;NTRK2;PTEN;ITGAV;POLG;ITGA3;FAP;BFAR;NOL3;COL1A2;PINK1;BRCA2;TP53;PYCARD;ATP9A;STIM1;BAG6;SERPINC1;TRIP4;DVL3;COL3A1;A2M
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.28196910369732975,-0.9190306854083292,0.5702702702702702,0.8498243124233048,1.0,5/29,9.87%,PTPRJ;ACE;MAPK14;GCH1;PPM1D
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.24797297816519784,0.9173534560876453,0.6398601398601399,0.9116760989203031,1.0,33/188,16.89%,TBX18;ZBTB20;ATF5;ETV5;TCF7L2;BASP1;ERBB4;THRA;PER3;REST;FOS;SOX6;CREB3L2;BCOR;PER2;SOX2;GLI1;SOX10;TP53;DHX36;TFEB;PRDM5;CARM1;ELK1;CREB3L1;TFAP4;DHX9;AR;CRY2;KLF11;NONO;HNRNPL;ATMIN
prerank,cholesterol transfer activity (GO:0120020),0.36916013923897595,0.915912035864058,0.5663865546218487,0.9116703702970341,1.0,1/16,1.24%,GRAMD1B
prerank,chemokine receptor activity (GO:0004950),0.3423152821019635,0.9152400277036364,0.5801652892561984,0.9098116564056234,1.0,2/24,3.26%,CCR9;ACKR2
prerank,sodium:proton antiporter activity (GO:0015385),-0.3647359454600965,-0.9138550505996383,0.585081585081585,0.8574086469178397,1.0,2/11,3.15%,SLC9A2;SLC9B2
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.19742321454880205,-0.9126855494297219,0.8125,0.8555218330770207,1.0,67/248,19.48%,RHOBTB1;MRAS;KRAS;RRAS2;GNAS;GBP7;MYL6;RASL12;RAP1A;DRG1;RAB23;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ATP2B1;RAB21;ARHGDIB;ABCA3;VCP;GBP4;RAB5A;RHOC;RAB5C;DNM3;GBP2;GCH1;GPN1;RAB31;DRG2;EEF1A1;RRAGC;ARL2;RAB35;NKIRAS1;MYO1E;GBP6;RALB;CLPX;RAN;RAB38;RRAS;GNL1;SMCHD1;TOR1A;RAP2C;GNAZ;ATL3;GPN3;CHD3;GNA14;ARL1;RAB1A;RAB6A;DYNC1I1;GTPBP1;KIF1C;RAP2B;ABCB10;GNG11;TSR1;RERG;GSPT2;RAB4A;RAB8B;RRAGB
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3997927354803399,0.9125562013505457,0.5680272108843537,0.9125612132880815,1.0,4/11,15.19%,PRMT3;NDUFAF7;CARM1;PRMT2
prerank,cyclic nucleotide binding (GO:0030551),0.35609205508111336,0.912280451383271,0.5664939550949913,0.9099566363529064,1.0,5/21,14.27%,RAPGEF4;PDE4B;CNBD2;HCN1;PDE4A
prerank,phospholipase A2 activity (GO:0004623),0.3339824440309303,0.9112391761093906,0.5636363636363636,0.9091274513587616,1.0,3/26,8.19%,PLA2G2C;PRDX6;PLA2G7
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.2848286938691796,-0.910344605591463,0.6212534059945504,0.8562886633610933,1.0,9/27,22.04%,CRCP;POLR2B;TERT;POLR2G;POLR2C;POLR1H;POLRMT;POLR1C;POLR3K
prerank,nucleosomal DNA binding (GO:0031492),0.3457740237414325,0.9096516390032039,0.5629984051036683,0.9093177574061316,1.0,4/21,11.15%,HDAC1;CHD4;MBD3;RCC1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.38951909823241115,0.909629687325757,0.566607460035524,0.9061287904485513,1.0,2/11,9.92%,NAA10;NAA50
prerank,G protein-coupled receptor binding (GO:0001664),0.2575597640829135,0.9076049480523548,0.6682750301568154,0.907482433726225,1.0,15/132,11.54%,XCL1;NPB;RTP4;WNT5A;REEP2;PTCH2;PDYN;TUB;CALCA;NPY;GNA11;WNT3;CCL25;USP33;PSMC5
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2930764962958685,-0.9071044830127747,0.6149425287356322,0.8592123923981347,1.0,3/26,3.07%,AEBP1;CPE;CPD
prerank,MHC class I protein binding (GO:0042288),-0.35879589137019324,-0.9070605408892906,0.5591647331786543,0.8546672312098369,1.0,3/13,10.50%,ATP5F1B;TAPBP;TAP2
prerank,E-box binding (GO:0070888),0.3155241023585711,0.9057059002108234,0.6101190476190477,0.9088333215068451,1.0,6/34,17.00%,ZEB1;TCF4;TWIST1;TFAP4;MYC;CIART
prerank,MAP-kinase scaffold activity (GO:0005078),0.3998319535058289,0.9044082618880345,0.5789473684210527,0.9086843561921661,1.0,1/11,0.33%,SH3RF1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.39770544739008723,0.9025171130612019,0.5711835334476844,0.9096306936550402,1.0,3/11,11.67%,ITPR1;TRPC3;TRPC7
prerank,motor activity (GO:0003774),0.2862193070256025,0.9021935806961734,0.5971223021582733,0.9071975560466597,1.0,20/60,23.60%,GPR88;CENPE;STARD9;MYO6;KIF5C;KIF9;KIF3C;KIFC2;KIF2A;KIF21A;KIF13B;KIF6;SMC3;KIF3A;KIF7;KIF11;KIF1B;KIF15;KIF14;KIF23
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2544440727222388,0.9017067945198886,0.6393643031784841,0.9050581455958157,1.0,9/134,4.87%,SLC1A3;SLC1A5;SLC6A13;SLC6A8;SLC16A12;SLC25A21;SLC35B3;GJA1;SLC7A8
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.3959116072150763,0.901108825388455,0.5975609756097561,0.9032329314519139,1.0,5/12,21.61%,CDK8;CDK13;CCNK;MAPK1;CDK7
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3954768446016569,0.8999293797775505,0.5899814471243042,0.9026804078250742,1.0,3/11,17.47%,NEIL3;HMCES;APEX2
prerank,acetylcholine receptor activity (GO:0015464),0.3447907497521052,0.8987150630952446,0.5764119601328903,0.9022485907173141,1.0,1/22,2.20%,CHRNB4
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4040446170466313,0.8986817954266665,0.5831842576028623,0.8992106045432869,1.0,4/11,12.28%,CASP6;CASP4;PYCARD;CASP12
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.2725704670880568,-0.8983366779998059,0.6153846153846154,0.870806912598232,1.0,7/32,9.18%,KDM4A;KDM4C;TET3;EGLN3;RIOX2;PHF8;ALKBH5
prerank,metalloexopeptidase activity (GO:0008235),-0.24899216224219012,-0.8978376208887852,0.6567656765676567,0.8673561368672756,1.0,6/51,5.43%,AEBP1;CPE;CPD;XPNPEP3;ERAP1;ACE
prerank,adenyl ribonucleotide binding (GO:0032559),0.2361690207721727,0.8965505846656548,0.7277657266811279,0.9006708504417906,1.0,52/291,14.93%,ENPP1;RAPGEF4;ATP1A2;PEAK1;ABCD2;EIF4A3;PDE4B;PDXK;P2RY1;MAP4K4;MYO1B;CDKL5;ATP1A3;PRKCI;CNBD2;MTHFD1L;CARS1;TARS1;RHOBTB3;MYO6;CDC42BPA;PRKACB;PIF1;PINK1;PFKM;ABCB6;HCN1;GCK;NOL9;PRPS1L1;PRPS1;PTPA;DHX36;P2RX4;HSPA13;TGFBR1;MTREX;PDK2;ACLY;KCNJ8;MAP4K1;LONP1;PIM1;ATP7A;NME1;WNK2;PDE4A;HSPA5;SYN2;HSPA4;CHD8;DHX9
prerank,metalloaminopeptidase activity (GO:0070006),-0.3268329755443763,-0.8946026196985067,0.6211764705882353,0.8700807267815036,1.0,4/16,20.36%,XPNPEP3;ERAP1;MMP15;TRHDE
prerank,sulfuric ester hydrolase activity (GO:0008484),0.384155239205985,0.8940214660317046,0.568935427574171,0.9032151156215857,1.0,4/12,19.65%,SULF1;GNS;ARSK;ARSJ
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.2664726009916084,-0.8939359048743288,0.6711956521739131,0.8671845674194132,1.0,7/34,12.86%,RICTOR;IQGAP1;CALM1;CAB39;MAP2K2;ALS2;ETAA1
prerank,cation channel activity (GO:0005261),0.2632010705391064,0.8927388305750412,0.648989898989899,0.9029421828677945,1.0,14/94,12.52%,TRPA1;SLC24A5;CACNA1E;NALCN;RYR2;TRPV3;KCNG1;TRPC3;TMEM38B;TMEM175;HCN1;TRPM2;KCNK1;CUL5
prerank,anion channel activity (GO:0005253),0.2865572172633564,0.8903051328183302,0.6207366984993179,0.9051659701558568,1.0,13/61,13.85%,VDAC2;ANO4;GABRA1;GABRD;CLCC1;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;LRRC8A
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.2985972603604159,-0.8880723448844912,0.6373626373626373,0.8758392755967886,1.0,10/22,24.52%,SQSTM1;PARP10;OPTN;RNF169;TAB2;TNFAIP3;IKBKE;ZRANB3;IKBKG;ATRIP
prerank,transferrin receptor binding (GO:1990459),0.4102620074656924,0.8873237233139317,0.6263345195729537,0.9082972684808458,1.0,2/10,12.94%,RGMA;CD81
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.34337201223693387,-0.8839083554594614,0.6102088167053364,0.8804803531342202,1.0,7/13,23.01%,PIK3C2B;PIK3CB;PIK3CD;PIP4K2C;PIP5K1A;PIP5K1B;PIK3C2A
prerank,myosin II binding (GO:0045159),-0.3735495120430506,-0.8821608090251781,0.6155606407322655,0.8796727883541589,1.0,4/10,16.17%,SHROOM4;GSN;SHROOM1;LLGL2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.38657853919951146,0.8816034519487012,0.6070175438596491,0.9175665589349522,1.0,3/11,18.56%,KCNE4;KCNJ8;KCNJ3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2839973950220582,0.880731763484589,0.648686030428769,0.9163033598292883,1.0,10/54,13.60%,MIER2;HDAC1;NIT1;SIRT6;ASPA;ACR;ACY1;AGA;PIGL;HDAC10
prerank,mRNA 5'-UTR binding (GO:0048027),0.330279248792183,0.8795133282858689,0.6428571428571429,0.9158064830572133,1.0,4/24,5.48%,GNL3;FMR1;LARP6;CCT5
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3416020177526442,-0.8793623257558519,0.619815668202765,0.881212129339876,1.0,2/12,3.15%,SLC9A2;SLC9B2
prerank,WW domain binding (GO:0050699),0.3217138395815927,0.8768267174217876,0.6282467532467533,0.9185181551792736,1.0,4/26,10.47%,TRAF4;WBP11;TCEAL5;NDFIP2
prerank,iron ion binding (GO:0005506),0.28735849739260433,0.8759332052527049,0.6589928057553956,0.9172805013804046,1.0,11/48,18.50%,HIF1AN;DNAJC24;EGLN2;FXN;AGMO;HEPH;FTO;ALKBH3;AOX1;CYP2R1;ALOX5
prerank,methyl-CpG binding (GO:0008327),0.33501304831102385,0.8751927455479048,0.6252019386106623,0.9158266251033859,1.0,6/22,19.19%,MBD3;ZCWPW1;ERH;MBD2;MBD1;CHTOP
prerank,antiporter activity (GO:0015297),0.3360045466197417,0.8749067085799734,0.6110210696920584,0.9134364334865669,1.0,8/20,22.00%,ATP1A3;CLCN3;SLC25A30;SLC35E1;SLC25A14;SLC35E3;SLC25A16;SLC35A1
prerank,MAP kinase kinase activity (GO:0004708),-0.3287765967877765,-0.874425988246224,0.6287015945330297,0.8872962298739272,1.0,5/15,15.15%,MAP2K4;MAPK14;MAP2K7;MAP2K2;MAP2K5
prerank,cardiolipin binding (GO:1901612),0.38986370407298987,0.8731552690795887,0.6065573770491803,0.9139955957942655,1.0,3/10,19.67%,OPA1;GSDMD;GSDME
prerank,neuropeptide binding (GO:0042923),0.3477598645455491,0.8723925019907736,0.6341463414634146,0.9125922704381758,1.0,2/18,16.07%,SORL1;GPR37
prerank,single-stranded RNA binding (GO:0003727),0.2919408229815551,0.871482485222875,0.6253776435045317,0.911492429156432,1.0,14/43,19.77%,AGO4;ADARB2;FMR1;DHX58;TLR8;AGO3;LONP1;DHX9;EXOSC10;SRA1;AGO1;ILF3;FXR1;CNBP
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.27018606893635094,0.8713529088289309,0.6675567423230975,0.908743936342523,1.0,9/75,9.57%,ADH1A;RDH10;RDH11;MDH1;H6PD;GRHPR;KCNAB1;PRXL2B;HSD17B8
prerank,NAD binding (GO:0051287),0.323035769087087,0.8706407281375563,0.6609907120743034,0.907126221463482,1.0,5/26,9.57%,ALDH1A1;GRHPR;SIRT6;UXS1;HSD17B8
prerank,histone acetyltransferase activity (GO:0004402),0.30996194053149345,0.8697247872319628,0.6473429951690821,0.9059890363205815,1.0,12/30,24.32%,NCOA3;BRCA2;KAT2A;NAA50;EPC1;ATF2;KAT7;TAF10;MCM3AP;CREBBP;SRCAP;USP22
prerank,protein kinase C binding (GO:0005080),-0.24313195113588776,-0.8695349679808685,0.7160493827160493,0.8932152509613513,1.0,14/43,21.46%,PDLIM5;SQSTM1;CAVIN2;YWHAG;CAVIN3;ADCY6;CCDC88A;HSPB1;TRPV4;HINT1;DACT2;PKP2;ADAM9;TWF2
prerank,ubiquitin protein ligase activity (GO:0061630),-0.18728787998498556,-0.868011566925863,0.8925619834710744,0.8918794296738549,1.0,41/228,13.77%,WWP1;RNF152;XIAP;MGRN1;ASB2;RNF43;RNF185;KCMF1;PELI1;WWP2;ARIH1;UBE2D3;TRIM24;HLTF;TRIP12;TRIM25;CDC42;TRIM5;TRIM11;VPS18;TRIM14;SH3RF2;RNF8;MSL2;SMURF2;UBR1;RC3H1;RNF125;RNF11;RNF144B;RNF41;NEURL2;RNF114;UBR2;RCHY1;HERC2;VPS11;TRIM63;UBE3D;RING1;AMFR
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.26147584933963997,-0.8678272272392051,0.6862170087976539,0.8877559831399956,1.0,11/38,23.10%,APP;SERPIND1;SERPINE1;SERPINI1;SERPINA2;SERPINE2;FURIN;SPINT2;AGT;SERPINB8;TFPI
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.29037141175004133,0.8624185161739354,0.6671575846833578,0.917655616898197,1.0,12/42,22.78%,CDKN2A;CCNJ;CDKN2D;CCNB2;CDKN2C;CCNA2;CCNK;CCNE1;CDK5R1;CCND3;CCNT2;CCNQ
prerank,carboxypeptidase activity (GO:0004180),-0.25619005626377983,-0.8622282383687991,0.6580459770114943,0.8952759767016847,1.0,9/35,19.43%,AEBP1;CPE;CPD;MINDY1;SCPEP1;AGBL1;CTSZ;ACE2;VASH1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.25737661224502395,0.8618892702988467,0.6961538461538461,0.9158473527516452,1.0,22/91,17.76%,SVIL;STXBP6;WDR45B;GBF1;MYO1B;GRAMD2A;SLC9A1;ADAP2;COMMD1;SYT7;GSDMD;EXOC1;MYO1G;PLEKHA5;SDCBP2;CLVS1;AMER2;TIRAP;LDLRAP1;FCHO2;SYTL2;WIPI2
prerank,pseudouridine synthase activity (GO:0009982),-0.3280265092438156,-0.8590699665097821,0.6714628297362111,0.8974826789371837,1.0,7/13,34.72%,PUS10;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,RNA methyltransferase activity (GO:0008173),-0.2922359060678138,-0.857703095784914,0.6714975845410628,0.8955231719205139,1.0,8/19,29.30%,TRMT9B;FTSJ1;TRDMT1;TRMT5;MEPCE;MRM2;TRMT12;TGS1
prerank,histone acetyltransferase binding (GO:0035035),0.3359282524845177,0.8571168398606248,0.6661237785016286,0.9225940304509045,1.0,9/21,23.88%,EPAS1;GLI3;KANSL1;TP53;ZBTB7A;TRIP4;HIF1A;TRIM68;STAT1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3290904404054997,-0.8556487377035297,0.6604651162790698,0.895092647861568,1.0,5/13,18.07%,FTSJ1;TRMT5;THUMPD2;TRMT11;TRMT10B
prerank,Hsp70 protein binding (GO:0030544),0.304299745568924,0.8550342767394825,0.6843702579666161,0.9238129904839415,1.0,8/31,18.23%,PPID;DNAJB12;DNAJC10;GPR37;TSC1;DNAJB14;DNAJC8;SACS
prerank,protein heterodimerization activity (GO:0046982),0.23380669417852093,0.8543780576618702,0.7578579743888242,0.922249061399071,1.0,40/178,19.24%,BHLHA9;TENM3;ATP1A2;TCF4;ITGA3;PIK3R2;TOP2B;TENM4;GTF2A1;FMR1;TLR6;EPAS1;ADCY8;TENM2;QTRT2;TENM1;TLR4;CYBA;IRAK1;SAE1;TP53;KATNA1;RCC1;BCL2L2;IL12A;SDCBP2;ARNT2;BAK1;HEXA;ZHX3;MTTP;GABBR2;RRAGA;ADRA2A;TOP2A;SMC1A;RRAGD;HIF1A;ARNT;FXR1
prerank,ATP binding (GO:0005524),0.2265304222832013,0.8539309245953598,0.801762114537445,0.9201971664252794,1.0,79/266,24.37%,ENPP1;ATP1A2;PEAK1;ABCD2;EIF4A3;PDXK;P2RY1;MAP4K4;MYO1B;CDKL5;ATP1A3;PRKCI;MTHFD1L;CARS1;TARS1;RHOBTB3;CDC42BPA;PRKACB;PIF1;PINK1;PFKM;ABCB6;GCK;NOL9;PRPS1L1;PRPS1;PTPA;DHX36;P2RX4;HSPA13;TGFBR1;MTREX;PDK2;ACLY;KCNJ8;MAP4K1;LONP1;PIM1;ATP7A;NME1;WNK2;HSPA5;SYN2;HSPA4;CHD8;DHX9;BRSK2;HARS1;SARS2;MAST1;MSH6;NVL;PEX6;STK26;KSR1;ABCA2;PDK3;PPIP5K1;TRIP13;LATS2;PXK;HSPA9;PI4K2A;BMPR1B;MYO9B;BCKDK;BMPR1A;NLK;ABL1;TDG;BTK;MVK;KIF14;AARS1;DAPK3;UBA2;MAP4K5;PIP4K2B;MTHFS
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.31887605016275544,-0.8538105144237325,0.6619385342789598,0.8941796074584317,1.0,6/15,30.74%,AGPAT4;LCLAT1;PNPLA3;AGPAT2;AGPAT5;LPCAT2
prerank,acylglycerol lipase activity (GO:0047372),-0.3494827347345138,-0.8527385825925428,0.6403712296983759,0.8920776094513335,1.0,3/11,9.86%,MGLL;LIPE;ABHD2
prerank,deubiquitinase activity (GO:0101005),0.2570143176155717,0.8527285911275231,0.6980392156862745,0.91970861619969,1.0,32/88,25.21%,STAMBPL1;EIF3H;USP1;UCHL3;USP42;MINDY4;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;USP21;USP16;USP13;STAMBP;PSMD14;USP49;USP14;USP46;USP45;MINDY2;USP48;USP31;UFD1;USP24;USP22;OTUD7A;JOSD2;USP2;USP36
prerank,Notch binding (GO:0005112),-0.27646560416637694,-0.8522042069598476,0.7077294685990339,0.8888973453041752,1.0,4/22,11.60%,SNED1;CCN3;DNER;GALNT11
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.34973306455307285,-0.8520135517351807,0.6666666666666666,0.885015559294662,1.0,2/11,9.81%,LEF1;GATA2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3247849320763819,-0.8504257877725394,0.6484560570071259,0.884066187425468,1.0,2/13,3.15%,SLC9A2;SLC9B2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.25513807151532414,-0.8498290835952969,0.7336814621409922,0.8811031205726214,1.0,15/33,26.85%,RNF185;ARIH1;TOLLIP;RNF125;RNF144B;UBE3D;SIAH3;SIAH2;DCUN1D3;ANKIB1;RNF5;RNF19A;FOXL2;PARK7;DCUN1D1
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.18368981838841153,-0.848603654960136,0.9642857142857143,0.8792969897018746,1.0,41/232,13.77%,WWP1;RNF152;XIAP;MGRN1;ASB2;RNF43;RNF185;KCMF1;PELI1;WWP2;ARIH1;UBE2D3;TRIM24;HLTF;TRIP12;TRIM25;CDC42;TRIM5;TRIM11;VPS18;TRIM14;SH3RF2;RNF8;MSL2;SMURF2;UBR1;RC3H1;RNF125;RNF11;RNF144B;RNF41;NEURL2;RNF114;UBR2;RCHY1;HERC2;VPS11;TRIM63;UBE3D;RING1;AMFR
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.2952583963190354,0.8476412411149187,0.672386895475819,0.9266722823461095,1.0,7/35,14.07%,PEAK1;TXK;PTK2;FGR;FYN;MELK;LYN
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2617295768495689,0.8474324512504917,0.7104194857916103,0.9241356821195622,1.0,14/74,12.15%,PDXK;ADK;IPMK;NADK;COASY;PI4KA;DGKQ;PAPSS2;CHKA;GK;NOL9;FGGY;DGKI;AGK
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3226811162062475,-0.8469423662359603,0.6859688195991092,0.8786262076649947,1.0,5/13,13.96%,EZR;GSK3B;KCNQ1;PRKAR2A;PRKAR2B
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2587973180392213,0.8461075309609927,0.7289972899728997,0.9237000548463173,1.0,21/78,19.76%,CAPN5;USP1;CASP6;CASP4;CAPN3;USP42;LGMN;CAPN6;PYCARD;USP33;CASP12;USP34;CAPN15;USP16;USP13;USP49;CAPN10;USP14;CAPN2;CTSK;USP46
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3676375299082486,0.8456037569613927,0.6564625850340136,0.9217725870311546,1.0,2/14,4.16%,RSAD1;SDHB
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.2626031452485132,-0.8444533258625557,0.6909620991253644,0.8794321534642001,1.0,11/30,26.61%,XIAP;CST3;PTTG1;RPS6KA1;TNFAIP8;PRDX3;CAST;BIRC3;MT3;CD27;RPS6KA3
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.30581023975423005,0.8418563636840953,0.6764705882352942,0.9260670982639149,1.0,5/29,15.03%,SLC1A5;SLC25A21;SLC25A22;SLC25A30;SLC25A14
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3082271216914184,-0.8414857411027735,0.7006960556844548,0.8811175775734741,1.0,4/15,13.13%,PIK3C2B;PIK3CB;PIK3CD;ATM
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.33120221491037805,0.8382417120180317,0.6434634974533107,0.9300883113212723,1.0,5/18,18.57%,ALDH1A1;ALDH3B1;AKR1B1;ALDH9A1;ALDH3A2
prerank,cysteine-type peptidase activity (GO:0008234),0.2559837859025667,0.8375804702117619,0.7246963562753036,0.9284526935989658,1.0,19/73,19.76%,ATG4A;USP1;CASP6;BLMH;CASP4;CAPN3;OTULINL;USP42;LGMN;USP33;USP34;USP21;USP16;USP13;USP49;USP14;CAPN2;CTSK;USP46
prerank,protein phosphatase regulator activity (GO:0019888),0.27300985838974867,0.8366097096112283,0.7374301675977654,0.9274516917832037,1.0,23/53,27.25%,PTN;BOD1;PPP6R2;PPP2R2A;PPP2R3A;EIF2AK2;PTPA;RCAN3;ANKLE2;PPP6R3;RCAN1;PPP4R2;B3GAT3;PPP2R2D;BOD1L1;PPP2R1B;PPP2R5A;STYXL1;CALM2;IGBP1;PPME1;SAG;PPP2R2B
prerank,I-SMAD binding (GO:0070411),-0.3302364610853984,-0.8330167802176439,0.6757990867579908,0.893182649309368,1.0,7/13,26.16%,SMAD6;SMAD3;SMAD1;TGFB1I1;SMAD7;SMURF1;SMAD4
prerank,cation:chloride symporter activity (GO:0015377),-0.34438987880294375,-0.8321925042013121,0.7085106382978723,0.8905927085428401,1.0,2/10,10.68%,SLC12A7;SLC12A8
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2620169247575512,0.8305184864508147,0.7170596393897365,0.9363791180693829,1.0,8/60,12.09%,CDC14B;PTEN;DUSP1;LRRK2;PPP6C;PPP3CB;PDP1;LRRC39
prerank,potassium:proton antiporter activity (GO:0015386),0.3695911715270709,0.8303679409653266,0.6642984014209592,0.9337978805907342,1.0,2/10,6.01%,SLC9A9;SLC9A1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.2644970762276594,-0.8292314069763937,0.713903743315508,0.891767824617316,1.0,2/26,1.41%,CSGALNACT1;B3GALT1
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.17053031923891032,-0.8276292220515888,0.9615384615384616,0.8907086946236588,1.0,95/346,24.48%,WWP1;RNF152;XIAP;LMO7;MGRN1;RNF146;KLHL13;UBE2G1;ASB2;RNF43;RNF185;KCMF1;PELI1;WWP2;ARIH1;CDC23;UBE2D3;TRIM24;HLTF;TRIP12;TRIM25;CUL1;CDC42;TRIM5;TRIM11;VPS18;TRIM14;SH3RF2;RNF8;MSL2;UBE2H;MIB1;SMURF2;UBR1;TRIM36;FBXO25;TSPAN17;RC3H1;UBE2A;RNF125;KLHL20;RNF11;ZFP91;RNF144B;RNF41;NEURL2;RNF114;UBR2;RCHY1;HERC2;VPS11;TRIM63;UBE3D;RING1;AMFR;UBE2N;TRAF3;TRIM35;SIAH3;TRIM27;UBE2L6;HECTD3;FBXL14;SIAH2;CUL3;ANAPC11;PPP1R11;CHFR;ANKIB1;RNF141;CDC34;TNFAIP3;MAEA;RNF166;PRPF19;IRF2BPL;RNF5;TNFAIP1;TRAF1;FBXO3;MEX3C;RFFL;FBXO22;BIRC3;MKRN1;FBXW2;FBXO10;RFWD3;SMURF1;RLIM;RNF111;RNF20;TRIM39;RNF2;RNFT2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.297578414239863,-0.8271527288857888,0.7119815668202765,0.8873874513729855,1.0,11/16,36.99%,CD38;OARD1;SARM1;MACROD1;NEIL1;ADPRH;NTHL1;SMUG1;RPS3;NEIL2;BST1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3084656221924875,0.826808947690697,0.6949429037520392,0.9380327135557451,1.0,7/24,15.02%,AK1;AK4;NME6;IP6K1;AK8;NME1;AK3
prerank,serine-type peptidase activity (GO:0008236),0.24761918301266683,0.8265623188891322,0.7730769230769231,0.935671758251974,1.0,9/96,12.26%,MASP1;FAP;PCSK2;HTRA3;ACR;PLAU;RHBDL3;HTRA2;ENDOU
prerank,sodium channel regulator activity (GO:0017080),0.2813145335207201,0.824106976348962,0.7029096477794793,0.9374975697424117,1.0,8/37,15.57%,GPLD1;SCN2B;NEDD4;COMMD1;FXYD4;FGF12;FGF14;SGK1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.23454824295460835,-0.8234992361143683,0.7699386503067485,0.8898916525291856,1.0,13/38,22.42%,PARD3;PLA2G4A;SNX21;SH3PXD2B;ATG2B;HIP1;DENND1A;JPH2;ATG2A;SNX3;PLA2G4E;WDR45;LANCL2
prerank,heme binding (GO:0020037),0.2561118821406671,0.8233966541698149,0.746922024623803,0.9360297068221483,1.0,5/65,4.27%,SLC48A1;HRG;PGRMC2;RSAD1;PTGES2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.272284562081916,0.8228142508887206,0.7121879588839941,0.9342490339764107,1.0,16/44,21.56%,KMT2E;KMT2A;CXXC1;SETD5;WDR5;NSD1;SMYD5;DOT1L;N6AMT1;ASH2L;SUV39H2;SETD4;EHMT2;MEN1;KMT2C;RBBP5
prerank,methyltransferase activity (GO:0008168),0.27160572591442095,0.8207199367570862,0.7553956834532374,0.9351499611627605,1.0,8/46,15.53%,EEF1AKMT4;PRMT3;RRP8;COQ3;GAMT;NDUFAF7;AMT;N6AMT1
prerank,chemoattractant activity (GO:0042056),0.2985274845441605,0.8190067215539443,0.6963434022257552,0.9355977857704403,1.0,2/26,5.34%,CXCL10;CCL15
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3067565836605856,0.8172744811617635,0.6943521594684385,0.9358922115935572,1.0,6/22,22.62%,DUSP12;DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,kinesin binding (GO:0019894),-0.2547051579398397,-0.8158594461681524,0.7712765957446809,0.899616373865372,1.0,7/27,15.39%,ACTB;NEK6;MAPK8IP3;SPAG9;TOR1A;MAPK8IP1;CROCC
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3515794533103255,0.8144518356718592,0.6707964601769911,0.9381989084615315,1.0,5/12,22.77%,SLC35B3;LRRC8A;SLC25A17;SLC19A1;SLC25A24
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3045062250639907,-0.813411132436344,0.717391304347826,0.8995260465080407,1.0,4/15,18.80%,COX15;COX5B;COX4I1;COX6B1
prerank,3'-5' exonuclease activity (GO:0008408),0.27150483677577414,0.8130974488528734,0.7368421052631579,0.9378989791576406,1.0,13/45,21.29%,POLG;PDE12;REV3L;EXOSC9;DIS3L2;EXOSC10;CNOT7;EXOSC5;WRN;REXO4;TRIR;REXO2;PNLDC1
prerank,ephrin receptor binding (GO:0046875),0.31143227614858904,0.8128380498133146,0.7128874388254486,0.9356447473807424,1.0,10/21,22.80%,CHN1;ANKS1B;FYN;CRK;LYN;EFNA1;PIK3CG;EFNB3;CBL;ABL1
prerank,phosphate ion binding (GO:0042301),-0.34808503177415506,-0.8112409935003011,0.7228381374722838,0.8993403833636561,1.0,5/10,37.21%,ADSS2;PNP;RELA;CHST14;MTHFD2
prerank,RNA binding (GO:0003723),0.20255206085045077,0.8069005256862605,0.982,0.9434531512220422,1.0,292/1321,20.73%,DCN;C1D;LRP1;RBFOX1;EIF4G3;RBMS1;GNL3;TEP1;TRA2B;NAT10;FNDC3A;EIF4A3;BICC1;NANOS3;AGO4;CDKN2A;ISY1;RPP40;NOVA1;SPOUT1;CTU1;FNDC3B;ARL6IP4;EPRS1;ELP1;HTATSF1;WDR36;MYEF2;AFF2;SPTBN1;POP5;RBM46;EIF3H;BZW1;FSCN1;GTPBP10;YWHAZ;ADARB2;LRRC59;EIF1AX;SPATS2L;LSM14A;SNRNP35;SF3B6;MTCL1;ZMAT3;ZC3H12D;RBMS3;FMR1;DND1;RRP8;LARP6;ADK;PSTK;ZC3H7B;CAPRIN1;IFIT2;RTF1;DHX58;TBL2;RRBP1;NOL3;LIN28B;KHDRBS3;ZNF346;LSM4;ACTN1;TLR8;LRPPRC;TRIM56;CARS1;TAF15;SRF;DUS2;STAU1;KRR1;ZFP36L2;PCBP3;UTP11;LYAR;HNRNPA2B1;MRPL44;SEC63;EIF4A2;SRSF11;MPHOSPH10;TRNAU1AP;RALYL;WBP11;ERH;DDX19B;SNUPN;TENT4B;DHX30;NMD3;CDK13;CHD2;PNO1;MRM3;NOC2L;EDF1;PHF6;ALG13;GPATCH8;CELF4;MRPS31;CFAP65;DDX19A;DDX17;SRRT;MRPS24;RP9;CWC22;STAU2;DDX41;POP7;TENT5A;SRPRA;FAM32A;NUDT21;LUC7L2;NOC3L;DBR1;EIF2AK2;SEC61B;ZC3H8;RBFOX3;DHX36;NUP42;RCAN3;NTPCR;RIMS1;RPL37;NAP1L1;AGO3;TEFM;MKI67;SNW1;EDC3;MTREX;MRPS26;NUSAP1;PRPF38B;CASC3;CSDC2;TNPO1;R3HDM2;DNM1;SRSF10;DNAJC21;EXOSC9;UTP15;NDUFV3;ENDOU;SYF2;HSP90B1;CISD2;RBM20;SSRP1;PPAN;MRPL28;FAM98B;CLNS1A;PPIL4;HDLBP;DDX18;CNOT1;MRPS30;LGALS1;EIF2S1;SYNE1;MRPL10;RBM18;DIMT1;PRR3;MRTO4;TDRD9;DAP3;DDX31;EIF4ENIF1;LONP1;CDC42EP4;NME1;ZNF326;RBM4B;SLBP;PUS7;RRS1;HNRNPUL1;DUS3L;HNRNPD;DHX9;UTP6;RNASEH1;SNRPF;ERAL1;ISG20L2;DDX59;SAFB2;YARS1;ZCCHC9;CSNK1E;EXOSC10;RC3H2;SNRNP70;ADAR;TNRC6B;FYTTD1;PTCD1;HNRNPLL;SRRM2;NOL4;HEATR6;SRSF9;IGF2BP3;ZCCHC3;RBM5;NONO;CHERP;PPP1R8;THOC5;HNRNPL;SRRM3;ZCCHC24;EIF5B;SF3A3;MRPS23;PRKRIP1;MRPL3;MAZ;SUGP2;CALR;MTIF2;SARS1;SARS2;AGO1;SRSF6;RPP21;EIF3C;DMGDH;RPS17;TOP2A;SAFB;HABP4;DXO;SMC1A;RRP1B;SEPSECS;ILF3;LSM14B;SSBP1;MRPS5;REXO4;KHDRBS1;YTHDF1;PPIG;EIF3G;KPNB1;FKBP3;NVL;ZCRB1;RBM6;LLPH;CHTOP;FXR1;BYSL;CANX;RBM28;HSPE1;DHX29;RO60;SUMO2;CNBP;ZC3H14;LRRFIP1;NOL12;ZC3H7A;URB1;NOL10;DDX1;CCDC86;LUC7L3;PRPF8;MRPS27;UTP20;KMT2C;ZNFX1;TRMT10A;FLNB;DDX39B;HEATR1;RPL35
prerank,lipid phosphatase activity (GO:0042577),0.34167420795988734,0.8067708197486819,0.7030411449016101,0.9409131430852835,1.0,3/14,10.68%,PLPPR3;PLPPR2;PLPP6
prerank,delayed rectifier potassium channel activity (GO:0005251),0.27936257021249455,0.8027639537663757,0.75,0.9453830919303948,1.0,7/32,20.65%,KCNQ3;KCNG1;KCNC2;KCNE4;KCNA6;KCNH1;KCNS3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.27128508087064657,-0.8025690462278962,0.7405405405405405,0.9097047486016949,1.0,7/22,22.25%,ATP6V0A4;ATP5F1B;ATP2A3;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3159899582656589,-0.8016255724846671,0.7330097087378641,0.9071881253519851,1.0,8/12,46.79%,DDI2;BACE2;SPPL3;CTSE;HM13;NAPSA;PSEN1;SPPL2A
prerank,endonuclease activity (GO:0004519),0.2651516666049583,0.7999523830725952,0.7756874095513748,0.947473561717226,1.0,11/49,19.33%,ANKLE1;FEN1;ERCC5;ZC3H12D;ERCC4;AGO3;ENDOU;MBD4;AGO1;REXO4;NOB1
prerank,ion gated channel activity (GO:0022839),0.3046239806497823,0.7990960384039238,0.7280130293159609,0.946175272137468,1.0,2/24,3.06%,KCNT2;ANO4
prerank,lysine-acetylated histone binding (GO:0070577),0.31403941898047555,0.7984195804200228,0.7066246056782335,0.9418456200477778,1.0,11/20,26.17%,PHIP;KMT2A;DPF2;CARM1;BRD7;THAP7;ATAD2B;BRD9;ZMYND8;BRDT;YEATS4
prerank,acetylation-dependent protein binding (GO:0140033),0.31403941898047555,0.7984195804200228,0.7066246056782335,0.9418456200477778,1.0,11/20,26.17%,PHIP;KMT2A;DPF2;CARM1;BRD7;THAP7;ATAD2B;BRD9;ZMYND8;BRDT;YEATS4
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.23683029640090925,-0.798185584530801,0.8117283950617284,0.9089534312296815,1.0,14/35,26.06%,TRMT9B;FTSJ1;TRDMT1;TARS2;PTRH2;TRMT5;MTFMT;ELAC2;MRPL58;GATC;PUS10;DUS1L;TRMT12;TRPT1
prerank,kinase binding (GO:0019900),0.20405907374969232,0.7972784563126659,0.9266247379454927,0.9409088766174212,1.0,55/434,11.89%,PTN;GHR;IL15RA;UTRN;ATF5;RND3;TCF7L2;ERCC6L2;PTPRR;CDKN2A;DLG3;YWHAZ;SPRED1;FBXO5;RAC3;PTPN22;DLG2;MYCN;NEFH;DCTN2;SGO1;TBL2;MTCP1;LLGL1;CADPS;SIKE1;POLA1;TEX14;CEP68;CDKN2D;RHOBTB3;UNC5C;DGKQ;PTK2;LRRC14;SPRED2;GOLGA2;PFKM;PRKACA;JTB;CEP192;SP100;RB1CC1;DAXX;CNKSR2;CACUL1;TNS2;IRAK1;FGR;TP53;TTC28;DLG4;WDCP;FBXW5;DNM1
prerank,DNA-binding transcription factor binding (GO:0140297),0.2185828348405198,0.7972562638026005,0.8628571428571429,0.9382011866195505,1.0,43/189,20.71%,PPARA;MIER2;HDAC1;TCF7L2;PPARD;YWHAZ;TBX3;FOS;RUNX1T1;CHD4;TLE2;CRTC2;SRF;LYAR;FIZ1;DGKQ;PIAS2;TWIST1;NOC2L;TLE1;TP53;ZFPM2;PSMC5;PRDM5;ATN1;ELK1;DHX9;DMAP1;AR;ATF2;MYC;ZBTB7A;LDB2;LDB1;BBS1;SP1;DDRGK1;CRTC3;MTA3;MTA1;RERE;FHL2;BBS4
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.32044026330131503,-0.7930707028616842,0.7308584686774942,0.9133758061279866,1.0,4/11,24.22%,PPP1R1A;PABIR1;PPP1R11;PPP1R2
prerank,voltage-gated anion channel activity (GO:0008308),0.3319872124529772,0.7927370151358407,0.7318840579710145,0.9431938318879697,1.0,4/15,12.66%,VDAC2;CLCN3;CLCN2;CLCN6
prerank,kinase inhibitor activity (GO:0019210),-0.23770519066066173,-0.7917563838569854,0.8057324840764332,0.9114216962473602,1.0,13/33,23.69%,YWHAB;NCK1;LRP6;MAPK8IP1;CDKN1A;GSKIP;HEXIM1;NPM1;DNAJC3;DUSP19;RHOH;SOCS3;QARS1
prerank,peptidase inhibitor activity (GO:0030414),-0.24058945864182318,-0.7902192236383125,0.8084507042253521,0.9098264860235457,1.0,5/33,6.59%,CST3;PSMF1;GPC3;SERPIND1;RENBP
prerank,carbohydrate:cation symporter activity (GO:0005402),0.3429575696711022,0.7890542490494451,0.7164948453608248,0.9465167220425617,1.0,11/11,65.73%,SLC2A9;SLC5A11;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A10;SLC5A3;SLC23A1;SLC23A2;SLC17A5
prerank,disordered domain specific binding (GO:0097718),0.3010798068440903,0.7883156245053252,0.7263157894736842,0.9450753506776239,1.0,5/23,11.50%,TEAD2;NCOA3;TP53;FYN;BCL2L2
prerank,pre-mRNA binding (GO:0036002),0.2907301401330183,0.7856786919426406,0.7661290322580645,0.9469302780931744,1.0,8/28,17.44%,TRA2B;RBM24;ZRSR2;CELF4;SLU7;SLBP;HNRNPL;SRSF6
prerank,myosin binding (GO:0017022),0.25254578158716057,0.7840701920090163,0.7857142857142857,0.9468829742649106,1.0,8/55,12.75%,NPC1L1;LARP6;RAB8A;LLGL1;RAB3C;NKD2;PYCARD;TRIOBP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.35589600289445644,0.7829119076367664,0.725,0.9461320361067582,1.0,2/10,11.00%,ADARB2;DCTD
prerank,glucose transmembrane transporter activity (GO:0005355),-0.2779641227451468,-0.7809344166392055,0.7511737089201878,0.9203148186223991,1.0,13/17,55.95%,SLC2A1;SLC2A4;SLC2A2;PPBP;SLC5A3;SLC2A5;SLC2A3;SLC2A6;SLC2A10;SLC5A10;SLC5A1;SLC5A2;SLC5A9
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.3087866201624201,-0.7762101804058488,0.7452380952380953,0.9234504066968878,1.0,7/12,35.25%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1
prerank,ribosomal small subunit binding (GO:0043024),0.3082036347474867,0.7755412346218403,0.7612687813021702,0.9553491132617858,1.0,6/17,22.26%,PIM1;NME1;ERAL1;MTIF2;DHX29;EIF4B
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.32254335476648854,0.7752349597603261,0.7508591065292096,0.9530965934510262,1.0,3/14,9.14%,RECK;SPOCK3;LXN
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.3369858587727602,0.7735188019580592,0.745945945945946,0.953242331997983,1.0,5/13,24.19%,BMP7;PYCARD;BMP2;BMP5;BMP4
prerank,MHC protein binding (GO:0042287),-0.26510288973788454,-0.7687242472373748,0.7959697732997482,0.9302913135342029,1.0,5/20,20.40%,ATP5F1B;TAPBP;TAP2;CD74;ABCB9
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.35318022132980986,0.7675249865159502,0.7513513513513513,0.9599011176257967,1.0,3/10,14.88%,DSE;GALE;GNE
prerank,magnesium ion binding (GO:0000287),-0.17261874881217307,-0.7672717754674984,0.9534883720930233,0.9283568680129111,1.0,22/135,15.33%,EYA2;MARK1;NEK6;MAP3K5;GCLC;SIK3;SNRK;NUDT3;AASDHPPT;SIK1;CDC42BPB;MAP2K7;STK38L;DYRK2;RRAGC;RP2;SRPK1;RAN;PGP;CDC42BPG;ENDOV;ERN1
prerank,cation transmembrane transporter activity (GO:0008324),-0.20909322835361113,-0.7667548680239472,0.8986928104575164,0.9250468662998532,1.0,22/48,30.78%,SLC6A6;SLC7A1;SLC3A2;SLC41A1;SLC38A5;SLC7A5;SLC1A1;SFXN1;SLC6A7;SLC36A4;SLC22A2;SLC38A6;SLC38A7;SLC38A2;MMGT1;PKD2L1;MFSD12;SLC39A1;PKD1L3;SLC8B1;SLC7A2;SLC36A2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.23194723365016948,-0.7659962140599988,0.8760806916426513,0.9221483213712184,1.0,7/34,15.97%,UBE2G1;UBE2D3;UBE2F;UBE2H;UBE2A;UBE2N;UBE2L6
prerank,ATP hydrolysis activity (GO:0140603),0.2603739564321169,0.7656917994663572,0.8107714701601164,0.9599347493754615,1.0,9/41,17.34%,ABCD2;VWA8;RHOBTB3;ABCB6;ABCA4;TDRD9;DHX9;CLU;VPS4B
prerank,SUMO binding (GO:0032183),-0.2984699216054937,-0.7653529642640501,0.7750556792873051,0.919220063500982,1.0,5/13,23.64%,CASP8AP2;HERC2;USP25;SERBP1;RNF111
prerank,SH3 domain binding (GO:0017124),0.23838506570492388,0.7651507789378117,0.8433048433048433,0.9581325757563556,1.0,9/62,11.26%,WIPF1;AKAP5;CBLB;ELMO1;PTPN22;RUFY1;CYBA;ADAM12;CABYR
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.29435716545205565,0.7651377446370562,0.794912559618442,0.9554885781098793,1.0,6/23,17.76%,WDR45B;GBF1;COMMD1;PLEKHA5;CLVS1;WIPI2
prerank,serine-type endopeptidase activity (GO:0004252),0.2321426972224551,0.7644272515794094,0.833981841763943,0.953891637236284,1.0,7/80,12.14%,MASP1;FAP;PCSK2;ACR;PLAU;RHBDL3;HTRA2
prerank,lysophospholipase activity (GO:0004622),-0.2631908462320167,-0.7641666937982432,0.806282722513089,0.9168999679128951,1.0,5/20,11.59%,PLA2G4A;MGLL;GDPD3;ENPP2;PLA2G6
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.34811213531745855,0.7637079822232988,0.7454873646209387,0.9522392270435538,1.0,3/10,12.28%,CASP6;CASP4;CASP12
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.31813580746889136,0.7602021921343254,0.7659574468085106,0.9548547894327641,1.0,2/14,7.03%,BLVRB;PYCR1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.23156922830079676,0.7593480332029457,0.8423841059602649,0.9534914516065073,1.0,29/83,25.21%,STAMBPL1;USP1;UCHL3;USP42;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;USP21;USP16;USP13;STAMBP;PSMD14;USP49;USP14;USP46;USP45;USP48;USP31;UFD1;USP24;USP22;OTUD7A;JOSD2;USP2;USP36
prerank,BMP receptor binding (GO:0070700),0.3370010332837744,0.7581613642824098,0.7649186256781193,0.9526833232112213,1.0,5/12,24.19%,BMP7;PYCARD;BMP2;BMP5;BMP4
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2383451361735628,-0.7570523499215688,0.8409703504043127,0.9226987936248218,1.0,8/28,17.86%,PRKAA2;MAP2K4;MAPK14;MAP2K7;RPS6KA1;MAP2K2;MAP2K5;AKT1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.3092101335122085,0.7555449283244028,0.751269035532995,0.9539822140026438,1.0,2/15,11.18%,P2RY1;P2RX4
prerank,microtubule motor activity (GO:0003777),0.2454197858566619,0.7528081473284599,0.844903988183161,0.9554934528172144,1.0,18/51,23.60%,CENPE;STARD9;KIF5C;KIF9;KIF3C;KIFC2;KIF2A;KIF21A;KIF13B;KIF6;SMC3;KIF3A;KIF7;KIF11;KIF1B;KIF15;KIF14;KIF23
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.25849016810055336,0.7524987515834823,0.8014705882352942,0.9533284569752086,1.0,8/37,17.22%,EPRS1;CARS1;TARS1;EARS2;YARS1;HARS1;SARS1;SARS2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.26594947529856605,0.7504999614532687,0.8247261345852895,0.9536577433294475,1.0,6/31,11.99%,SLC12A6;KCNG1;TMEM38B;TMEM175;HCN1;KCNK1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.2582038279491929,0.7494130560601674,0.8219814241486069,0.9526319765304903,1.0,6/35,10.80%,HDAC1;FOS;GTF2A1;TBPL1;TP53;TAF1B
prerank,telomerase RNA binding (GO:0070034),0.2842165623559069,0.7483834596554054,0.7922705314009661,0.9514705326344263,1.0,4/22,15.30%,TEP1;TENT4B;DHX36;EXOSC10
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.33180888401117453,0.7470139101102169,0.7837837837837838,0.9509257388599575,1.0,5/10,20.89%,CXCL10;PKIG;PRKAR1A;PKIB;PRKAR1B
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.31296489505929076,-0.7468009490181123,0.7795454545454545,0.9322817291247686,1.0,3/10,16.91%,ECHDC1;HADHA;AUH
prerank,neurexin family protein binding (GO:0042043),0.34094207917806285,0.7466939371729029,0.7820738137082601,0.9487658132024885,1.0,1/10,2.79%,CEL
prerank,transaminase activity (GO:0008483),-0.302427262663514,-0.7438933465992247,0.8263736263736263,0.9321100906841684,1.0,4/11,20.22%,GOT2;OAT;PSAT1;AGXT
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.24159019199322157,0.7377302974009374,0.851528384279476,0.9585932677356531,1.0,8/46,15.26%,OGT;PIGQ;GCNT2;B3GNT8;PIGP;PIGA;B3GALT5;HEXA
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.22860714946610244,-0.7335287474067327,0.8804878048780488,0.9408710550923938,1.0,9/27,18.71%,ARIH1;TOLLIP;RNF125;RNF144B;UBE3D;SIAH3;SIAH2;DCUN1D3;ANKIB1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.28329044706044504,0.7273778855799702,0.811864406779661,0.9698195866047249,1.0,4/20,16.65%,EIF3H;OTULINL;YOD1;USP21
prerank,adenylyltransferase activity (GO:0070566),0.2792735420976162,0.726349459059915,0.8431372549019608,0.968506428950179,1.0,4/21,11.84%,NMNAT3;COASY;TENT4B;TENT2
prerank,SUMO transferase activity (GO:0019789),-0.2657878983148748,-0.725317256409591,0.8431372549019608,0.9470046007705432,1.0,1/16,1.93%,HDAC4
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3272533769539352,0.725178466956464,0.8102466793168881,0.9674602133031471,1.0,3/10,15.32%,BRCA2;NAA50;ATF2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3150763099533679,0.7250015496883763,0.7910189982728842,0.9650899583136685,1.0,4/12,18.93%,TENT4B;TENT5A;TENT2;PAPOLB
prerank,death receptor binding (GO:0005123),-0.2747648407581884,-0.723197223080184,0.8306878306878307,0.9454381764765253,1.0,4/15,12.22%,CASP8AP2;NGF;MADD;BID
prerank,lipase activity (GO:0016298),0.24097310204363953,0.7217780946830353,0.8715728715728716,0.9665364304992733,1.0,5/43,12.04%,CEL;LIPC;LIPH;ABHD16A;ABHD12
prerank,nucleotidyltransferase activity (GO:0016779),0.2856845534327326,0.7193808346433663,0.8297161936560935,0.9671224729999977,1.0,5/19,15.97%,PAPSS2;TENT4B;TENT2;REV1;CRPPA
prerank,thioesterase binding (GO:0031996),0.3216970756192535,0.7183632487236237,0.8125,0.9659254292157184,1.0,1/11,1.93%,TRAF4
prerank,Hsp90 protein binding (GO:0051879),-0.21780663388821206,-0.7176462281426511,0.9279279279279279,0.9476648905249401,1.0,8/33,17.04%,PTGES3;KDR;MAPT;PPEF2;HDAC8;NR3C1;ERN1;UNC45B
prerank,GABA receptor binding (GO:0050811),0.31624585931204546,0.7169619702803534,0.7953321364452424,0.9651994662654282,1.0,1/11,1.57%,AKAP5
prerank,glutamate receptor binding (GO:0035254),0.29102809946623825,0.7152231438418274,0.8373702422145328,0.9647762221411033,1.0,7/17,21.37%,AKAP5;SYNDIG1;SHISA6;DLG4;CAMK2A;HOMER3;HOMER2
prerank,endopeptidase regulator activity (GO:0061135),-0.20668048787420956,-0.7147594409875758,0.921875,0.9469743765560361,1.0,12/40,23.10%,CST3;PSMF1;SERPIND1;RENBP;APH1A;APH1B;PSME3;SPINT2;PSME2;CAST;ADRM1;TFPI
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.279808803313861,-0.7143578653816421,0.8389423076923077,0.943567972377164,1.0,4/13,29.81%,SREBF2;MIF;EBP;DDT
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.258662654638096,0.7122302287618169,0.8486739469578783,0.9658256096310833,1.0,10/29,20.89%,CDKN2A;SPRED1;CDKN2D;SPRED2;CDKN2C;PKIG;PRKAR1A;PKIB;SPRY2;PRKAR1B
prerank,microtubule plus-end binding (GO:0051010),0.28050766904821306,0.7122228182138142,0.8250401284109149,0.9633164712011479,1.0,5/20,15.82%,CLIP3;CLIP2;CLASP2;STIM1;CLASP1
prerank,carbohydrate kinase activity (GO:0019200),-0.2863201381096012,-0.708052272679494,0.8441558441558441,0.9466423953990013,1.0,2/11,7.72%,HK1;HK2
prerank,ribonuclease activity (GO:0004540),0.22736903590174654,0.7073170310271045,0.8868715083798883,0.9665583304582733,1.0,15/56,19.33%,RPP40;ZC3H12D;AGO3;EXOSC9;ENDOU;DIS3L2;RNASEH1;EXOSC10;CNOT7;EXOSC8;EXOSC5;PPP1R8;AGO1;RNASE12;NOB1
prerank,translation elongation factor activity (GO:0003746),-0.2729882006363915,-0.7055614280810674,0.8697788697788698,0.9452950017297661,1.0,5/14,30.99%,EEF1A1;EEFSEC;GTPBP1;GTPBP2;TUFM
prerank,ubiquitin-specific protease binding (GO:1990381),-0.24929859687487965,-0.7053535021718458,0.8875878220140515,0.9416915792349044,1.0,7/19,26.33%,LCOR;VCP;AMFR;SELENOS;RHBDD2;SUMO1;PARK7
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.2110728851812279,-0.704187102416889,0.9347826086956522,0.939012624160076,1.0,8/34,15.85%,PARN;PAN3;ERI1;CNOT8;DIS3L;EXOSC2;ANGEL2;EXOSC3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.32736841168908526,0.7033694864336312,0.822380106571936,0.9686001390512867,1.0,3/10,16.77%,DPYSL2;DPYS;DPEP1
prerank,N-methyltransferase activity (GO:0008170),0.2701765822608245,0.7008252496211148,0.8497576736672051,0.9690361729696406,1.0,5/20,23.63%,HNMT;DIMT1;N6AMT1;METTL15;METTL5
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.2973759277160504,0.699059690234896,0.8196428571428571,0.9684150568530049,1.0,1/13,1.50%,ALDH1A1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.17948896839969045,-0.6956027639582459,0.9818181818181818,0.9438481106070216,1.0,16/69,20.94%,LPGAT1;KAT6B;ZDHHC21;PLA2G4A;DBT;ESCO1;ZDHHC16;ZDHHC14;SOAT1;PLAAT3;ZDHHC18;PLA2G4E;CERS2;ZDHHC3;PLA2G4C;ELP3
prerank,protein kinase inhibitor activity (GO:0004860),0.23197601246571123,0.6954353981905225,0.895741556534508,0.9701502398161561,1.0,4/42,8.14%,SPRY4;SPRED1;DUS2;SPRED2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.3092870382348567,0.6911626891794146,0.8272727272727273,0.9722585791695887,1.0,2/10,9.84%,SETD5;NSD1
prerank,tRNA methyltransferase activity (GO:0008175),0.2769727905261936,0.6910017610878926,0.8461538461538461,0.9699338854720628,1.0,7/16,21.93%,TRMT13;TYW3;TRMT44;THUMPD3;METTL2B;METTL2A;LCMT2
prerank,calcium channel inhibitor activity (GO:0019855),0.305431824046784,0.6893641038293425,0.8515901060070671,0.9691687275661046,1.0,1/11,2.31%,ITPR1
prerank,protein phosphatase 2A binding (GO:0051721),0.26275445824959426,0.6843474589105514,0.8614457831325302,0.9720562111858266,1.0,5/23,12.99%,BOD1;ADCY8;TP53;PTPA;ANKLE2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.24065523755001023,0.6840317549642462,0.8933933933933934,0.9674575024804725,1.0,13/34,26.70%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8;NDUFB10
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.24065523755001023,0.6840317549642462,0.8933933933933934,0.9674575024804725,1.0,13/34,26.70%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8;NDUFB10
prerank,diacylglycerol kinase activity (GO:0004143),0.3007430574735058,0.6819717288630626,0.8399311531841652,0.9671070696334833,1.0,3/11,12.15%,DGKQ;DGKI;AGK
prerank,mannose binding (GO:0005537),0.30022232960018336,0.680408741801957,0.8455008488964346,0.9661149945205877,1.0,2/12,9.26%,ACR;MBL2
prerank,RNA polymerase binding (GO:0070063),-0.24411715805097484,-0.6802283086746408,0.8784119106699751,0.9545141255034723,1.0,2/18,4.28%,PHRF1;STOM
prerank,acetyltransferase activity (GO:0016407),0.23987520611714985,0.6776527226838879,0.897196261682243,0.9663410003361805,1.0,4/31,10.37%,NAA10;NAT10;NAA50;NAT8L
prerank,hormone receptor binding (GO:0051427),0.28773943858772394,0.6732720770692402,0.8478632478632478,0.9681275189778041,1.0,1/14,3.37%,JAK1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.2755876106651912,-0.669621662402675,0.8792270531400966,0.9599520079427936,1.0,3/11,21.38%,AMFR;ANAPC11;PRPF19
prerank,RNA cap binding (GO:0000339),-0.2400292030659921,-0.6684449982446137,0.905,0.9571377078759993,1.0,6/16,26.31%,EIF3D;AGO2;DCPS;NCBP2;CYFIP2;NCBP3
prerank,DNA secondary structure binding (GO:0000217),0.2425294255901801,0.6683440785481596,0.915625,0.9702267887031529,1.0,10/31,22.80%,KMT2A;ERCC5;NEIL3;XPC;MSH6;WRN;MEN1;LIN54;HMGB1;ABL1
prerank,P-type ion transporter activity (GO:0015662),-0.2666842750655855,-0.6658096244879325,0.891566265060241,0.9555173374459602,1.0,3/12,12.90%,ATP2B1;ATP2B2;ATP2A3
prerank,O-methyltransferase activity (GO:0008171),0.29902251604823654,0.6636924376679503,0.8639705882352942,0.9720863465090006,1.0,1/10,5.61%,COQ3
prerank,actin monomer binding (GO:0003785),-0.2237002894987263,-0.6558345490029647,0.9536082474226805,0.9594229778648261,1.0,9/22,32.23%,NOS3;COBL;LIMA1;TMSB4X;TWF2;MYL4;PRKCE;PFN2;MRTFA
prerank,gap junction channel activity (GO:0005243),0.2510140193236399,0.6547282950103002,0.8970588235294118,0.9774745941610462,1.0,4/22,15.15%,GJA1;GJC3;GJA4;GJA5
prerank,four-way junction DNA binding (GO:0000400),-0.23741013326509286,-0.6531493190656915,0.9413145539906104,0.9577980210995162,1.0,8/17,30.56%,RAD51D;RAD51C;HMGB2;XRCC2;GEN1;MSH2;YY1;XRCC3
prerank,retinoid X receptor binding (GO:0046965),0.28600483780652514,0.6517880233347043,0.8724954462659381,0.9775999082942511,1.0,3/11,14.17%,NSD1;NRIP1;MED25
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.30278361226694617,0.6507371530235352,0.8661971830985915,0.9760362423916242,1.0,1/10,4.12%,FEN1
prerank,CARD domain binding (GO:0050700),0.2764927475149058,0.646404320782548,0.8978494623655914,0.9769719468040104,1.0,2/14,6.85%,CASP4;CARD19
prerank,wide pore channel activity (GO:0022829),0.246508933091693,0.6413010240078088,0.9098360655737705,0.978474952346106,1.0,4/23,15.15%,GJA1;GJC3;GJA4;GJA5
prerank,aminopeptidase activity (GO:0004177),-0.2065733809176271,-0.6395413670871671,0.9417721518987342,0.9635817079476914,1.0,4/26,13.17%,XPNPEP3;ERAP1;CTSH;MMP15
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.27336570553528305,0.6392526088186243,0.89419795221843,0.9776908781879078,1.0,3/13,12.95%,SLC66A1;SLC7A3;SLC25A29
prerank,ankyrin binding (GO:0030506),-0.2177880161066521,-0.6381663793316186,0.9398148148148148,0.960787366380569,1.0,2/19,3.96%,CDH1;PLEC
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.191949945808712,-0.6363009956128622,0.9756838905775076,0.9582576596231829,1.0,8/33,19.33%,PARN;ERI1;CNOT8;DIS3L;EXOSC2;ANGEL2;EXOSC3;ANGEL1
prerank,fatty acid synthase activity (GO:0004312),0.28125496851736165,0.6339835760818965,0.8743169398907104,0.9791420481773134,1.0,5/10,26.24%,ELOVL2;ELOVL6;ELOVL1;ELOVL5;OXSM
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2427576557361212,-0.6267716774881052,0.9236276849642004,0.9605143485869536,1.0,5/12,25.59%,NQO2;CBR4;CRYZ;CBR1;NQO1
prerank,proton transmembrane transporter activity (GO:0015078),-0.17675186348420957,-0.6229945952582682,0.9858356940509915,0.9589246164349888,1.0,12/39,29.15%,CLCN5;COX15;SLC33A1;NNT;COX5B;COX4I1;COX6B1;UQCRQ;SLC11A2;UQCRC1;ATP6V1B2;NDUFA4L2
prerank,ribosomal large subunit binding (GO:0043023),0.27234788604744453,0.6224087278750208,0.902229845626072,0.984940963886372,1.0,3/11,21.58%,NMD3;MALSU1;DHX33
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.22192895389213946,0.6199251683660327,0.9517884914463453,0.9842152629275277,1.0,9/31,20.86%,UBE2QL1;UBE2G2;UBE2Q2;UBE2D1;UBE2E3;UBE2E2;BIRC6;UBE2J1;UBE2K
prerank,ATPase regulator activity (GO:0060590),0.21438993567566506,0.6190739728713994,0.962178517397882,0.9824597193226418,1.0,7/38,16.24%,DNAJC19;DNAJC1;DNAJC24;DNAJC10;DNAJC15;BRSK2;TSC1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.26157562508318066,0.6165360226699057,0.9046762589928058,0.9818163816496109,1.0,5/14,21.43%,MINDY4;ATXN3;YOD1;USP13;MINDY2
prerank,store-operated calcium channel activity (GO:0015279),0.2770907667122536,0.615591958764222,0.9071428571428571,0.9800306747505934,1.0,3/10,19.44%,TRPC3;TRPC7;TRPC1
prerank,cAMP response element binding (GO:0035497),0.2815467870766367,0.6146689348453774,0.903107861060329,0.9782115520799565,1.0,3/10,15.32%,CREB3L2;CREB3L1;ATF2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.24563655036353216,0.6094129587933779,0.9262435677530018,0.9790378084474813,1.0,3/18,9.56%,NOL3;PRDX5;BIRC2
prerank,inward rectifier potassium channel activity (GO:0005242),0.22687350604343237,0.6088713181247807,0.9240506329113924,0.976967053863153,1.0,7/24,21.24%,KCNK1;KCNN2;KCNJ8;KCNJ10;KCNJ3;KCNJ16;ABCC9
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.27042463995947186,0.6040107927159016,0.9155405405405406,0.9775580098652286,1.0,2/11,12.95%,SLC25A20;SLC25A29
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.18977207473255084,0.5960834389094034,0.9847222222222223,0.9795463629772667,1.0,15/57,22.58%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;UQCRH;CYBRD1;COX7A2L;NDUFS4;COX5A;NDUFB3;UQCR11;NDUFA10;NDUFS1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.19788150621944467,-0.585746830581634,0.9805013927576601,0.9739398715507455,1.0,8/21,41.38%,FGF1;FRS2;FGF2;NPTN;FGF18;KLB;FGF22;FGF20
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.19248427706949287,0.5645474164129045,0.9846860643185299,0.9919637176324316,1.0,9/40,21.03%,RRP8;HNMT;GAMT;METTL9;N6AMT1;DNMT3A;THUMPD3;METTL2B;METTL2A
prerank,palmitoyltransferase activity (GO:0016409),-0.17014891085476258,-0.5488096681090939,0.9947368421052631,0.9836456446923248,1.0,10/28,30.47%,ZDHHC21;ZDHHC16;ZDHHC14;ZDHHC18;ZDHHC3;GLUL;GOLGA7;ZDHHC5;ZDHHC23;ZDHHC12
prerank,snRNA binding (GO:0017069),0.18939549992691676,0.5476930030594714,0.9910979228486647,0.9961632122650113,1.0,4/42,8.46%,SNRNP35;LSM4;LSM11;SNRPB2
prerank,neuropeptide receptor binding (GO:0071855),0.22922145004823447,0.5445822673820955,0.9608177172061328,0.9948231523994429,1.0,2/14,14.72%,NPY;NMU
prerank,telomeric DNA binding (GO:0042162),0.19551354762641987,0.543119764391879,0.9817073170731707,0.9929025933944058,1.0,4/32,8.13%,RPA1;HNRNPA2B1;TERF1;PIF1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.1791286913984742,0.5052218350345393,0.9887459807073955,1.0,1.0,10/29,26.73%,ENGASE;PGGHG;GUSB;IDUA;NEU3;GANAB;CTBS;GLA;PARG;MGAM
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.22250837081741948,0.5007564375311043,0.964221824686941,0.9993947194328157,1.0,2/10,16.78%,CYBA;NOX1
prerank,glutathione transferase activity (GO:0004364),0.18791000536980673,0.4970698684793425,0.9885807504078303,0.9977159706170778,1.0,2/23,8.14%,GSTA3;PTGES
prerank,peptide hormone receptor binding (GO:0051428),-0.2033145182917343,-0.4929634751751364,0.9864559819413092,0.9920777599573387,1.0,3/11,27.69%,PTHLH;GNRH1;CCK
prerank,U6 snRNA binding (GO:0017070),0.20715810977258242,0.4852465140708054,0.9913793103448276,0.9975348101127302,1.0,6/14,28.32%,LSM4;PRPF8;DDX39B;LSM3;TUT1;EIF5A
prerank,O-acyltransferase activity (GO:0008374),0.17188884460685827,0.4837109294925976,0.9924012158054711,0.995455981240179,1.0,4/30,14.42%,PRDX6;SOAT2;MBOAT7;GPAT3
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.19464518020042454,0.4720175335061827,0.9898132427843803,0.9949193251842644,1.0,3/14,17.56%,CYBA;NOX1;KMO
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.17389584884282533,0.4698248977183122,0.9914383561643836,0.9928473016152201,1.0,6/24,20.03%,ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
